0001829794 true --12-31 2023 Q3 This amendment (Form 10-Q/A) is being provided for the sole purpose of providing a conformed signature on Exhibit 32.1 inadvertently omitted from our Form 10-Q for the period ended September 30, 2023, as filed on November 1, 2023. No other changes have been made to the Form 10-Q. 0001829794 2023-01-01 2023-09-30 0001829794 2023-10-30 0001829794 2023-09-30 0001829794 2022-12-31 0001829794 2023-07-01 2023-09-30 0001829794 2022-07-01 2022-09-30 0001829794 2022-01-01 2022-09-30 0001829794 us-gaap:CommonStockMember 2022-12-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001829794 us-gaap:RetainedEarningsMember 2022-12-31 0001829794 us-gaap:CommonStockMember 2021-12-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001829794 us-gaap:RetainedEarningsMember 2021-12-31 0001829794 2021-12-31 0001829794 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001829794 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001829794 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001829794 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001829794 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001829794 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001829794 us-gaap:CommonStockMember 2023-09-30 0001829794 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001829794 us-gaap:RetainedEarningsMember 2023-09-30 0001829794 us-gaap:CommonStockMember 2022-09-30 0001829794 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001829794 us-gaap:RetainedEarningsMember 2022-09-30 0001829794 2022-09-30 0001829794 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001829794 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001829794 VLCN:WarrantsConvertibleNoteMember 2022-01-01 2022-09-30 0001829794 VLCN:ConvertibleNotesAndWarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:ConvertibleNotesMember 2022-01-01 2022-09-30 0001829794 VLCN:ConvertibleNotesAndWarrantsMember 2022-08-01 2022-08-31 0001829794 VLCN:AdditionalConvertibleNotesMember 2023-01-01 2023-09-30 0001829794 2023-05-01 2023-05-31 0001829794 2023-05-31 0001829794 2023-09-17 2023-09-18 0001829794 2023-09-18 0001829794 2023-09-29 2023-10-30 0001829794 2023-10-12 2023-10-13 0001829794 us-gaap:MachineryAndEquipmentMember 2023-01-01 2023-09-30 0001829794 us-gaap:VehiclesMember 2023-01-01 2023-09-30 0001829794 VLCN:InternalUseManufacturedVehiclesMember 2023-01-01 2023-09-30 0001829794 us-gaap:FurnitureAndFixturesMember 2023-01-01 2023-09-30 0001829794 us-gaap:ComputerEquipmentMember 2023-01-01 2023-09-30 0001829794 2023-06-01 2023-06-30 0001829794 us-gaap:MachineryAndEquipmentMember 2023-09-30 0001829794 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001829794 us-gaap:VehiclesMember 2023-09-30 0001829794 us-gaap:VehiclesMember 2022-12-31 0001829794 VLCN:InternalUseManufacturedVehiclesMember 2023-09-30 0001829794 VLCN:InternalUseManufacturedVehiclesMember 2022-12-31 0001829794 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001829794 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001829794 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001829794 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001829794 us-gaap:ComputerEquipmentMember 2023-09-30 0001829794 us-gaap:ComputerEquipmentMember 2022-12-31 0001829794 VLCN:VehicleFinancingMember 2020-12-31 0001829794 VLCN:VehicleFinancingMember 2020-12-01 2020-12-31 0001829794 VLCN:VehicleFinancing1Member 2021-04-30 0001829794 VLCN:VehicleFinancing1Member 2021-04-01 2021-04-30 0001829794 VLCN:FinancingArrangementMember us-gaap:VehiclesMember 2023-03-31 0001829794 VLCN:FinancingArrangementMember us-gaap:VehiclesMember srt:MaximumMember 2023-03-01 2023-03-31 0001829794 VLCN:FinancingArrangementMember us-gaap:VehiclesMember srt:MinimumMember 2023-03-01 2023-03-31 0001829794 VLCN:FinancingArrangementMember us-gaap:VehiclesMember 2023-03-01 2023-03-31 0001829794 VLCN:SeniorConvertibleNotesMember 2022-08-24 0001829794 VLCN:SeniorConvertibleNotesMember 2022-08-23 2022-08-24 0001829794 2022-08-24 0001829794 VLCN:NoteWarrantsMember 2022-08-24 0001829794 VLCN:NoteWarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:ConvertibleNotesMember 2022-08-23 2022-08-24 0001829794 VLCN:ConvertibleNotesMember VLCN:NoteWarrantsMember 2022-08-23 2022-08-24 0001829794 VLCN:ConvertibleNotesMember 2022-08-24 0001829794 VLCN:ConvertibleNotesMember VLCN:NoteWarrantsMember 2022-08-24 0001829794 VLCN:ConvertibleNotesMember 2023-07-01 2023-09-30 0001829794 VLCN:ConvertibleNotesMember 2023-01-01 2023-09-30 0001829794 VLCN:SeniorConvertibleNewNotesMember 2023-05-24 0001829794 VLCN:SeniorConvertibleNewNotesMember 2023-05-23 2023-05-24 0001829794 VLCN:NewWarrantsMember 2023-05-24 0001829794 VLCN:SeriesANotesMember 2023-05-24 0001829794 VLCN:SeriesANotesMember 2023-05-23 2023-05-24 0001829794 VLCN:SeriesBNotesMember 2023-05-24 0001829794 VLCN:SeriesBNotesMember 2023-05-23 2023-05-24 0001829794 us-gaap:SubsequentEventMember 2023-10-31 0001829794 us-gaap:IPOMember 2023-05-23 2023-05-24 0001829794 us-gaap:IPOMember 2023-05-24 0001829794 VLCN:May2023NotesMember 2023-05-24 0001829794 VLCN:May2023NotesMember 2023-05-23 2023-05-24 0001829794 2022-08-31 0001829794 2022-08-30 2022-08-31 0001829794 VLCN:NewWarrantsAndExchangeWarrantsMember 2023-05-24 0001829794 VLCN:NewWarrantsAndExchangeWarrantsMember 2023-09-30 0001829794 us-gaap:IPOMember 2023-01-01 2023-09-30 0001829794 us-gaap:IPOMember 2023-09-30 0001829794 VLCN:WarrantInducementAgreementMember 2023-09-30 0001829794 VLCN:ReloadWarrantsMember 2023-09-30 0001829794 VLCN:ReloadWarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:NewNotesAndExchangeNotesMember 2023-09-30 0001829794 VLCN:May2023NotesMember 2023-07-01 2023-09-30 0001829794 VLCN:May2023NotesMember 2023-01-01 2023-09-30 0001829794 VLCN:NewNotesAndNewWarrantsMember 2023-09-30 0001829794 VLCN:NewNotesMember 2023-07-01 2023-09-30 0001829794 VLCN:NewNotesMember 2023-01-01 2023-09-30 0001829794 VLCN:NewNotesMember 2023-09-30 0001829794 VLCN:SeriesAExchangeNotesMember 2023-09-30 0001829794 VLCN:SeriesBExchangeNotesMember 2023-09-30 0001829794 VLCN:TotalMay2023NotesMember 2023-09-30 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2023-05-23 2023-05-24 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2023-08-02 2023-08-03 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-05-23 2023-05-24 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-08-02 2023-08-03 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputConversionPriceMember 2023-05-23 2023-05-24 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputConversionPriceMember 2023-08-02 2023-08-03 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputExpectedTermMember 2023-05-23 2023-05-24 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputExpectedTermMember 2023-08-02 2023-08-03 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-05-23 2023-05-24 0001829794 VLCN:ConversionFeatureLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-08-02 2023-08-03 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2023-05-23 2023-05-24 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2023-08-02 2023-08-03 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-05-23 2023-05-24 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-08-02 2023-08-03 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputConversionPriceMember 2023-05-23 2023-05-24 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputConversionPriceMember 2023-08-02 2023-08-03 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputExpectedTermMember 2023-05-23 2023-05-24 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputExpectedTermMember 2023-08-02 2023-08-03 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-05-23 2023-05-24 0001829794 VLCN:WarrantLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-08-02 2023-08-03 0001829794 VLCN:ConversionFeatureNewNotesMember 2023-05-24 0001829794 VLCN:ConversionFeatureNewNotesMember 2023-08-03 0001829794 VLCN:ConversionFeatureSeriesAExchangeNotesMember 2023-05-24 0001829794 VLCN:ConversionFeatureSeriesAExchangeNotesMember 2023-08-03 0001829794 VLCN:ConversionFeatureSeriesBExchangeNotesMember 2023-05-24 0001829794 VLCN:ConversionFeatureSeriesBExchangeNotesMember 2023-08-03 0001829794 VLCN:NewWarrantsMember 2023-05-24 0001829794 VLCN:NewWarrantsMember 2023-08-03 0001829794 VLCN:ExchangeWarrantsMember 2023-05-24 0001829794 VLCN:ExchangeWarrantsMember 2023-08-03 0001829794 2023-05-24 0001829794 2023-08-03 0001829794 VLCN:May2023NotesMember 2023-08-01 2023-08-03 0001829794 VLCN:May2023WarrantsMember 2023-08-01 2023-08-03 0001829794 VLCN:May2023WarrantsMember 2023-07-01 2023-09-30 0001829794 VLCN:May2023WarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:May2023NotesAndMay2023WarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:PinkPossumMember 2023-01-01 2023-09-30 0001829794 2022-01-01 2022-12-31 0001829794 VLCN:PinkPossumMember 2021-03-22 2021-03-26 0001829794 VLCN:HighbridgeMember 2021-03-22 2021-03-25 0001829794 VLCN:PinkPossumMember 2021-03-26 0001829794 VLCN:HighbridgeMember 2021-03-25 0001829794 VLCN:HighbridgeMember 2021-12-19 2021-12-20 0001829794 us-gaap:CommonStockMember 2023-06-14 0001829794 us-gaap:PreferredStockMember 2023-06-14 0001829794 us-gaap:CommonStockMember 2022-01-30 2022-02-01 0001829794 us-gaap:CommonStockMember 2022-02-01 0001829794 us-gaap:CommonStockMember 2023-05-23 2023-05-24 0001829794 us-gaap:CommonStockMember 2023-05-24 0001829794 us-gaap:CommonStockMember 2023-09-17 2023-09-18 0001829794 us-gaap:CommonStockMember 2023-09-18 0001829794 VLCN:ReservedForConversionOfNotesAndExerciseOfWarrantsMember VLCN:May2023WarrantsMember 2023-09-30 0001829794 VLCN:NoteWarrantsMember 2022-08-24 0001829794 VLCN:NoteWarrantsMember VLCN:PlacementAgentMember 2022-08-24 0001829794 us-gaap:WarrantMember 2023-05-31 0001829794 us-gaap:WarrantMember 2023-05-01 2023-05-31 0001829794 VLCN:CommonStockWarrantsMember 2023-01-01 2023-09-30 0001829794 VLCN:CommonStockWarrantsMember 2023-07-01 2023-09-30 0001829794 VLCN:CommonStockWarrantsMember 2022-07-01 2022-09-30 0001829794 VLCN:CommonStockWarrantsMember 2022-01-01 2022-09-30 0001829794 VLCN:CommonStockWarrantsMember 2022-12-31 0001829794 VLCN:CommonStockWarrantsMember 2023-09-30 0001829794 VLCN:Volcon2021PlanMember 2021-01-31 0001829794 VLCN:Volcon2021PlanMember 2022-07-26 0001829794 VLCN:Volcon2021PlanMember 2023-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2022-05-14 2022-05-15 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001829794 VLCN:PerformanceBasedSharesMember 2022-02-28 2022-03-01 0001829794 VLCN:PerformanceBasedSharesMember VLCN:Volcon2021PlanMember 2021-12-31 0001829794 VLCN:Volcon2021PlanMember VLCN:PerformanceMilestonesFor2022Member 2022-12-31 0001829794 VLCN:Volcon2021PlanMember VLCN:PerformanceMilestonesFor2022Member 2023-02-05 2023-02-06 0001829794 VLCN:Volcon2021PlanMember VLCN:PerformanceMilestonesFor2022Member 2023-01-01 2023-03-31 0001829794 VLCN:Volcon2021PlanMember VLCN:PerformanceMilestonesFor2023Member 2023-09-30 0001829794 us-gaap:StockOptionMember 2023-07-01 2023-09-30 0001829794 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001829794 us-gaap:StockOptionMember 2022-07-01 2022-09-30 0001829794 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001829794 us-gaap:StockOptionMember 2023-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001829794 us-gaap:StockOptionMember 2022-12-31 0001829794 VLCN:CostOfGoodsSoldMember 2023-07-01 2023-09-30 0001829794 VLCN:CostOfGoodsSoldMember 2022-07-01 2022-09-30 0001829794 VLCN:CostOfGoodsSoldMember 2023-01-01 2023-09-30 0001829794 VLCN:CostOfGoodsSoldMember 2022-01-01 2022-09-30 0001829794 VLCN:SalesAndMarketingMember 2023-07-01 2023-09-30 0001829794 VLCN:SalesAndMarketingMember 2022-07-01 2022-09-30 0001829794 VLCN:SalesAndMarketingMember 2023-01-01 2023-09-30 0001829794 VLCN:SalesAndMarketingMember 2022-01-01 2022-09-30 0001829794 VLCN:ProductDevelopmentMember 2023-07-01 2023-09-30 0001829794 VLCN:ProductDevelopmentMember 2022-07-01 2022-09-30 0001829794 VLCN:ProductDevelopmentMember 2023-01-01 2023-09-30 0001829794 VLCN:ProductDevelopmentMember 2022-01-01 2022-09-30 0001829794 VLCN:GeneralAndAdministrativeMember 2023-07-01 2023-09-30 0001829794 VLCN:GeneralAndAdministrativeMember 2022-07-01 2022-09-30 0001829794 VLCN:GeneralAndAdministrativeMember 2023-01-01 2023-09-30 0001829794 VLCN:GeneralAndAdministrativeMember 2022-01-01 2022-09-30 0001829794 VLCN:ConvertibleNotesMember 2023-01-01 2023-09-30 0001829794 VLCN:ConvertibleNotesMember 2022-01-01 2022-09-30 0001829794 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001829794 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001829794 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001829794 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001829794 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to__________

 

Commission file number: 001-40867

 

Volcon, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   84-4882689

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

3121 Eagles Nest Street, Suite 120, Round Rock, TX   78665
(Address of Principal Executive Offices)   (Zip Code)

 

(512) 400-4271

(Registrant's Telephone Number, Including Area Code)

 

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock VLCN The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐
Non-Accelerated Filer Smaller Reporting Company
  Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

 

The registrant had 6,819,278 shares of common stock outstanding at October 30, 2023.

 

 

   

 

 

 

EXPLANATORY NOTE

 

This amendment (Form 10-Q/A) is being provided for the sole purpose of providing a conformed signature on Exhibit 32.1 inadvertently omitted from our Form 10-Q for the period ended September 30, 2023, as filed on November 1, 2023. No other changes have been made to the Form 10-Q.

 

 

 

 

 

   

 

 

 

TABLE OF CONTENTS

 

    Page
PART I — FINANCIAL INFORMATION  
     
Item 1. Financial Statements 3
  Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 (unaudited) 3
  Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 (unaudited) 4
  Consolidated Statements of Stockholders Equity for the Nine Months Ended September 30, 2023 and 2022 (unaudited) 5
  Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 (unaudited) 7
  Notes to the Financial Statements (unaudited) 8
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 32
Item 3. Quantitative and Qualitative Disclosures About Market Risk 41
Item 4. Controls and Procedures 42
     
PART II — OTHER INFORMATION  
     
Item 1. Legal Proceedings 43
Item 1A. Risk Factors 43
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46
Item 3. Defaults Upon Senior Securities 46
Item 4. Mine Safety Disclosures 46
Item 5. Other Information 46
Item 6. Exhibits 46
Signatures 48

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

VOLCON, INC.

CONSOLIDATED BALANCE SHEETS
(Unaudited)

         
  

September 30,

2023

   December 31,
2022
 
         
ASSETS          
Current assets:          
Cash  $2,425,820   $10,986,592 
Restricted cash   551,250    551,250 
Accounts receivable, net of allowance for doubtful accounts of $118,689 and $62,451 at September 30, 2023 and December 31, 2022, respectively   206,447    864,957 
Inventory   7,051,537    5,645,883 
Inventory deposits   406,743    427,662 
Prepaid expenses and other current assets   2,807,355    1,850,666 
Total current assets   13,449,152    20,327,010 
Long term assets:          
Property and equipment, net   1,264,166    601,766 
Intangible assets, net   1,453    5,813 
Other long-term assets   199,281    285,037 
Right-of-use assets - operating leases   1,231,092    1,505,987 
TOTAL ASSETS  $16,145,144   $22,725,613 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities:          
Accounts payable  $3,470,898   $1,036,628 
Accrued liabilities   1,809,092    2,045,239 
Exercised Warrants - Shares to be issued   537,250     
Accrued Purchase commitments       28,600 
Current portion of notes payable   14,910    18,670 
Convertible notes, net of issuance costs   29,709,960    17,353,748 
Right-of-use operating lease liabilities, short-term   423,849    391,117 
Customer deposits   201,005    23,471 
Total current liabilities   36,166,964    20,897,472 
Notes payable, net of current portion   73,099    50,116 
Right-of-use operating lease liabilities, long-term   845,117    1,143,011 
Total liabilities   37,085,180    22,090,599 
           
COMMITMENTS AND CONTINGENCIES        
           
Stockholders' (deficit) equity:          
Preferred stock: $0.00001 par value, 5,000,000 shares authorized, no shares outstanding        
Common stock: $0.00001 par value, 250,000,000 shares authorized, 6,403,166 shares issued and outstanding at September 30, 2023 and 100,000,000 shares authorized, 4,885,252 shares issued and outstanding as of December 31, 2022   63    48 
Additional paid-in capital   96,450,387    76,369,892 
Accumulated deficit   (117,390,486)   (75,734,927)
Total stockholders’ (deficit) equity   (20,940,036)   635,013 
           
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY  $16,145,144   $22,725,613 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 3 

 

 

VOLCON, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023, AND 2022
(Unaudited)

                 
   Three Months
Ended
   Nine Months
Ended
 
  

September 30,

2023

  

September 30,

2022

  

September 30,

2023

  

September 30,

2022

 
                 
Revenue  $487,430   $242,710   $2,177,188   $3,795,065 
Cost of goods sold   (3,542,468)   (2,012,829)   (5,107,096)   (11,549,871)
Gross margin   (3,055,038)   (1,770,119)   (2,929,908)   (7,754,806)
                     
Operating expenses:                    
Sales and marketing   1,870,532    1,282,014    6,040,519    3,942,827 
Product development   2,983,197    2,177,347    5,936,280    6,775,768 
General and administrative expenses   1,544,344    2,085,211    5,003,135    7,409,601 
Total operating expenses   6,398,073    5,544,572    16,979,934    18,128,196 
                     
Loss from operations   (9,453,111)   (7,314,691)   (19,909,842)   (25,883,002)
                     
Other income (expense)   (54,702)   33,814    (38,199)   72,800 
Loss on extinguishment of Convertible Notes           (22,296,988)    
Gain (loss) on change in fair value of financial liabilities   (684,994)       5,107,794     
Interest expense   (1,135,089)   (618,307)   (4,518,324)   (627,789)
Total other expense   (1,874,785)   (584,493)   (21,745,717)   (554,989)
                     
Loss before provision for income taxes   (11,327,896)   (7,899,184)   (41,655,559)   (26,437,991)
Provision for income taxes                
                     
Net loss  $(11,327,896)  $(7,899,184)  $(41,655,559)  $(26,437,991)
                     
Net loss per common share – basic  $(1.84)  $(1.62)  $(7.57)  $(5.64)
Net loss per common share – diluted  $(1.84)  $(1.62)  $(7.57)  $(5.64)
                     
Weighted average common shares outstanding – basic   6,162,589    4,869,044    5,502,512    4,690,805 
Weighted average common shares outstanding – diluted   6,162,589    4,869,044    5,502,512    4,690,805 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 4 

 

 

VOLCON, INC.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023
(Unaudited)

 

                     
   Common stock   Additional         
   Number       paid-in   Accumulated     
   of Shares   Amount   capital   deficit   Total 
                     
Balance at January 1, 2023   4,885,252   $48   $76,369,892   $(75,734,927)  $635,013 
                          
Issuance of common stock for exercise of stock options and vesting of restricted stock   10,000        25,000        25,000 
                          
Issuance of common stock for public offerings, net of issuance costs of $629,900   1,480,000    15    4,570,085        4,570,100 
                          
Stock-based compensation   27,772        2,223,356        2,223,356 
                          
Reclassification of derivative liabilities to equity           13,262,055        13,262,055 
                          
Shares issued for rounding due to reverse stock split   142                 
                          
Net loss               (41,655,559)   (41,655,559)
                          
Balance at September 30, 2023   6,403,166   $63   $96,450,387   $(117,390,486)  $(20,940,036)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 5 

 

 

VOLCON, INC.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022

(Unaudited)

 

    Common stock    Additional           
    Number of         

paid-in

    Accumulated      
    Shares    Amount    capital    Deficit    Total 
                          
Balance at January 1, 2022   3,461,837   $35   $47,803,736   $(41,499,522)  $6,304,249 
                          
Issuance of common stock for public offering, net of issuance costs of $1,910,816   1,333,334    13    18,089,171        18,089,184 
                          
Issuance of common stock for cashless exercise of warrants   16,711                 
                          
Issuance of common stock for exercise of stock options and restricted stock   48,022        40,000        40,000 
                          
Stock-based compensation   10,925        2,642,139        2,642,139 
                          
Forfeiture of performance shares   (576)                
                          
Issuance of Note Warrants and underwriter warrants, net of issuance costs of $1,003,513           7,177,976         7,177,976 
                          
Net loss               (26,437,991)   (26,437,991)
                          
Balance at September 30, 2022   4,870,253   $48   $75,753,022   $(67,937,513)  $7,815,557 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 6 

 

 

VOLCON, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(Unaudited)

 

         
   September 30,   September 30, 
   2023   2022 
Cash flow from operating activities:          
Net loss  $(41,655,559)  $(26,437,991)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss on extinguishment of convertible notes   22,296,988     
Gain on change in fair value of financial liabilities   (5,107,794)    
Stock-based compensation   2,223,356    2,642,139 
Loss on write down of inventory and inventory deposits   1,786,365    1,650,838 
Loss on lease terminations   85,756    395,138 
(Gain) loss on sale/write off of property & equipment   (6,423)   250,369 
Bad debt expense   66,990     
Write off of intangible assets       6,427 
Non-cash interest expense   4,516,041    614,366 
Amortization of right-of-use assets   274,895    342,112 
Depreciation and amortization   173,803    574,117 
Changes in operating assets and liabilities:          
Accounts receivable   591,520    (1,541,983)
Inventory   (3,192,019)   (1,463,778)
Inventory deposits   20,919    1,061,846 
Prepaid assets and other current assets   (956,689)   289,387 
Other assets       (29,120)
Accounts payable   2,434,270    (978,962)
Accrued liabilities   (264,747)   293,626 
Right-of-use liabilities - operating leases   (265,161)   (269,836)
Customer deposits   177,534    (2,218,856)
Net cash provided by (used in) operating activities   (16,799,955)   (24,820,161)
Cash flow from investing activities:          
Purchase of property and equipment   (818,399)   (620,290)
Proceeds from sale of vehicles   89,000     
Net cash used by investing activities   (729,399)   (620,290)
Cash flow from financing activities:          
Repayment of notes payable   (76,801)   (12,768)
Proceeds from issuance of common stock from public offerings, net if issuance costs of $629,900   4,570,100     
Proceeds from issuance of convertible notes and warrants, net of issuance costs of $586,968   3,913,033     
Proceeds from exercise of warrants   537,250      
Proceeds from issuance of common stock from public offering, net of issuance costs of $1,910,816       18,089,184 
Proceeds from issuance of convertible notes, net of issuance costs of $2,312,895       15,122,345 
Proceeds from issuance of warrants to convertible note holders, net of issuance costs of $1,003,513       7,177,976 
Proceeds from exercise of stock options   25,000    40,000 
Net cash provided by financing activities   8,968,582    40,416,737 
           
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH  $(8,560,772)  $14,976,286 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD   11,537,842    5,572,199 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD  $2,977,070   $20,548,485 

 

SUPPLEMENTAL CASH FLOW INFORMATION

         
   2023   2022 
Supplemental disclosure of cash flow information:          
Cash paid for interest  $6,474   $4,401 
Cash paid for income taxes  $   $ 
           
Non-cash transactions          
Recognition of initial right-of-use asset - operating lease  $   $1,128,609 
Acquisition of property and equipment with note payable  $96,024   $ 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 7 

 

 

VOLCON, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

 

 

NOTE 1 – ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN

 

Organization and Nature of Operations

 

Volcon, Inc. (“Volcon” or the “Company”) was formed on February 21, 2020, as a Delaware corporation, under the name Frog ePowersports, Inc. The Company was renamed Volcon, Inc. on October 1, 2020. Volcon designs and sells all-electric off-road powersport vehicles.

 

On January 5, 2021, the Company created Volcon ePowersports, LLC (“Volcon LLC ''), a Colorado wholly-owned subsidiary of the Company, to sell Volcon vehicles and accessories in the United States. Volcon LLC is no longer used for selling vehicles and accessories.

 

Going Concern

 

The accompanying interim consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has recurring losses and has generated negative cash flows from operations since inception.

 

In August 2022, the Company ceased manufacturing the Grunt motorcycle in Round Rock, Texas and has outsourced all manufacturing of its vehicles to third-parties. Further, the Company has, or plans to, outsource the manufacturing of all its future vehicles to third-parties for the foreseeable future. The Company has also outsourced certain design and prototype services of its vehicles to third-parties. In September 2022, management reduced headcount and employee related costs in its product development and administrative departments to reduce operating costs.

 

Also in August 2022, the Company received net proceeds of approximately $22.3 million for the issuance of convertible notes due February 2024 (“Convertible Notes”) and warrants (see Note 6).

 

The Company received net proceeds of approximately $3.9 million for the issuance of additional convertible notes in May 2023 due February 2024 (“New Notes”) and warrants. On the issuance date of the New Notes, the Company exchanged the Convertible Notes for Series A and Series B notes (collectively the “Exchange Notes). The Exchange Notes require the Company to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the Exchange Notes is $15,000,000 or greater as of December 31, 2023 (the September 30, 2023 requirement under the Convertible Notes was removed). The cash on deposit requirement is reduced dollar for dollar to the extent the outstanding principal (and interest, if any) of the Exchange Notes is less than $15 million on this date. The Company also exchanged the warrants issued with the Convertible Notes for new warrants (the “Exchange Warrants”) (see Note 6 for further discussion).

 

On September 14, 2023, the holders of the New Notes and Exchange Notes (collectively the “May 2023 Notes”) entered into an agreement to modify the terms to extend the due date to January 31, 2025. In addition, the requirement to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the Exchange Notes is $15 million or greater as of December 31, 2023 was amended to reduce the unrestricted and unencumbered cash on deposit to $5 million if the outstanding principal (and interest, if an) of the Exchange Notes is $15 million or greater as of June 30, 2024. The cash on deposit requirement is reduced dollar for dollar to the extent the outstanding principal (and interest, if any) of the Exchange Notes is less than $15 million on this date. In addition, the Company must sell 250 units of its Stag UTV by December 31, 2023. The Company may factor up to $10 million of its accounts receivables provided the factoring lender executed a subordination and intercreditor agreement on terms acceptable to the holders of the May 2023 Notes, which was completed on October 17, 2023. The Company was also required to perfect a security interest in the assets of the Company no later than September 22, 2023, which the Company has completed.

 

 

 

 8 

 

 

In May 2023, the Company received net proceeds of approximately $4.0 million for the issuance of 1,200,000 shares of common stock at $3.75 per share.

 

On September 18, 2023, the Company received net proceeds of approximately $571,400 for the issuance of 280,000 shares of common stock at $2.50 per share.

 

In a series of warrant inducement transactions from September 29, 2023 to October 30, 2023, as more fully discussed below, the Company raised $1,027,495.

 

Management anticipates that our cash on hand as of September 30, 2023 plus, the cash received from the warrant inducements, and cash expected to be generated from operations will not be sufficient to fund planned operations and maintain required cash balances for the Exchange Notes beyond one year from the date of the issuance of the financial statements as of and for the three and nine months ended September 30, 2023. There can be no assurance that additional funding, if needed, would be available to the Company on acceptable terms, or at all. These factors raise substantial doubt regarding our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that may result should the Company be unable to continue as a going concern.

 

Nasdaq Compliance


On July 5, 2023, the Company received a notice from Nasdaq that it was not in compliance with Nasdaq’s Listing Rule 5550(b)(2), which requires that it maintain a market value of listed securities (“MVLS”) of $35 million. MVLS is calculated by multiplying the Company’s shares outstanding by the closing price of its common stock. On July 6, 2023, the Company received a notice from Nasdaq that it was not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of its common stock had been below $1.00 per share for 30 consecutive business days. On October 30, 2023, the Company received a notice from Nasdaq that it has now regained compliance with Rule 5550(a)(2), as the minimum bid price of its common stock was above $1.00 for 10 consecutive business days.

 

The Company has until January 2, 2024, to regain compliance with the MVLS requirement. To regain compliance with the MVLS requirement, the Company’s MVLS must close at $35 million or more for a minimum of ten consecutive business days during this grace period. While the Company may be able to qualify for additional time to attempt to regain compliance, there can be no assurance that it will qualify for additional time to regain compliance, or that it will regain compliance with or without such additional time. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting.

Impact of Russia and Ukraine Conflict


On February 24, 2022, Russia invaded Ukraine. The conflict between Russia and Ukraine could impact the availability of nickel, an element used in the production of lithium ion cells used in batteries that power our vehicles. The shortage of these cells could have an impact on our ability to produce vehicles to meet our customers’ demands. In addition, sanctions against Russia could impact the price of elements, including nickel, that are used in the production of batteries which would result in higher costs to produce our vehicles. These sanctions have also impacted the U.S. and global economies and could result in an economic recession which could cause a broader disruption to the Company’s supply chain and distribution network and customer demand for our products.

 

Impact of the United Auto Workers Union Strike

 

On September 15, 2023, the United Auto Workers Union went on strike. This strike could cause a disruption to the Company’s supply chain, specifically General Motors’ ability to supply batteries and drive train components used in the Stag UTV. Shortages of these components could have an impact on our ability to produce vehicles to meet our customers’ demands.

 

 

 

 9 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Interim Unaudited Financial Information

 

The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (“SEC”) on March 7, 2023. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted from this report on Form 10-Q pursuant to the rules and regulations of the SEC.

 

Results for the interim periods in this report are not necessarily indicative of future financial results and have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary to present fairly our interim consolidated financial statements as of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022. These adjustments are of a normal recurring nature and consistent with the adjustments recorded to prepare the annual audited consolidated financial statements as of December 31, 2022.

 

Basis of Presentation

 

As discussed in Note 14, the Company completed a reverse 1 for 5 stock split on October 13, 2023, all share and per share amounts have been adjusted to reflect the impact of this reverse stock split.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts, transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of any contingent assets and liabilities as of the dates of the financial statements and the reported amounts of expenses during the reporting periods.

 

Making estimates requires management to exercise judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ significantly from those estimates.

  

Cash, Cash Equivalents and Restricted Cash

 

Cash and cash equivalents include short-term investments with original maturities of 90 days or less at the date of purchase. The recorded value of our cash and cash equivalents approximates their fair value. There were no cash equivalents as of September 30, 2023 or December 31, 2022. Restricted cash includes cash restricted as collateral for the Company’s corporate credit cards and a letter of credit with the Company’s bank.

 

 

 

 10 

 

 

Revenue Recognition

 

For sales of the Grunt motorcycle directly to consumers, revenue was recognized when the Company transferred control of the product to the consumer and the 14-day acceptance period had expired, or earlier acceptance had been received from the consumer. Sales directly to consumers were completed as of June 1, 2022. Beginning in February 2023 the Company began selling the Brat E-Bike and Volcon Youth motorcycles directly to consumers in addition to dealers, revenue for direct to consumer sales is recognized when transfer of control of the product is made to the consumer.
 

For sales to dealers or distributors revenue is recognized when transfer of control of the product is made as there is no acceptance period or right of return. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring control of vehicles, parts, and accessories. Consideration that is received in advance of the transfer of goods is recorded as customer deposits until delivery has occurred or the customer cancels their order, and the consideration is returned to the customer. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s sales do not presently have a financing component.

 

Sales promotions and incentives. The Company provides for estimated sales promotions and incentives, which are recognized as a component of sales in measuring the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Examples of sales promotion and incentive programs include rebates, distributor fees, dealer co-op advertising and volume incentives. Sales promotions and incentives are estimated based on contractual requirements. The Company records these amounts as a liability in the balance sheet until they are ultimately paid. Adjustments to sales promotions and incentives accruals are made as actual usage becomes known to properly estimate the amounts necessary to generate consumer demand based on market conditions as of the balance sheet date.

 

Shipping and handling charges and costs. The Company records shipping and handling amounts charged to the customer and related shipping costs as a component of cost of goods sold when control has transferred to the customer.

 

Product Warranties

 

The Company provides a one-year warranty on vehicles, and a two-year warranty on the battery pack. The Company accrues warranty reserves at the time revenue is recognized. Warranty reserves include the Company’s best estimate of the projected cost to repair or to replace any items under warranty, based on actual warranty experience as it becomes available and other known factors that may impact the evaluation of historical data. The Company reviews its reserves quarterly to ensure that the accruals are adequate to meet expected future warranty obligations and will adjust estimates as needed. Factors that could have an impact on the warranty reserve include the following: changes in manufacturing quality, shifts in product mix, changes in warranty coverage periods, product recalls and changes in sales volume. Warranty expense is recorded as a component of cost of goods sold in the statement of operations and is recognized as a current liability.

  

Inventory and Inventory Deposits

 

Inventories and prepaid inventory deposits are stated at the lower of cost (first-in, first-out method) or net realizable value.

 

Certain vendors require the Company to pay an upfront deposit before they will manufacture and ship the Company’s parts or accessories. These payments are classified as prepaid inventory deposits on the balance sheet until title and risk of loss transfers to the Company, at which time they are classified as inventory.

 

Raw materials inventory costs include the cost of parts, including duties, tariffs, and shipping. Work-in-process and finished goods include the cost of parts, labor and manufacturing overhead costs associated with the assembly of the vehicle. Finished goods also include accessories for the vehicle and branded merchandise such as hats and shirts.

 

Through August 2022 the Company assembled the Grunt motorcycle in a leased facility. The Company ceased assembly operations at the end of August and outsourced the assembly of the Grunt to a third-party. In May 2023, the Company transferred substantially all of its raw materials and work-in-process inventory for the Grunt to the third-party manufacturer. Title to the inventory transferred to the third-party manufacturer and it will provide the Company with a credit towards future purchases of finished goods once it begins production of the Grunt EVO.
 

 

 

 11 

 

 

Property and Equipment

 

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

   
Category   Estimated
Useful Lives
Machinery, tooling and equipment   3-7 years
Vehicles   5 years
Internal use manufactured vehicles   1 year
Furniture & Fixtures   5 years
Computers   3 years

 

Leasehold improvements are depreciated over the shorter period of their estimated useful life or term of the lease.

 

Intangible Assets


Intangible assets include acquired domain names and software. Domain names are amortized over 15 years and software is amortized over the life of the shorter of the software term or three years.

 

Long-Lived Assets

 

The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the historical carrying cost value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to the carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset.

 

Leases

 

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expenses for these leases on a straight-line basis over the lease term. The Company does not separate non-lease components from the lease components to which they relate, and instead accounts for each separate lease and non-lease component associated with that lease component as a single lease component.

  

ASC 842 defines initial direct costs as only the incremental costs of signing a lease. Initial direct costs related to leasing that are not incremental are expensed as general and administrative expenses in our statements of operations.

 

The Company’s operating lease agreements primarily consist of leased real estate and are included within ROU assets – operating leases and ROU lease liabilities – operating leases on the balance sheets. The Company’s lease agreements may include options to extend the lease, which are not included in minimum lease payments unless they are reasonably certain to be exercised at lease commencement. The Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

 

 

 

 12 

 

 

Research and Development Expenses

 

The Company records research and development expenses in the period in which they are incurred as a component of product development expenses.

 

Income Taxes

 

Deferred taxes are determined utilizing the “asset and liability” method, whereby deferred tax asset and liability account balances are determined based on the differences between financial reporting and the tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, when it's more likely than not that deferred tax assets will not be realized in the foreseeable future. Deferred tax liabilities and assets are classified as current or non-current based on the underlying asset or liability or if not directly related to an asset or liability based on the expected reversal dates of the specific temporary differences.

 

Fair Value of Financial Instruments

 
ASC Topic 820 Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  · Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
  · Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  · Level 3 — Inputs that are unobservable for the asset or liability.

 

The following section describes the valuation methodologies that the Company used to measure different financial instruments at fair value.

 

 

 

 13 

 

 

Debt

 

The fair value of the Company’s debt approximated the carrying value of the Company’s debt as of September 30, 2023 and December 31, 2022. Factors that the Company considered when estimating the fair value of its debt included market conditions, and term of the debt. The level of the debt would be considered as Level 2.

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

The Company accounts for derivative instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC Topic 815”), and all derivative instruments are reflected as either assets or liabilities at fair value on the consolidated balance sheets. The Company uses estimates of fair value to value its derivative instruments. Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between able and willing market participants. In general, the Company’s policy in estimating fair values is to first look at observable market prices for identical assets and liabilities in active markets, where available. When these are not available, other inputs are used to model fair value such as prices of similar instruments, yield curves, volatilities, prepayment speeds, default rates and credit spreads, relying first on observable data from active markets. Depending on the availability of observable inputs and prices, different valuation models could produce materially different fair value estimates. The values presented may not represent future fair values and may not be realizable. The Company categorizes its fair value estimates in accordance with ASC Topic 820, based on the hierarchical framework associated with the three levels or price transparency utilized in measuring financial instruments at fair value as discussed above.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e., at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Initial Measurement

 

The Company records its financial instruments classified as a liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement - Financial instruments classified as liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other expense/income. The Monte Carlo simulation is used to determine the fair value of derivatives for instruments with embedded conversion features and for free standing warrants as discussed further in Note 7.

 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash, accounts receivable, inventory, other assets, and accounts payable and accrued expenses approximate their fair value due to the short-term maturity of those items.

 

 

 

 14 

 

 

Warrant Liabilities and Convertible Liabilities

 

The fair value of the derivative liabilities is classified as Level 3 within the Company’s fair value hierarchy. Please refer to Note 7, Derivative Instruments, for further discussion of the measurement of fair value of the derivatives and their underlying assumptions.

 

Stock-Based Compensation

 

The Company has a stock-based incentive award plan for employees, consultants and directors. The Company measures stock-based compensation at the estimated fair value on the grant date and recognizes the amortization of stock-based compensation expense on a straight-line basis over the requisite service period, or when it is probable criteria will be achieved for performance-based awards. Fair value is determined based on assumptions related to the fair value of the Company common stock, stock volatility and risk-free rate of return. The Company has elected to recognize forfeitures when realized.

 

Concentration Risk

 

The Company outsources certain portions of product design and development for its vehicles to third-parties. In addition, the Company has outsourced the manufacturing of all of its vehicles to third-party manufacturers, including one manufacturer for three of its vehicles and this third-party is also performing product design and development services on these vehicles.

 

One supplier provides the battery and drivetrain components for the Company’s utility terrain vehicle, the Stag. The components are critical to the operation of the Stag.

 

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU 2016-13 effective January 1, 2023. The Company determined that the update applied to trade receivables, but that there was no material impact to the consolidated financial statements from the adoption of ASU 2016-13.

  

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

 

 

 

 15 

 

 

NOTE 3 – INVENTORY

 

Inventory consists of the following:

        
  

September 30,

2023

  

December 31,

2022

 
Raw materials  $3,561,150   $3,060,160 
Work-in-process       439,839 
Finished goods   3,490,387    2,145,884 
Total inventory  $7,051,537   $5,645,883 

 

The Company has purchase commitments for future payments due for inventory where initial deposits were paid as of September 30, 2023. The total additional payments due subsequent to September 30, 2023 are $252,548. In June 2023, the Company wrote down all remaining Torrot branded inventory in the amount of $84,000. In September 2023, the Company wrote down the Volcon co-branded Torrot youth motorcycles in the amount of $1,622,262 to reduce their cost to the estimated net realizable value.

 

NOTE 4 – LONG – LIVED ASSETS

 

Property and Equipment

 

Property and equipment consist of the following:

        
  

September 30,

2023

  

December 31,

2022

 
Machinery, tooling and equipment  $1,011,351   $352,137 
Vehicles   213,528    156,648 
Internal use manufactured vehicles   274,385    274,385 
Fixtures & furniture   90,768    50,768 
Leasehold improvements   44,663    44,663 
Computers   234,898    228,671 
    1,869,593    1,107,272 
Less: Accumulated depreciation   (605,427)   (505,506)
Total property and equipment  $1,264,166   $601,766 

 

Depreciation expense for the three and nine months ended September 30, 2023 was $65,725 and $169,443, respectively. Depreciation expense for the three and nine months ended September 30, 2022 was $265,907 and $569,757, respectively.

 

 

 

 16 

 

 

NOTE 5 – NOTES PAYABLE

 

In December 2020, the Company entered into a financing arrangement for $75,702 with an interest rate of 8.64% for a vehicle. The Company was required to make monthly payments of $1,211 over 72 months. In April 2021, the Company entered into a financing arrangement for $30,942 with an interest rate of 7.64% for a vehicle. The Company was required to make monthly payments of $753 over 48 months. The Company sold both vehicles in the three months ended March 31, 2023 and paid off these notes.

 

In March 2023, the Company entered into two financing arrangements to purchase two vehicles. The total principal of these arrangements is $96,024 with interest rates of 11.44% and 8.63% and monthly payments totaling $1,923 are due through January 2028 and $908 per month until February 2029.

 

The following table provides the maturities of notes payable as of September 30, 2023: 

    
Remainder of 2023  $5,768 
2024   23,073 
2025   23,073 
2026   23,073 
2027   23,073 
2028   12,927 
2029   1,816 
Total future payments   112,803 
Less: Interest   (24,794)
Total notes payable   88,009 
Less current portion   (14,910)
Long-term notes payable  $73,099 

 

NOTE 6 - CONVERTIBLE NOTES

 

On August 24, 2022, the Company issued senior convertible notes with an aggregate principal amount of $27,173,913 due February 24, 2024. The Convertible Notes had an initial conversion price of $11.25 per share of common stock (2,415,459 total shares if fully converted) and were issued with an original issue discount of 8.0% and did not bear interest unless an event of default occurred, upon which interest would have accrued at 10% per annum. The holders of the Convertible Notes could have converted any portion of the principal at any time during the term of the notes. The holders of the Convertible Notes also received fully vested warrants (the “Note Warrants”) to purchase 1,811,595 shares of the Company’s common stock at an initial exercise price of $14.25 per share. The conversion and warrant exercise prices were subject to adjustment if the Company declared a stock dividend, stock split or recapitalization. The Company received net cash proceeds, after issuance costs (excluding the value of the warrants issued to the placement agent as discussed below) of $22,300,321.

 

 

 

 17 

 

 

Company allocated the net proceeds received from the issuance of the Convertible Notes and Note Warrants based on the relative fair values of each resulting in net proceeds of $15,122,345 being allocated to the Convertible Notes recorded as a current liability in the balance sheet and net proceeds of $6,561,247 being allocated to the Note Warrants which was recorded in equity. The Company recorded non-cash interest expense through May 24, 2023 (see below for discussion of issuance of additional convertible notes) to accrete the allocated value of the Convertible Notes using the effective interest method and an interest rate of 39.6%. The Company incurred debt issuance costs of $3,316,409 upon issuance of the Convertible Notes, which includes $616,730 for the fair value of the warrants issued to the placement agent of the Convertible Notes as further described in Note 9. These debt issuance costs were amortized as additional interest expense through May 24, 2023. Total interest expense for the Convertible Notes for the three and nine months ended September 30, 2023 was zero and $2,913,632, respectively, prior to the recognition of the unamortized discount and issuance costs upon issuance of the additional senior convertible notes noted below. Substantially all of the assets of the Company are collateral for the Convertible Notes.

 

On May 24, 2023, the Company issued additional senior convertible notes (“New Notes'') with an aggregate principal amount of $4,934,783 due February 24, 2024 to the same investors of the Convertible Notes. The New Notes had an initial conversion price of $12.70 per share of common stock, which was subject to adjustment to $3.75 upon stockholder approval (1,315,942 total shares if fully converted at $3.75 per share, stockholder approval was received on August 3, 2023). The conversion price is also subject to further adjustment if the Company completes an equity or convertible note offering with a price below $3.75, or completes a stock split, reverse stock split or recapitalization where the lowest day’s volume weighted average price (“VWAP”) of the Company’s stock price is below $3.75 in the five days following the stock split, with a floor price of $0.22 (subject to stockholder approval, which was obtained on August 3, 2023). The conversion price is also subject to further adjustment if the Company completes an equity or convertible note offering with a price below $3.75. The New Notes were issued with an original issue discount of 8.8% and do not bear interest unless an event of default has occurred, upon which interest accrues at 10% per annum.

 

The holders of the New Notes also received fully vested warrants (the “New Warrants”) to purchase 1,086,957 shares of the Company’s common stock at an initial exercise price of $5.45 per share.

 

Concurrent with the issuance of the New Notes, the Company exchanged the Convertible Notes into two new notes, Series A Notes and Series B Notes both due February 24, 2024 (collectively the “Exchange Notes” and collectively with the New Notes the “May 2023 Notes”). The aggregate principal amount of Series A Notes is $3,690,422 and these are convertible into the Company’s common stock at an initial conversion price of $3.75 per share (984,113 total shares if fully converted). The aggregate principal amount of the Series B Notes is $23,483,491 and were initially convertible into the Company’s common stock at an initial conversion price of $5.45 per share (4,308,898 total shares if fully converted) but were subject to adjustment to $3.75 upon stockholder approval (6,262,265 total shares if fully converted at $3.75 per share), which approval was received on August 3, 2023.

 

In September 2023, the holders of the May 2023 Notes agreed to modify the due date of these notes to January 31, 2025. In October 2023, the conversion price of the Notes and exercise price of the Warrants were reduced to $1.369 per share. See discussion of further modifications below.

 

The Company completed a public offering and sold 280,000 shares of common stock at $2.50 per share. The holders of the May 2023 Notes waived their right to reduce the conversion price to the equity issuance price and agreed to reduce the conversion price to $2.75 per share (11,675,892 total shares if fully converted at $2.75 per share).


The May 2023 Notes contain certain conversion limitations, providing that no conversion may be made if, after giving effect to the conversion, the holder, together with any of its affiliates, would own in excess of 9.99% of the Company’s outstanding shares of common stock after giving effect to such conversion. The Company can force conversion of the Series A and Series B Notes at any time if the weighted average price of the Company’s common stock for ten consecutive trading days equals or exceeds $5.85 or $8.45, respectively, subject to the share limitations described above. In addition to default interest of 10% accruing on the May 2023 Notes, the holders may require the Company to redeem a portion or all of the outstanding May 2023 Notes.

 

 

 

 18 

 

 

Events of default for the May 2023 Notes are defined in the note agreements and include the following:

 

  · Failure of the Company to file a registration statement, and have declared effective to register the shares of the Company’s common stock within a specified period (the Company has met this requirement as of September 28, 2023)
  · Suspension of trading, or failure to be listed, of the Company’s common stock on an eligible market, as defined, for a period of two consecutive trading days or an aggregate of ten trading days in a 365 day period
  · Failure to deliver shares of the Company’s common stock within five days following a conversion notification
  · Failure to reserve shares of the Company’s common stock for the conversion of the May 2023 Notes and May 2023 Warrants
  · Any acceleration prior to maturity of any indebtedness of the Company, declaration of bankruptcy, or court ordered bankruptcy
  · Final judgment or judgments for payment aggregating in excess of $250,000 are rendered against the Company not covered by insurance or indemnity and are not discharged or stayed pending appeal within 60 days of judgment
  · Breach of any representation, warranty or covenant by the Company to the transaction documents of the May 2023 Notes and Exchange Warrants
  · Any material damage to, or loss, theft or destruction of a material amount of the property of the Company
  · Failure to remove any restrictive legends on any shares of the Company’s common stock issued to the holders of the May 2023 Notes
  · Electronic transfer of shares of the Company’s common stock is not available

 

As of September 30, 2023, the Company is in compliance with all covenants. The May 2023 Notes originally required the Company to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the May 2023 Notes is $15 million or greater as of December 31, 2023. The cash on deposit requirement is reduced dollar for dollar to the extent that the outstanding principal (and interest, if any) of the May 2023 Notes is less than $15 million on December 31, 2023.

In September 2023, the note holders modified this requirement to change the date from December 31, 2023 to June 30, 2024 and reduced the cash on deposit requirement to $5 million. All other provisions for this cash on deposit requirement remain unchanged. The holders also included a new requirement that the Company sell at least 250 units of its Stag utility terrain vehicle by December 31, 2023 or the Company would be in default on the Notes.

 

The Company also exchanged the 1,811,595 Note Warrants with an exercise price of $14.25 per share issued with the Convertible Notes in August 2022 for 3,411,596 warrants which had an initial exercise price of $5.45 per share (the “Exchange Warrants”), and which exercise price was adjusted to $3.75 per share upon stockholder approval, which approval was received on August 3, 2023. The Exchange Warrants expire August 24, 2027.

 

The conversion prices of the Exchange Notes, and the exercise prices of the New Warrants and Exchange Warrants (collectively the “May 2023 Warrants”) are subject to further adjustment in the event that the Company issues additional common stock, stock options, warrants or convertible notes with prices below $3.75 per share, or completes a stock split, reverse stock split or recapitalization where the lowest day’s VWAP of the Company’s stock price is below $3.75 in the five days following the stock split with a floor of $0.22 per share. As discussed above, in September 2023 the Company completed a public offering of 280,000 shares of its common stock at $2.50 per share. The exercise price of the May 2023 Warrants were reduced to $2.50 per share as a result of the public offering.


Also in September 2023, the Company and the holders of the Exchange Warrants entered into a warrant inducement agreement whereby the Exchange Warrant holders agreed to exercise 307,001 Exchange Warrants at a reduced exercise price of $1.75 per share. The Company issued the holders 307,001 warrants (“Reload Warrants”) with an exercise price of $2.50 per share. The Reload Warrants are immediately exercisable for unregistered shares of the Company’s common stock and have the same terms as the May 2023 Warrants and expire August 24, 2027. The Company recognized equity issuance costs of $216,855 for the issuance of the Reload Warrants.

 

 

 

 19 

 

 

As discussed in Note 14, the Company completed a 1 for 5 reverse stock split on October 13, 2023 and the lowest day’s VWAP in the five days following the reverse split was $1.369 per share and the conversion price of New Notes and Exchange Notes, and the exercise price of the New Warrants and Exchange Warrants were reduced to $1.369 per share effective October 20, 2023.

 

Holders of the May 2023 Notes, the May 2023 Warrants and Reload Warrants (collectively the “Holders”) do not have voting rights to the extent they have not converted their notes or exercised their warrants.  

The May 2023 Warrants and Reload Warrants contain certain conversion limitations, providing that a holder thereof may not exercise such warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such exercise. The May 2023 Warrants and Reload Warrants provide the holders the right to exercise these warrants on a non-cash basis if the Company does not have an effective registration statement for the underlying shares of common stock.


The Company has evaluated the issuance of the New Notes and Exchange Notes and related warrants and has determined that the Convertible Notes were extinguished based on the conclusion that the terms of the New Notes and Exchange Notes are substantially different from the Convertible Notes in accordance with ASC 470, Debt. In addition, the Company has recognized a loss on the extinguishment of the Convertible Notes based on the carrying value of the Convertible Notes at the transaction date, plus gross proceeds received from the issuance of New Notes and New Warrants, less the fair value of the i) New Notes and conversion option, ii) New Warrants, iii) Exchange Notes and conversion options, and iv) Exchange Warrants. The resulting loss on extinguishment was $22,296,988, which includes the unamortized issuance costs of $1,330,296 of the Convertible Notes as of the date of the issuance of the New Notes. The fair value of the May 2023 Notes were estimated based on the future cash flows discounted at an interest rate of 14.9%. The May 2023 Notes were recorded at their initial fair values as follows:

 

        
   Fair Value   Principal Amount 
New Notes  $4,410,058   $4,934,783 
Series A Exchange Notes   3,298,012    3,690,422 
Series B Exchange Notes   20,986,449    23,483,891 
Total May 2023 Notes  $28,694,519   $32,109,096 

 

The Company recognized interest expense of $958,640 and $1,364,993 in the three and nine months ended September 30, 2023 for the accretion of the discount on the May 2023 Notes during the periods.

 

The Company estimated the fair value of the conversion features of the New Notes, Exchange Notes, New Warrants and Exchange Warrants as of May 24, 2023 as discussed in Note 7 below.

 

The Company incurred debt issuance costs of $586,968 upon issuance of the New Notes and New Warrants. The Company will amortize these issuance costs as additional interest expense over the remaining term of the New Notes. The Company recognized interest expense of $172,194 and $237,416 for the amortization of these issuance costs for the three and nine months ended September 30, 2023.

 

As of September 30, 2023, there were no conversions of the May 2023 Notes.

 

 

 

 20 

 

 

NOTE 7 - DERIVATIVE FINANCIAL INSTRUMENTS

 

As discussed in Note 6, the Company recognized a loss on the extinguishment of the Convertible Notes based on the fair values of the New Notes including the conversion feature, New Warrants, Exchange Notes and conversion feature and Exchange Warrants. The Company determined that there was a derivative liability associated with the conversion features in the New Notes and Exchange Notes due to the variable conversion price subject to stockholder approval in the conversion feature. Therefore, the Company has separated conversion features from the New Notes and Exchange Notes and has recorded them at fair value and will continue to adjust them to fair value until the conversion price is fixed. The Company has also determined that the New Warrants and Exchange Warrants are derivative liabilities due to the potential adjustment in the exercise prices. The Company has accounted for the New Warrants and Exchange Warrants as liabilities at fair value and will continue to adjust them to fair value until the exercise prices are fixed.

 

The fair value of the conversion features and warrant liabilities were calculated using a Monte Carlo simulation and the following assumptions and methodologies:

          
  

 

 

May 24, 2023

  

 

August 3, 2023

 
Conversion Feature Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   86.3%    84.1% 
Conversion price per share  $0.75   $0.75 
Note term (years)   0.76    0.56 
Risk free interest rate   5.1%    5.4% 
Warrant Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   119.2%    115.0% 
Conversion price per share  $0.75   $0.75 
Warrant term (years)   4.25    4.06 
Risk free interest rate   3.8%    4.3% 

 

In addition to the above factors, the Company also used a probability assessment for the initial and June 30, 2023 valuation to evaluate whether stockholder approval would be received to lower the conversion and exercise prices. The Company utilized a 50/50 assessment that stockholders would or would not approve the lower conversion and exercise price. Management notes that at the time of the assessment, the stockholder vote had not yet started therefore there was no data to determine whether one scenario was more likely than another. Since the stockholders approve the lower conversion and exercise price on August 3, 2023, no probability assessment was used.

 

Based on the above factors, the estimated fair value of the Company’s financial derivative liabilities carried at fair value at May 24, 2023 and August 2, 2023 as follows:

 

          
   May 24, 2023   August 3, 2023 
Conversion Feature - New Notes  $663,096   $557,168 
Conversion Feature - Series A Exchange Notes   970,805    416,672 
Conversion Feature - Series B Exchange Notes   4,324,792    2,651,436 
New Warrants   3,123,682    2,445,244 
Exchange Warrants   9,287,474    7,191,535 
Total  $18,369,849   $13,262,055 

 

 

 

 

 21 

 

 

On August 3, 2023, shareholders approved the adjustment of the conversion price of the New Notes and Exchange Notes and the exercise price of the New Warrants and Exchange Warrants. The conversion and exercise prices can adjust to a floor of $0.22 per share based on certain events defined in the agreements related to these instruments. The Company has concluded that as of August 3, 2023, the conversion feature of the May 2023 Notes and the May 2023 Warrants are no longer derivative liabilities. The Company recognized a (loss) gain of $(690,290) and 2,333,417 for the change in the fair values of the conversion features of the May 2023 Notes for the three and nine months ended September 30, 2023, respectively.

 

The Company has calculated the fair value of May 2023 Warrants at August 3, 2023, and recognized a gain of $5,296 and $2,774,377 in the three and nine months ended September 30, 2023. The total gain recognized for the nine months ended September 30, 2023 for the May 2023 Notes conversion features and May 2023 Warrants is $5,107,794.

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

During 2022, the Company issued purchase orders and made prepayments for prototype parts of $21,860 to a vendor that Pink Possum, LLC (“Pink Possum”), an entity controlled by Mr. Okonsky, one of the Company’s founders, Chairman of the Board and Chief Technology Officer, holds an equity interest of 25% as of September 30, 2023. This vendor is expected to provide additional prototype and product parts for a prototype of an upgraded version of the Stag expected to be released in the future.

 

In November 2020, the Company entered into an operating lease with an entity controlled by the Company’s two founders for its future headquarters and production facility in Liberty Hill, Texas. The lease had a lease term of 5 years, and monthly payments ranging from approximately $15,000 per month to $17,000 per month over the lease term and gave the Company access to the land for use in testing its vehicles prior to the construction of any facilities. In February 2021, the Company entered into an amendment of the lease related to its future headquarters to expand the leased premises. The Company paid an additional security deposit of $139,230 and additional prepaid rent of $315,588. The total minimum lease payments under the amended lease totaled approximately $3,930,170.

 

In October 2021, the Company began discussions for an additional amendment to the lease, in anticipation of manufacturing the Stag at this location, which would have resulted in the monthly payment increasing to $100,000 for the first year of the lease and increasing annually throughout the term of the lease to $107,000 in the final year. Monthly payments for the initial lease and the amended agreement would have begun at the time a certificate of occupancy was received by the landlord.

 

The Company evaluated the cost of this facility in relation to other lower cost options, including having a third-party manufacturer the Stag, and determined that it would be in the best interest of the Company to terminate this lease. On April 27, 2022, the Company informed the landlord that it would be terminating the lease. On May 27, 2022, the landlord notified the Company that the landlord would refund $85,756 of the prepaid rent and security deposit balance of $601,818 paid by the Company. The unrefunded portion of the prepaid rent and security deposit related to some survey, architecture and construction design costs that were incurred by the landlord prior to the Company terminating the lease. In September and October 2023, the landlord notified the Company that there were additional costs that exceeded the amount of the refund and the landlord released the Company from paying any amounts in excess of the original expected refund. The landlord also released the Company from any remaining obligations under the lease and amendments. The Company has recognized a loss on the termination of this lease of $247,525 in the year ended December 31, 2022 and $85,756 in the three and nine months ended September 2023.

 

Total amortization expense for the right-of-use asset recorded for the initial lease for the nine months ended September 30, 2022 was $61,709. There was no amortization expense recorded in 2023.

In June 2021, the Company entered into an agreement with a company controlled by the Company’s Chairman and co-founder to lease office space for $2,000 per month for a period of one year. In May 2022, the Company informed the landlord that it would terminate this lease, and the landlord confirmed that the lease terminated effective September 1, 2022. Total expense recorded for this lease for the three and nine months ended September 30, 2022 was $4,000 and $16,000, respectively.

 

 

 

 22 

 

 

On August 28, 2020, the Company entered into three-year consulting agreements with Pink Possum, and Highbridge Consultants, LLC (“Highbridge”), an entity controlled by Mr. Adrian James, a co-founder of the Company, pursuant to which Messrs. Okonsky and James provide the Company with services. In consideration for entering into the consulting agreements, the Company issued the two entities ten-year warrants to purchase the Company’s common stock at an exercise price of $0.004 per share. The number of shares of common stock issuable pursuant to the warrants was based on the number of shares of the Company’s common stock outstanding at the time of exercise and provided that Pink Possum and Highbridge would receive 18.75% and 25%, respectively, of the Company’s shares of common stock outstanding at the time of exercise on a fully diluted basis. On March 26, 2021 and March 25, 2021, respectively, Pink Possum and Highbridge entered into amendments to the consulting agreements agreeing to exchange the original warrants for new ten-year warrants to purchase 950,000 and 1,250,000 shares, respectively, of common stock at an exercise price of $4.90. During the year ended December 31, 2021, the Company recognized compensation expenses of $5.6 million and $7.4 million for the warrants issued to Pink Possum and Highbridge, respectively. On December 20, 2021, Highbridge exercised all of its warrants on a cashless basis and the Company issued 1,101,515 shares of common stock to Highbridge.

 

In addition, pursuant to the consulting agreements, upon the occurrence of a Fundamental Transaction (as defined below) for an aggregate gross sales price of $100.0 million or more, each entity will receive a cash payment equal to 1% of such gross sales price. For the purposes of the consulting agreements, “Fundamental Transaction” means any of the following: (i) a consolidation or merger involving the Company if the holders of the voting securities of the Company that are outstanding immediately prior to the consummation of such consolidation or merger do not, immediately after the consummation of such consolidation or merger, hold voting securities that collectively possess at least a majority of the voting power of all the outstanding securities of the surviving entity of such consolidation or merger or such surviving entity’s parent entity; (ii) a transfer or issuance (in a single transaction or series of related transactions) by one or more of the Company and its stockholders to one person or to any group of persons acting in concert, of shares of the Company’s capital stock then collectively possessing 50% or more of the voting power of all then outstanding shares of the Company’s capital stock (computed on an as-converted to common stock basis); or (iii) any sale, license, lease, assignment or other disposition of all or substantially all of the assets of the Company. Furthermore, commencing upon the completion of the Company’s initial public offering of the shares of our common stock, if the Company’s market capitalization exceeds $300.0 million for a period of 21 consecutive trading days, each of the entities will receive an additional cash payment equal to $15.0 million; provided that the Company will have the right, in its sole discretion, to make the foregoing $15.0 million payment by the issuance of shares of the Company’s common stock. The foregoing amounts will be payable to the entities if the above milestones occur any time prior to the ten-year anniversary of the original consulting agreements, or August 28, 2030.

 

In December 2022, the Company entered into an employment agreement with Mr. Okonsky whereby Mr. Okonsky became an employee on January 2, 2023 and the consulting agreement with Pink Possum was terminated. However, the warrants to Pink Possum, and the provisions for a Fundamental Transaction and the market capitalization thresholds and related payments owed to Pink Possum if these were to occur remain in effect subsequent to the employment agreement.

 

 
NOTE 9 – STOCKHOLDERS’ EQUITY

 

On June 14, 2023, the Company’s stockholders approved an increase in the Company’s authorized shares of common stock from 100,000,000 to 250,000,000. The Company’s common stock has a par value of $0.00001. In addition, the Company is authorized to issue 5,000,000 shares of preferred stock with a par value of $0.00001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

 

Common Stock

 

On February 1, 2022, the Company sold 1,333,334 shares of its common stock in a public offering at $15.00 per share. The Company received net proceeds of $18,089,184 after underwriter commissions and expenses of $1,910,816. The underwriter was also issued a warrant to purchase 66,667 shares of the Company’s common stock at an exercise price of $18.75 per share that expires 5.5 years from the date of issuance.

 

 

 

 23 

 

 

On May 24, 2023, the Company sold 1,200,000 shares of its common stock in a public offering at $3.75 per share. The Company received net proceeds of $3,998,700 after underwriter commissions and expenses of $501,300.

 

On September 18, 2023, the Company sold 280,000 shares of its common stock in a public offering at $2.50 per share. The Company received net proceeds of $571,400 after underwriter commissions and expenses of $128,600. The underwriter was also issued a warrant to purchase 56,000 shares of the Company’s common stock at an exercise price of $3.13 per share that expires 5.5 years from the date of issuance. The underwriter agreement provided the underwriter with a right of first refusal for any additional securities offerings within twelve months of this offering.

 

As discussed in Note 6 above, on May 24, 2023, the Company issued the May 2023 Notes and May 2023 Warrants, along with the warrants to the placement agent in August 2022 with the issuance of the Convertible Notes. The Company received consent from the underwriter to issue such securities. In addition, the Company was required to reserve 21,623,189 shares of common stock for future issuance of shares for the conversion of the May 2023 Notes and exercise of the May 2023 Warrants and 120,773 shares for the exercise of the placement agent warrants.  

 

Warrants

  

As discussed in Note 6, the Company issued the Note Warrants, which were fully vested, to purchase 1,811,595 shares of the Company’s common stock at an initial exercise price of $14.25. The Note Warrants expire August 24, 2027. Also, the Company issued to the placement agent of the Convertible Notes, fully vested warrants to purchase 120,773 shares of the Company’s common stock at an exercise price of $17.8125. The warrants were not exercisable until February 24, 2023 and expire on February 24, 2028. The Company valued all of these warrants using the closing price of the Company’s common stock on August 24, 2022 of $12.20, volatility of 79.81% based on peer companies, risk free interest rate of 3.03%, no dividends and an estimated life of 2.5 years.

 

In May 2023, all of the Note Warrants to purchase 1,811,595 shares of the Company’s common stock were exchanged for Exchange Warrants to purchase 3,411,595 shares of the Company’s common stock with an initial exercise price of $5.45 per share (which was adjusted to $3.75 per share upon stockholder approval). The Exchange Warrants expire August 24, 2027. Also in May 2023, in connection with the issuance of the New Notes, the Company also issued New Warrants to purchase 1,086,957 shares of common stock at an initial exercise price of $5.45 (which was adjusted to $3.75 per share upon stockholder approval which was received on August 3, 2023). As discussed in Note 14, as of October 20, 2023, the exercise price of the Exchange Warrants and New Warrants were adjusted to $1.369 per share.

 

As noted above, 307,001 of the Exchange Warrants were exercised at a price of $1.75 per share and 307,001 Reload Warrants were issued with an exercise price of $2.50 per share. The Reload warrants expire August 24, 2027.

 

During the three and nine months ended September 30, 2023, the Company recognized no expense from warrants and during the three and nine months ended September 30, 2022, the Company recognized expense of $0 and $7,302, respectively, related to common stock warrants as all warrants are fully vested as of September 30, 2023. As noted in Note 7 above, the Company has determined that the Exchange Warrants and New Warrants are derivative liabilities and is recording them at fair value with changes being recorded in earnings through August 3, 2023, the date of stockholder approval to fix the exercise price of these warrants.

 

 

 

 24 

 

 

The following is the activity related to common stock warrants during the nine months ended September 30, 2023:

                 
    Common Stock Warrants 
    Shares    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value 
                     
Outstanding at January 1, 2023   3,017,126   $11.67           
Granted   4,861,555   $2.35           
Canceled      $           
Exchanged   (1,811,595)  $14.25           
Expired      $           
Exercised   (307,001)  $1.75           
Outstanding at September 30, 2023   5,760,085   $3.61    4.52   $146,442 
Exercisable at September 30, 2023   5,760,085   $3.61    4.52   $146,442 

 

NOTE 10 – STOCK-BASED COMPENSATION

 

In January 2021, the Company’s board of directors adopted the Volcon, Inc. 2021 Stock Plan, (the “2021 Plan”). The 2021 Plan is a stock-based compensation plan that provides for discretionary grants of stock options, stock awards, and restricted stock unit awards to employees, members of the board of directors and consultants (including restricted stock units issued prior to the adoption of the plan as further discussed below). The Company initially reserved a total of 600,000 shares of the Company’s common stock for issuance under the 2021 Plan. On July 26, 2022, the Company’s stockholders approved an increase of 800,000 shares of the Company’s common stock for issuance under the 2021 plan, which may be adjusted for changes in capitalization and certain corporate transactions. To the extent that an award, if forfeitable, expires, terminates or lapses, or an award is otherwise settled in cash without the delivery of shares of common stock to the participant, then any unpaid shares subject to the award will be available for future grant or issuance under the 2021 Plan. Shares available for issuance under the 2021 Plan as of September 30, 2023, were 251,351 shares. Awards vest according to each agreement and as long as the employee remains employed with the Company or the consultant continues to provide services in accordance with the terms of the agreement.

  

Restricted Stock Units

 

The following is the restricted stock unit activity for the nine months ended September 30, 2023

    
Outstanding January 1, 2023   15,000 
Granted    
Vested (1)   (5,000)
Canceled   (5,000)
Outstanding September 30, 2023   5,000 

 

  (1) 5,000 RSUs were subject to cancellation due to termination of employment. However, the Company entered into a modification to allow the employee to fully vest in these RSUs as part of a severance agreement. The Company recorded additional expense of $31,487 during the three months ended March 31, 2023 related to this modification.

 

 

 

 25 

 

 

In January 2022, the Company modified the vesting terms of 20,000 RSUs that had vested as of December 31, 2021 to extend the vesting through May 15, 2022. The Company granted an additional 5,000 RSUs to the holders of these RSUs that vesting was extended and these additional RSUs vested as of May 15, 2022. The Company recorded an additional expense of $1,267,250 during 2022 related to these modifications.

 

For the three and nine months ended September 30, 2023, the Company recognized expense for RSUs of $(15,700) and $61,623, respectively. For the three and nine months ended September 30, 2022, the Company recognized expense for RSUs of $35,325 and $1,232,135, respectively. The Company expects to recognize additional compensation expenses of $3,925 related to RSUs assuming all awards outstanding at September 30, 2023 will vest.

  

Performance Shares

 

On March 1, 2022, the Compensation Committee of the board of directors approved a grant of 8,925 shares for the achievement of some of the Company’s 2021 performance milestones, and the Company recognized share-based compensation expenses of $82,050 related to the grant of these shares in the quarter ended March 31, 2022. Certain individuals whose employment terminated subsequent to December 31, 2021 forfeited their share grants totaling 576 shares and such shares are available for future issuance under the 2021 Plan.

 

In 2022 the compensation committee approved reserving 50,000 shares from the 2021 Plan to issue based on achievement of the Company’s 2022 performance milestones to employees who are employed in 2022 and are active employees on the date of approval in 2023 by the compensation committee. On February 6, 2023 the compensation committee of the board of directors approved a grant of 30,997 shares (27,772 were issued due a forfeiture of 132 shares and 3,093 shares withheld for payment of employee withholding taxes) for the achievement of some of the Company’s 2022 performance milestones. The Company recognized share-based compensation expenses of $257,717 related to the grant of these shares in the quarter ended March 31, 2023. The compensation committee also approved reserving the remaining 19,003 not issued for 2022 performance milestones for issuance to active employees on the date the first Stag is shipped to a customer.

 

In addition, the compensation committee also approved reserving 50,000 shares from the 2021 Plan to issue to employees based on achievement of the Company’s 2023 performance milestones to employees who are employed in 2023 and are active employees on the date of approval in 2024 by the compensation committee.

 

Stock Options

 

The following summarizes activity relating to common stock options to employees and consultants for services during the nine months ended September 30, 2023:

                
   Common Stock Options 
   Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Life in years
   Intrinsic Value 
Outstanding at January 1, 2023   657,782   $15.41           
Granted   497,103   $3.81           
Forfeited   (149.885)  $13.02           
Exercised   (5,000)  $5.00           
Outstanding at September 30, 2023   1,000,016   $10.06    8.98   $ 
Exercisable at September 30, 2023   399,024   $12.93    8.37   $ 

 

 

 

 26 

 

 

The Company valued the options using the closing stock price of the Company’s common stock on the date of grant, an estimated volatility between 78.7% - 81.5% based on peer companies, risk free interest rate between 3.54% - 3.95%, no dividends and an estimated life of 6 years. During the three and nine months ended September 30, 2023, the Company recognized share-based compensation expenses of $556,228, and $1,904,016, respectively, related to common stock options. During the three and nine months ended September 30, 2022 the Company recognized share-based compensation expenses of $389,745, and $1,385,402, respectively, related to common stock options. The Company expects to recognize additional compensation expense of $2,136,860 related to these common stock options assuming all awards will vest.

 

Total stock-based compensation recorded for the three and nine months ended September 30, 2023 and 2022 for all stock based compensation awards, including warrants, has been recorded as follows:

                     
   

Three Months
Ended

September 30,

2023

 

Three Months
Ended

September 30,

2022

 

Nine Months
Ended

September 30,

2023

 

Nine Months
Ended

September 30,

2022

 
Cost of Goods Sold   $ 131,525   $ 113,794   $ 487,605   $ 391,674  
Sales and Marketing     134,073     106,478     678,945     568,333  
Product Development     80,759     82,560     389,729     661,754  
General and Administrative     194,171     122,238     667,077     1,003,088  
Total   $ 540,528   $ 425,070   $ 2,223,356   $ 2,624,849  

 

NOTE 11 – LOSS PER COMMON SHARE

 

The basic net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the weighted average number of common shares during the year. The diluted net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the diluted weighted average number of common shares outstanding during the year. The diluted weighted average number of common shares outstanding is the basic weighted number of common shares adjusted for any potentially dilutive debt or equity. Diluted net loss per common share is equal to basic net loss per share due to the Company’s net loss and any potentially issuable shares are anti-dilutive.

                
  

Three months

Ended

  

Three months

Ended

  

Nine months

Ended

  

Nine months

Ended

 
  

September 30,

2023

  

September 30,

2022

  

September 30,

2023

  

September 30,

2022

 
                 
Numerator:                    
                     
Net loss  $(11,327,896)  $(7,899,184)  $(41,655,559)  $(26,437,991)
                     
Denominator:                    
                     
Denominator for basic and diluted net loss per common share - weighted average of common shares   6,162,589    4,869,044    5,502,512    4,690,805 
                     
Basic and diluted net loss per common share  $(1.84)  $(1.62)  $(7.57)  $(5.64)

 

 

 

 27 

 

 

Common shares consisting of shares potentially dilutive as of September 30, 2023 and 2022 are as follows:

        
   September 30, 2023   September 30, 2022 
Convertible Notes   11,675,892    2,415,459 
Warrants   5,760,085    3,017,124 
Stock options   1,000,016    681,567 
Restricted stock units   5,000    30,000 
Total   18,440,993    6,144,150 

 

NOTE 12 – INCOME TAXES

 

Deferred taxes are determined by applying the provisions of enacted tax laws and rates for the jurisdictions in which the Company operates to the estimated future tax effects of the differences between the tax basis of assets and liabilities and their reported amounts in the Company's financial statements. A valuation allowance is established to reduce deferred tax assets if it is more likely than not that the related tax benefits will not be realized.

 

Due to losses since inception and for all periods presented, no income tax benefit or expense has been recognized as a full valuation allowance has been established for any tax benefit that would have been recognized for the loss in any period presented.

 

Significant components of the Company's deferred tax assets and liabilities at September 30, 2023 and December 31, 2022 are as follows:

        
  

September 30,

2023

  

December 31,

2022

 
Deferred tax assets          
Net operating losses  $12,016,943   $9,106,430 
Depreciation and intangible assets   1,770,632    1,502,868 
Debt basis difference   5,029,077     
Research & development credit   1,457,768    1,308,956 
Lease liability   266,483    322,167 
Inventory   1,249,375    1,290,968 
Stock-based compensation   3,259,583    3,103,037 
Accrued expenses   154,650    233,284 
Capital loss carryover   276,522    261,922 
Other   222,062    177,074 
Total   25,703,095    17,306,705 
Valuation allowance   (25,244,039)   (16,661,612)
Net deferred tax asset   459,056    645,093 
Deferred tax liabilities          
Prepaid expenses   (200,526)   (328,836)
Right-of-use assets   (258,530)   (316,257)
Total net deferred taxes deferred tax liabilities  $   $ 

  

 

 

 28 

 

 

Management currently believes that since the Company has a history of losses it is more likely than not that the deferred tax regarding the loss carry forwards and other temporary differences will not be realized in the foreseeable future. The Company believes that carryforward limitations will be applied to the historical net operating losses due to the change of control that occurred upon the completion of the Company’s initial public offering. The Company's cumulative net operating loss carry forward of approximately $57.2 million as of September 30, 2023, may be limited in future years depending on future taxable income in any given fiscal year. The net operating losses can be carried forward indefinitely.

 

The Company has recorded no liability for income taxes associated with unrecognized tax benefits at the date of adoption and has not recorded any liability associated with unrecognized tax benefits. Accordingly, the Company has not recorded any interest or penalty in regard to any unrecognized benefit.

 

NOTE 13 – LEASES

 

The components of lease cost for operating leases for the three and nine months ended September 30, 2023 and 2022 is as follows:

                
  

Three Months

Ended

September 30,

2023

  

Three Months

Ended

September 30,

2022

  

Nine Months

Ended

September 30,

2023

  

Nine Months

Ended

September 30,

2022

 
Lease Cost                    
Operating lease cost  $117,249   $107,534   $351,748   $406,786 
Short-term lease cost   30,751    75,015    120,271    208,009 
Variable lease cost                
Sublease income                
Total lease cost  $148,000   $182,549   $472,019   $614,795 

 

Supplemental cash flow information related to leases for the nine months ended September 30, 2023 and 2022, is as follows:

        
   2023   2022 
Other Lease Information          
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flows from operating leases  $265,161   $269,836 
Amortization of right-of-use assets  $274,895   $342,112 

 

The following table summarizes the lease-related assets and liabilities recorded on the balance sheet at September 30, 2023 and December 31, 2022:

        
  

September 30,

2023

  

December 31,

2022

 
Lease Position          
Operating Leases:          
Operating lease right-of-use assets  $1,231,092   $1,505,987 
Right-of-use liabilities operating leases short-term   423,849    391,117 
Right-of-use liabilities operating leases long-term   845,117    1,143,011 
Total operating lease liabilities  $1,268,966   $1,534,128 

 

 

 

 29 

 

 

The Company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.

    
Lease Term and Discount Rate  September 30, 2023 
Weighted-average remaining lease term (years):     
Operating leases   2.9 
Weighted-average discount rate:     
Operating leases   6.05% 

 

The following table provides the maturities of lease liabilities at September 30, 2023:

    
   Operating 
   Leases 
Remainder of 2023  $116,557 
2024   471,638 
2025   485,702 
2026   340,591 
Total future undiscounted lease payments   1,414,488 
Less: Interest   (145,522)
Present value of lease liabilities  $1,268,966 

 

NOTE 14 - SUBSEQUENT EVENT

 

Elimination of Chief Operating Officer Position

 

On October 10, 2023, the Company eliminated the position of Chief Operating Officer, and terminated Stephanie Davis, the Company’s Chief Operating Officer, from that position. The responsibilities of the Chief Operating Officer will be assumed by other members of management.

 

Warrants Granted to GLV Ventures

 

On October 11, 2023, the Company entered into an amendment (the “Amendment”) to its Stag development and Stag supplier agreements with GLV Ventures (“GLV”). Pursuant to the Amendment, GLV agreed to provide the Company with extended payment terms and provide the Company with credit against new vehicles for the value of certain parts purchased by the Company. In consideration for entering into the Amendment No. 1, the Company agreed to issue GLV (or its designee) five-year warrants to purchase 400,000 shares of Company common stock with an exercise price of $2.10 per share, which was equal to the closing price of the Company's common stock on the date of the Amendment No. 1, 200,000 shares were fully vested upon issuance and the remaining warrants will vest 45 days from the issuance date.

 

 

 

 30 

 

 


Reverse Stock Split

 

On October 13, 2023, the Company completed a reverse 1 for 5 stock split effective at 4:01pm U.S. Eastern Standard Time. Any fractional shares as a result of the reverse stock split were rounded up to one full share of common stock. As discussed in Note 6, the conversion price of New Notes and Exchange Notes and exercise price of the New Warrants and Exchange Warrants were subject to adjustment to the lowest day’s VWAP in the five days following the reverse split, which was $1.369 per share. Total shares issuable for the New Notes and Exchange Notes based on this adjusted price would be 23,454,124.

 

Warrant Inducement

 

On October 13, 2023, the Company entered into an inducement offer letter agreement (the “Inducement Letter”) with the three holders (each, a “Holder”) of the May 2023 Warrants. The Company reduced the exercise price of up to 973,000 to the lesser of (i) $1.75 (after giving effect to the 1:5 reverse stock split that went into effect on October 13, 2023) and (ii) the exercise price in effect at the time of exercise of the Existing Warrants if further adjusted in accordance with the terms of the May 2023 Warrants ($1.369 per share after adjustment for the lowest day’s VWAP for the five days following the reverse stock split). The reduction of the exercise price of such Existing Warrants will remain in effect until October 27, 2023 (the “Inducement Period”). Any Warrants not exercised prior to the end of the Inducement Period be $1.369 (after given effect to the 1:5 reverse stock split and lowest day’s VWAP for the five days following the reverse stock split) as adjusted pursuant to other events that would result in a change in the exercise price under the original terms of the Existing Warrants.

 

In addition, pursuant to the Inducement Letter, the Holders who exercise such Existing Warrants for cash on or prior to October 27, 2023 would receive a new warrant (“Reload Warrant”) to purchase a number of shares of common stock equal to the number of shares of common stock exercised under the Existing Warrants. The exercise price of the Reload Warrants was determined based on the terms of the Existing Warrants, which was $1.369 per share.

 

On October 20, 2023, the Holders exercised 105,000 warrants at $1.369 per share.

 

On October 29, 2023, in an effort to raise cash, the Company entered into an inducement offer letter agreement (the “Inducement Reprice Letter”) with the Holders of the Company’s May 2023 Warrants. Pursuant to the Inducement Reprice Letter, in exchange for an aggregate cash payment of $346,500, the Company reduced the exercise price with respect to May 2023 Warrants exercisable into an aggregate of 350,000 shares of common stock from $1.369 per share to $0.01 per share.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 31 

 

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis is intended as a review of significant factors affecting the Company’s financial condition and results of operations for the periods indicated. This discussion and analysis should be read in conjunction with the financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the Company’s Annual Report on Form 10-K, which contains audited financial statements of the Company as of and for the year ended December 31, 2022, previously filed with the Securities and Exchange Commission. Results for the three and nine months ended September 30, 2023 are not necessarily indicative of results for the year ending December 31, 2023 or any future period.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with these safe harbor provisions.

 

In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our capital needs, and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.

While we believe we have identified material risks, these risks and uncertainties are not exhaustive. Other sections of this Form 10-Q describe additional factors that could adversely impact our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

 

 

 32 

 

 

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this Form 10-Q to conform our prior statements to actual results or revised expectations, and we do not intend to do so.

 

Forward-looking statements include, but are not limited to, statements about:

  · our ability to generate revenues from sales, generate cash from operations, or obtain additional funding to market our vehicles and develop new products;
  · our ability to successfully implement and effectively manage our outsourced manufacturing, design and development model and achieve any anticipated benefits;
  · the ability of third-party manufacturers to produce our vehicles in accordance with our design and quality specifications, with sufficient scale to satisfy customers and within a reasonable cost;
  · anticipated timing for the manufacture, design, production, shipping and launch of our vehicles;
  · the inability of our suppliers to deliver the necessary components for our vehicles at prices and volumes acceptable to our third-party manufacturers, and within the timeframes that we require;
  · our ability to establish a network of dealers and international distributors to sell and service our vehicles on the timeline we expect;
  · whether our vehicles will perform as expected;
  · our facing product warranty claims or product recalls;
  · our facing adverse determinations in significant product liability claims;
  · customer adoption of electric vehicles;
  · the development of alternative technology that adversely affects our business;
  · increased government regulation of our industry;
  · tariffs and currency exchange rates; and
  · the conflict with Russia and the Ukraine and the potential adverse effect it may have on the availability of materials used in the manufacturing of batteries for our vehicles.

 

Overview

We are an all-electric, off-road powersports vehicle company developing electric two and four-wheel motorcycles and utility terrain vehicles, or UTVs, also known as side-by-sides, along with a complete line of upgrades and accessories. In October 2020, we began building and testing prototypes for our future offerings with two off-road motorcycles – the Grunt and the Runt. Our motorcycles feature unique frame designs protected by design patents. Additional utility and design patents have been filed for other aspects of Volcon’s vehicles.

 

We initially began to sell and distribute the Grunt and related accessories in the United States on a direct-to-consumer sales platform. We terminated our direct-to-consumer sales platform in November 2021. Prior to the termination of our direct-to-consumer sales platform, U.S. consumers made deposits for 360 Grunts (net of cancellations) and five Runts, plus accessories and a delivery fee representing total deposits of $2.2 million. These orders were cancelable by the consumer until the vehicle was delivered and after a 14-day acceptance period, therefore the deposits were recorded as deferred revenue. As of June 30, 2022, we had completed shipping of all Grunts sold through our direct-to-consumer sales platform. Due to delays in developing the Runt, we refunded the deposits made for all Runts.

 

 

 

 33 

 

 

Beginning in November 2021, we began negotiating dealership agreements with powersports dealers to display and sell our vehicles and accessories. Customers can now, or will soon be able to, buy our vehicles and accessories directly from a local dealership. Some of these dealers will also provide warranty and repair services to customers. As of September 29, 2023, we have 133 active dealers. Dealers can order any of our available products provided they are current on their accounts receivable and are within their established credit limit. We are offering dealers payment terms of up to 90 days to make larger purchases of our vehicles. We have entered into an accounts receivable factoring arrangement to allow the Company the ability to generate cash for working capital. We have agreements with third-party financing companies to provide financing to qualified customers of each dealer. There is no recourse to the Company or the dealer if the dealer’s customer defaults on the financing agreement with the third-party.

 

As of September 30, 2023, we have signed agreements with six importers in Latin America and one importer for the Caribbean Region, collectively referred to herein as the LATAM importers, to sell our vehicles and accessories in their assigned countries/markets. In June 2022, we signed an exclusive distribution agreement with Torrot Electric Europa S.A., referred to herein as Torrot, to distribute their electric motorcycles for youth riders in Latin America. As discussed below, the agreement with Torrot was superseded by the December 2022 agreement to sell Volcon co-branded Torrot youth motorcycles. We use our LATAM importers to sell Volcon co-branded Torrot youth motorcycles in Latin America.

 

In October 2022, we signed an expanded agreement with Torrot to also be the exclusive distributor of Torrot and Volcon co-branded youth electric motorcycles in the United States as well as Latin America. This agreement supersedes the original Torrot agreement and once all Torrot branded inventory is sold, we will no longer distribute Torrot branded motorcycles. Finally, in December 2022, we signed an expanded agreement with Torrot to be the exclusive distributor of Volcon co-branded youth electric motorcycles in Canada. In June 2023, we wrote down all remaining Torrot branded inventory in the amount of $84,000. On September 27, 2023, we wrote down the Volcon co-branded Torrot youth motorcycles by $1,622,262 to reduce their cost to the estimated net realizable value. 

 

We expect to expand our global sales of our vehicles and accessories beyond our current LATAM importer base. We expect to sign more LATAM importers in 2023. We expect export sales to be executed with individual importers in each country that buy vehicles by the container. Each importer will sell vehicles and accessories to local dealers or directly to customers. Local dealers will provide warranty and repair services for vehicles purchased in their country. In October 2023, the Company made a decision to postpone expanding our dealer network in Canada for the foreseeable future and we have terminated the employment of our Canadian regional sales managers.

 

In July 2022, we expanded our offerings with the introduction of the first of our Volcon UTV models, the Stag, which we initially anticipated would be available for delivery to customers in October 2023, followed by additional models of the Stag expected in 2024 and 2025. Due to a delay in certain parts from third-party vendors, we expect delivery to customers to begin in November 2023. The Stag will be manufactured by a third-party and incorporate electrification units, which include batteries, drive units and control modules provided by General Motors. Beginning in June 2022, we have taken non-binding pre-production orders which are cancelable prior to delivery. We also expect to introduce a higher performance, longer range UTV (to be named) but development of this vehicle has not yet begun and no timeline for its development and release has been determined.

 

Through August 2022, we assembled the Grunt in a leased production facility in Round Rock, Texas. In August 2022, we announced that we would outsource the manufacturing of the Grunt to a third-party manufacturer, which has reduced costs and improved profitability on the Grunt. We also outsourced the manufacturing of the 2023 Grunt EVO to the same third-party manufacturer. The 2023 Grunt EVO has replaced the Grunt and has a belt drive rather than a chain drive as well as an updated rear suspension. We received prototypes of the Grunt EVO in the first quarter of 2023 and began selling the Grunt EVO in the third quarter of 2023.

 

In September 2022, we reduced our headcount in our product development and administration departments as we outsourced the design and development of certain components of our vehicle development. We also hired our Chief Marketing Officer and hired additional sales and marketing employees and increased marketing activities to further support our brand and products. In September 2023, we reduced our headcount in several departments to reduce costs and we continue to evaluate other cost reduction opportunities.

 

 

 

 34 

 

 

We began taking pre-orders for an E-Bike, the Brat, in September 2022 and shipments to customers began in the fourth quarter of 2022. The Brat is being manufactured by a third-party. In January 2023, we began selling the Brat directly to consumers through our website. Consumers who order the Brat from our website can have the Brat shipped to their specified destination.

 

In November 2022, we finalized an agreement with a third-party to manufacture the Runt LT. We received prototypes of the Runt LT in the first quarter of 2023 and expect to begin sales in the first quarter of 2024.

 

The estimated fulfillment of all orders we have received assumes that our third-party manufacturers can successfully meet our order quantities and deadlines. If they are unable to satisfy orders on a timely basis, our customers may cancel their orders.

 

Results of Operations

 

The following financial information is for the three and nine months ended September 30, 2023 and 2022.

 

   Three Months Ended   Nine Months Ended 
  

Sept 30,

2023

  

Sept 30,

2022

  

Sept 30,

2023

  

Sept 30,

2022

 
                 
Revenue  $487,430   $242,710   $2,177,188   $3,795,065 
Cost of goods sold   (3,542,468)   (2,012,828)   (5,107,096)   (11,549,871)
Gross margin   (3,055,038)   (1,770,119)   (2,929,908)   (7,754,806)
                     
Operating expenses:                    
Sales and marketing   1,870,532    1,282,014    6,040,519    3,942,827 
Product development   2,983,197    2,177,347    5,936,280    6,775,768 
General and administrative expenses   1,544,344    2,085,211    5,003,135    7,409,601 
Total operating expenses   6,398,073    5,544,572    16,979,934    18,128,196 
                     
Loss from operations   (9,453,111)   (7,314,691)   (19,909,842)   (25,883,002)
                     
Other income (expense)   (54,702)   33,814    (38,199)   72,800 
Loss on extinguishment of Convertible Notes           (22,296,988)    
Gain (loss) on change in fair value of financial liabilities   (684,994)       5,107,794     
Interest expense   (1,135,089)   (618,307)   (4,518,324)   (627,789)
Total other expense   (1,874,785)   (584,493)   (21,745,717)   (554,989)
                     
Loss before provision for income taxes   (11,327,896)   (7,899,184)   (41,655,559)   (26,437,991)
Provision for income taxes                
                     
Net loss  $(11,327,896)  $(7,899,184)  $(41,655,559)  $(26,437,991 

 

 

 

 35 

 

 

Revenue

 

Revenue for the three months ended September 30, 2023, was $487,430 which represents sales of Brats of $686,331, Grunt EVO motorcycles of $37,193, Volcon Youth and Torrot motorcycles of $43,407 and accessories and parts of $52,613 offset by an adjustment of $333,524 to increase dealer rebates due to a change in the rebate program for remaining unsold Grunts in dealer inventory and for discounts to dealers for a reduction in the manufacturer’s suggested retail price for Brats and Volcon Youth motorcycles.

 

Revenue for the nine months ended September 30, 2023, was $2,177,188 which represents sales of Grunt motorcycles of $170,388, Grunt EVO motorcycles of $37,193, Brats of $1,728,528, Volcon Youth of $303,886 and accessories and parts of $204,593. offset by an adjustment of $269,218 to increase dealer rebates due to a change in the rebate programs during the period for remaining unsold Grunts in dealer inventory and for discounts to dealers for a reduction in the manufacturer’s suggested retail price for Brats and Volcon Youth motorcycles. 

 

Revenue for the three and nine months ended September 30, 2022, was $242,710 and $3,795,065 which represents sales of Grunts of $953,429 and $4,493,951, and accessories and parts of $81,125 and $196,845, respectively. The sales of Grunts are offset by promotional rebates provided to dealers and distributors in the third quarter of 2022 on inventory held by them as of August 1, 2022 resulting in $812,600 being recorded to reduce revenue. The rebate is provided as a year-end incentive to dealers and distributors to sell their remaining 2022 Model Year Grunt inventory.  

 

Cost of Goods Sold

 

Cost of goods sold for the three months ended September 30, 2023 were $3,542,468 including payroll costs of $287,117 and stock-based compensation of $131,526 for employees performing warehouse and logistics management and quality control testing. Product costs for Brats, Grunt EVOs, and Volcon Youth sold during the period were $555,265, $96,332 and $40,018 (before net realizable value write down), respectively. We recorded a write down of Volcon Youth motorcycles of $1,622,262 to reduce their costs to the expected net realizable value. We recorded an expense of $19,500 related to fees paid to cancel purchase orders to reduce raw material quantities. Facilities costs were $126,501 for our warehouse facility and third-party warehousing costs. The Company also recorded an expense of $350,000 due to a reduction of the credit per Grunt EVO our third-party manufacturer will provide for inventory previously provided to it. The credit was reduced to $1,250 from $1,600 due to inventory provided by the Company that is in excess of the 1,000 units. Future credits could be received if the Company has the third-party manufacturer build more than 1,000 units.

 

Cost of goods sold for the nine months ended September 30, 2023, were $5,107,096. Costs include payroll costs of $969,461 and stock-based compensation of $487,605 for share-based awards for employees performing warehouse and logistics management and quality control testing. Product costs for Brats, Grunts, Grunt EVOs, and Volcon Youth, sold during the period were $1,150,905, $459,690, $97,051, and $295,427 (before inventory write down), respectively. We recorded write downs of Volcon Youth and Torrot Youth motorcycles of $1,622,262 to reduce the inventory value to its expected net realizable value. We recorded expense of $158,252 related to fees paid to cancel purchase orders to reduce raw material quantities, which was offset by a reduction in the net realizable valuation expense of $198,061 the Company was recording for excess quantities of raw materials that it was no longer obligated to purchase by paying these fees. Also, the one-year warranty for parts and labor on Grunts sold prior to September 30, 2022 expired (excluding the battery which is warranted for 2 years) and an adjustment to reduce the warranty accrual in the amount of $459,800 was recorded which reduced cost of goods sold. Facilities costs were $337,658 for our warehouse facility and third-party warehousing costs. Shipping costs were reduced by $347,729 due to the reversal of an accrual for shipping costs and tariffs expected to be incurred to ship our Grunt raw materials and work-in-process inventory to our third-party manufacturer in Mexico which was no longer needed.

 

 

 

 36 

 

 

Cost of goods sold for the three months ended September 30, 2022 were $2,012,828 including labor costs of $504,830 for employees and contractors performing assembly and quality control testing of Grunts and stock-based compensation of $113,795 for share-based awards for employees. Part costs for Grunts sold during the period were $48,627. We paid $223,758 for fees owed to cancel purchase orders to reduce quantities ordered to expected sales demand. Facilities costs were $131,344 for our manufacturing facility and inventory warehousing costs. Shipping costs and duties/tariffs for inventory purchases and shipments to customers were $701,825, which includes an accrual of $350,000 for costs expected to be incurred to ship our raw materials and work-in-process inventory to our third-party manufacturer. Depreciation expense of $123,008 was recorded in the period and a loss on the write-off of property and equipment of $170,657 was recognized for the disposal of manufacturing assets due to the outsourcing of Grunt assembly.

 

Cost of goods sold for the nine months ended September 30, 2022 were $11,549,871 including labor costs of $1,868,801 for employees and contractors performing assembly and quality control testing of Grunts and stock-based compensation of $392,244 for share-based awards for employees. Part costs for Grunts during the period were $5,402,140 which included parts costs for Grunts sold of $3,080,033, inventory adjustments for excess and obsolete inventory of $364,322 and adjustments of $1,643,505 to record inventory at its net realizable value. Facilities costs were $458,650 for our manufacturing facility and inventory warehousing costs. Shipping costs and duties/tariffs for inventory purchases and shipments to customers were $2,041,022 which includes an accrual of $350,000 for costs expected to be incurred to ship our raw materials and work- in-process inventory to our third-party manufacturer. Accrued warranty costs were $556,314. Depreciation expense of $270,526 was recorded in the period and a loss on the write-off of property and equipment of $170,657 was recognized for the disposal of manufacturing assets due to the outsourcing of Grunt assembly.

 

Beginning in the fourth quarter of 2023 we expect revenue and cost of goods sold, other than inventory write downs, to increase further due to the expected sales of the Grunt EVO, as there were minimal sales late in the third quarter, and Stag in November 2023. Our cost per Grunt EVO is fixed in our contract with the third-party manufacturer. We have identified a supplier who can build and deliver the Grunt EVO at a lower cost than we were able to source parts and assemble the Grunt EVO ourselves. We also transferred Grunt parts inventory of approximately $1.4 million to this supplier in exchange for a per unit reduction in the contractual cost the third-party manufacturer will charge the Company. Additional cost savings may be realized if the third-party manufacturer can source or manufacture parts at a lower cost.

 

Other than the cost of the batteries, we have a fixed cost per unit for the Stag in our contract with our third-party manufacturer. However, not all components have been fully sourced and additional costs for these components or price increases from suppliers for components already sourced could result in a higher cost per unit and we may not be able to increase the price we sell each unit to our customers which could negatively impact our expected margin.

 

The increase in costs for products will partially be offset by reductions in cost for salaries and benefits due to reductions in headcount completed in September and October 2023.

 

Sales and Marketing Expense

 

Sales and marketing expenses relate to costs to increase exposure and awareness for our products and developing our network of U.S. dealers and international distributors.

  

For the three months ended September 30, 2023, sales and marketing expenses were $1,870,532 and include $683,349 for promoting our products and brand, $816,564 for employee payroll costs, stock-based compensation expense of $134,073 for share-based awards granted to employees and consultants, $43,684 related to facilities costs, and travel costs of $79,500 primarily related to costs incurred for travel to build our dealer and distributor network and to attend events to promote our products. Bad debt expense was $15,792 and legal and consulting fees were $15,577.

 

 

 

 37 

 

 

Sales and marketing expenses were $6,040,519 for the nine months ended September 30, 2023 and were primarily related to expenses associated with promoting our products and brand of $2,239,652, employee payroll costs of $2,323,155, stock-based compensation of $678,944 for share-based awards granted to employees and consultants, and travel costs of $259,777 primarily related to costs incurred for travel to build our dealer and distributor network and to attend events to promote our products. Facilities costs were $128,821. Bad debt expense was $66,990 and legal and consulting fees mainly related to entering into international distribution agreements were $156,846.

 

For the three months ended September 30, 2022 sales and marketing expenses were $1,282,014 and include $432,640 for promoting our products and brand, $479,848 for employee payroll costs, stock-based compensation expense of $123,678 for share-based awards granted to employees and consultants, and travel costs of $76,555 primarily related to costs incurred for travel to build our dealer and distributor network.
 

For the nine months ended September 30, 2022 sales and marketing expenses were $3,942,827 and include $1,094,886 for promoting our products, employee payroll costs of $1,379,911, stock-based compensation of $550,563 for share-based awards granted to employees and consultants, $317,746 for facilities costs, including costs of $148,323 for closing our Denver store, primarily to operate our now closed dealership in Denver, Colorado and travel costs of $182,845 primarily related to costs incurred for travel to build our dealer network.

 

We expect sales and marketing expenses to decrease as we reduce costs for marketing our products once we start selling the Grunt EVO and Stag, which we expect to be offset partially for an increase in selling costs such as commissions. In addition, we decreased headcount in September 2023 to reduce selling costs.

 

Product Development Expense

 

Product development expenses relate to development and testing of our products and process to manufacture these products.

 

For the three months ended September 30, 2023, product development expenses totaled $2,983,198 and primarily relate to expenses associated with employee payroll costs of $426,332, stock-based compensation of $80,759 for share-based awards granted to employees, professional fees of $274,389 for consultants assisting with product design and programming, prototype vehicles and parts costs of $2,003,330, facilities costs of $49,879 and $38,000 for supplies and software.

 

Product development expenses were $5,936,280 for the nine months ended September 30, 2023 and were primarily related to expenses associated with employee payroll costs of $1,365,841, stock-based compensation of $389,729 for share-based awards granted to employees and consultants, professional fees of $570,364 for consultants assisting with product design and programming, prototype vehicles and parts costs of $2,913,425, tooling costs of $70,173 for prototype parts, testing costs of $143,072 to complete testing of vehicles including any required regulatory tests, shipping costs of $56,133 related to shipping prototypes, $133,571 for supplies and software and facilities costs of $143,185.

 

For the three months ended September 30, 2022, product development expenses totaled $2,177,347 and primarily relate to expenses associated with employee payroll costs of $1,199,179, stock-based compensation of $81,191 for share-based awards granted to employees and consultants, professional fees of $64,444 for product design, research and development costs of $115,034, prototype parts and tooling costs of $500,532, and facilities costs of $74,540.

 

For the nine months ended September 30, 2022, product development expenses totaled $6,775,768 and primarily related to expenses associated with employee payroll costs of $3,077,064, stock-based compensation of $646,350 for share-based awards granted to employees and consultants, professional fees of $293,706 including $173,001 for product design and $95,130 for employee recruiting, research and development costs of $624,984, prototype parts and tooling costs of $1,569,902, and facilities cost of $204,781.

 

We expect product development costs related to employee costs to remain consistent with the expense level of the nine months ended September 30, 2023. We expect cost increases for outsourced design and development costs and costs related to prototype costs for the Stag and Runt LT and prototype costs, especially for the Stag. We will receive more design validation Stag units and expect to receive production validation units in the fourth quarter of 2023. These units will be used to validate engineering and manufacturing design. Beginning in 2024, we expect prototype costs to decrease as we will be in production for the Stag.

 

 

 

 38 

 

 

General and Administrative Expense

 

General and administrative expenses relate to costs for our finance, accounting and administrative functions to support the development, manufacturing and sales of our products.

 

For the three months ended September 30, 2023, general and administrative expenses were $1,544,344 and were primarily related to expenses associated with employee payroll costs of $509,914, stock-based compensation of $194,171 for share-based awards granted to employees and consultants, professional fees of $161,523 (including legal fees of $61,201 for legal services and tax and audit fees of $71,008), software costs of $93,190, insurance costs of $339,714, facilities costs of $131,974, which includes $85,756 of lease termination costs, other public company expenses of $23,555 and the special stockholders meeting cost $104,840.

  

For the nine months ended September 30, 2023, general and administrative expenses were $5,003,135 and were primarily related to expenses associated with employee payroll costs of $1,649,373, stock-based compensation of $667,077 for share-based awards granted to employees, professional fees of $665,463 (including legal fees of $276,082, tax and audit fees of $258,185 and recruiting fees of $30,098), software costs were $328,584, insurance costs of $1,022,905, facilities costs of $214,488, which includes $85,756 of lease termination costs, annual and special shareholder meeting costs of $192,155 and other public company expenses were $164,308.

 

For the three months ended September 30, 2022, general and administrative expenses were $2,085,211 and were primarily related to expenses associated with employee payroll costs of $659,262, stock-based compensation of $123,608, professional fees of $431,763, including legal fees of $331,483 and recruiting fees of $29,073, insurance costs of $419,581 and public company costs excluding legal fees of $190,083.

 

For the nine months ended September 30, 2022, general and administrative expenses were $7,409,601 and were primarily related to expenses associated with employee payroll costs of $2,085,487, stock-based compensation of $1,018,582, professional fees of $1,874,017, including legal fees of $1,450,289 and recruiting fees of $173,122, insurance costs of $1,165,738, and public company costs excluding legal fees of $349,073.

 

We expect general and administrative expenses to decrease over the next several quarters as we have taken actions to reduce costs through headcount reductions and lower expected legal costs. The reduction will be partially offset by costs such as product liability insurance which has increased due to new product offerings and increased costs due to public company reporting and compliance requirements.

 


Interest and Other Expenses

 

Interest and other income/expenses for the three and nine months ended September 30, 2023 were $1,874,785 and $21,745,717, respectively. A loss on extinguishment of the Convertible Notes of $22,296,988 was recognized in the nine months ended September 30, 2023 (see Note 6 to the consolidated financial statements). Non-cash interest expense of $1,130,837 and $4,516,041 was recognized for the amortization of debt issuance costs and accretion of principal on the Convertible Notes issued in August 2022 prior to extinguishment of the Convertible Notes and for the May 2023 Notes for the three and nine months ended September 30, 2023, respectively. A (loss) gain on the change in the valuation of derivative financial liabilities of ($684,994) and $5,107,794 was recognized in the three and nine months ended September 30, 2023 (see Note 7 to the consolidated financial statements).

 

Interest and other expenses for the three and nine months ended September 30, 2022 were $618,307 and $627,789. Non-cash interest expense of $614,366 was recognized for the amortization of debt issuance costs and accretion of principal on the Convertible Notes issued in August 2022.

 

We expect interest expense to increase in the future as we recognize interest on the New Notes and Exchange Notes issued in May 2023. The New Notes and Exchange Notes were discounted using a 14.9% interest rate This discount will be accreted to interest expense over the term of these notes and does not result in any cash payments to be made unless the Company has an event of default as discussed in Note 6 to the financial statements. Additional interest will be recognized for the amortization of issuance costs of $586,968 incurred for the New Notes and Exchange Notes.

 

 

 

 39 

 

 

Net Loss

 

Net loss for the three and nine months ended September 30, 2023, was $11,327,896 and $41,655,559, respectively.

 

Net loss for the three and nine months ended September 30, 2022, was $7,899,184 and $26,437,991, respectively.

 

Liquidity and Capital Resources

 

On September 30, 2023, we had cash and restricted cash of $3.0 million, including $0.5 million of restricted cash, and we had a working capital deficit of $22.7 million. Since inception we have funded our operations from proceeds from debt and equity sales.

 

Cash used in operating activities

 

Net cash used in operating activities was $16.8 million for the nine months ended September 30, 2023 and includes all of our operating costs except stock-based compensation, write-down of inventory, depreciation and amortization, non-cash interest expense for the amortization of debt issuance costs and accretion of principal on Convertible Notes and May 2023 Notes, gain on change in derivative financial liabilities, loss on extinguishment of Convertible Notes, bad debt expense and gain on sale of assets and loss on lease termination. Cash used in operating activities includes a decrease in accounts receivable of $0.6 million for collections net of sales, increases in inventory of $3.2 million due to the purchase of Brats, Volcon Youth motorcycles and purchases of batteries for the Stag offset by the transfer of Grunt inventory of $1.4 million to one of our third-party manufacturers, an increase of $2.4 million in accounts payable primarily due to purchases of batteries for the Stag and amounts due to our third-party manufacturer of the Stag and Grunt EVO, a decrease of $0.3 million in accrued liabilities due reversal of an accrual for anticipated shipping and tariffs related to shipping raw material and subassembly inventory for the Grunt to our third-party manufacturer. As of September 30, 2023 we have $0.2 million in customer deposits, primarily from two of our Latin America distributors as prepayment for shipments of Brats and Grunt EVOs.

 

Net cash used in operating activities was $24.8 million for the nine months ended September 30, 2022 and includes all of our operating costs except stock-based compensation, write-down of inventory and prepaid inventory, depreciation and amortization, non-cash interest expense for the amortization of debt issuance costs and accretion of principal on Convertible Notes, and losses on write-off of assets and leases. Cash used in operating activities includes increases in accounts receivable of $1.5 million for sales made to dealers, an increase in inventory of $1.4 million offset by a reduction in inventory deposits of $1.1 million as we made fewer deposits based on outsourcing of the assembly of the Grunt in August 2022 as the third-party manufacturer will purchase raw materials prospectively, a decrease of $2.2 million of customer deposits as we fulfilled all direct to consumer orders, a decrease of $1.0 million due to timing of payments on accounts payables, an increase of $0.3 million in accrued liabilities and an increase in prepaid expenses of $0.3 million.

 

Cash used in investing activities

 

Net cash used in investing activities was $0.7 million for the nine months ended September 30, 2023, consisting of $0.8 million of purchases of equipment and tooling offset by proceeds of $0.1 million received for the sale of two vehicles. Net cash used in investing activities was $0.6 million for the nine months ended September 30, 2022, consisting of $0.2 million of purchases of equipment and tooling related to our Grunt manufacturing and product development, $0.2 million for the cost of Grunts capitalized as demonstration units, and $0.2 million related to computers and equipment due to the growth in headcount during the period.

 

 

 

 40 

 

 

Cash provided by financing activities

 

Cash provided by financing activities for the nine months ended September 30, 2023, was $9.0 million and was related primarily to proceeds from the public offerings of 1.5 million shares of our common stock for net proceeds of $4.6 million and issuance of convertible notes in a private offering with a principal amount of $4.9 million and net proceeds of $3.9 million. We also received proceeds of $0.5 million from the exercise of 307,001 warrants. In addition, we used $0.1 million from proceeds received from the sale of two vehicles to pay off the related notes payable on the vehicles.

 

Cash provided from financing activities for the period ended September 30, 2022, was $40.4 million and was related to proceeds received from both the public offering of our common stock in February 2022 where we sold 1,333,334 shares at $15.00 per share and the issuance of senior convertible notes and warrants in August 2022 for net cash proceeds of $22.3 million.

 

Our continuation as a going concern is dependent upon our ability to attain profitable operations and if necessary, obtain continued financial support from the issuance of debt or equity. As of September 30, 2023, we had incurred an accumulated deficit of $117.4 million since inception. Additionally, one of the covenants for our May 2023 Notes requires us to have $5 million of cash on hand if principal (and interest, if any) of $15 million or more of the May 2023 Notes are outstanding as of June 30, 2024 (subject to adjustment if the principal (and interest, if any) is below $15 million). Further, our May 2023 Notes require us to sell at least 250 units of our Stag UTV by December 31, 2023.

 

Management anticipates that our cash on hand as of September 30, 2023 plus the cash expected to be generated from operations will not be sufficient to fund planned operations and maintain required cash balances at June 30, 2024 for the May 2023 Notes beyond one year from the date of the issuance of the financial statements as of and for the three and nine months ended September, 2023. There can be no assurance that additional funding would be available to the Company on acceptable terms, or at all. These factors raise substantial doubt regarding our ability to continue as a going concern.

 

JOBS Act Accounting Election

 

The recently enacted JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this extended transition period and, as a result, we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.

 

We have implemented all new accounting pronouncements that are in effect and may impact our financial statements and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

 

Critical Accounting Policies

 

No critical accounting policies or estimates existed as of September 30, 2023.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

 

 

 41 

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) are designed to ensure that information required to be disclosed by us in reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the appropriate time periods, and that such information is accumulated and communicated to our Chief Executive Officer, who serves as our principal executive officer, and Chief Financial Officer, who serves as our principal financial officer, as appropriate, to allow timely discussions regarding required disclosure. We, under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures.

 

Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures were not effective as of September 30, 2023 to provide assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to management as appropriate, to allow timely decisions regarding disclosures as we have previously missed filing certain forms timely and we have not implemented and tested controls and procedures to conclude that we have remediated this deficiency. Notwithstanding this conclusion, we believe that our unaudited consolidated financial statements contained in this Quarterly Report fairly present our financial position, results of operations and cash flows for the periods covered thereby in all material respects. Management is working to identify corrective actions for the weakness and will periodically re-evaluate the need to add personnel and implement improved review procedures. 

 

Changes in Internal Control over Financial Reporting

 

There were no changes to our internal control over financial reporting during the nine months ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 42 

 

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time in the ordinary course of our business, we may be involved in legal proceedings, the outcomes of which may not be determinable. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable. We have insurance policies covering potential losses where such coverage is cost effective.

 

ITEM 1A. RISK FACTORS

 

Except as set forth below, there have been no material changes to the risk factors included in the Form 10-K filed with the SEC on March 7, 2023, which is accessible on the SEC’s website atwww.sec.gov.

 

We will require additional capital funding in the near term, the receipt of which may impair the value of our common stock.

 

Our future capital requirements depend on many factors, including our sales and marketing activities. We will need to raise additional capital through public or private equity or debt offerings or through arrangements with strategic partners or other sources in the fourth quarter of 2023. There can be no assurance that additional capital will be available when needed or on terms satisfactory to us, if at all. To the extent we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution and the new equity securities may have greater rights, preferences or privileges than our existing common stock.

 

The terms of the May 2023 Notes and May 2023 Warrants imposed additional challenges on our ability to raise capital.

 

The agreements related to the sale of the May 2023 Notes and May 2023 Warrants contain a number of restrictive covenants that may impose significant operating and financial restrictions on us while the May 2023 Notes and May 2023 Warrants remain outstanding, unless the restrictions are waived by consent of each holder, including, but not limited to, restrictions on our ability to incur additional indebtedness and guarantee indebtedness; incur liens or allow mortgages or other encumbrances; redeem, or repurchase certain other debt; pay dividends or make other distributions or repurchase or redeem our capital stock; sell assets or enter into or effect certain other transactions; issue additional equity; and enter into variable rate transactions, among other restrictions.

 

A breach of the covenants or restrictions under the agreements related to the May 2023 Notes and May 2023 Warrants governing our indebtedness could result in an event of default under such agreements. As a result of these restrictions, we may be limited in how we conduct our business, unable to finance our operations through additional debt or equity financings and/or unable to compete effectively or to take advantage of new business opportunities.

 

Further, while we could potentially receive up to an aggregate of $6.2 million in gross proceeds from the exercise of the May 2023 Warrants and Reload Warrants outstanding as of September 30, 2023, assuming the exercise in full of all of the May 2023 Warrants and Reload Warrants based on the adjusted exercise price of $1.369 per share after the adjustment for the reverse stock split (as discussed in Note 14 of the financial statements), no assurances can be made that the holders of such warrants will elect to exercise any or all of such warrants and, accordingly, no assurance that we will receive any proceeds from the exercise of the May 2023 Warrants and Reload Warrants. If the trading price for our common stock is less than the exercise price for the May 2023 Warrants and Reload Warrants, we believe the holders of such warrants will be unlikely to exercise their warrants. Accordingly, we may not receive cash proceeds with respect to the May 2023 Warrants and Reload Warrants and we are restricted in our ability to conduct additional debt or equity financings.

 

 

 

 43 

 

 

The issuance of our common stock in connection with the May 2023 Notes and May 2023 Warrants could cause substantial dilution, which could materially affect the trading price of our common stock.

 

The May 2023 Notes and May 2023 Warrants are exercisable or convertible, as applicable, for up to 27,952,678 shares of our common stock based on the adjusted conversion price of $1.369 after giving effect for the October 13, 2023 reverse stock split as discussed in Note 14 of the financial statements. The additional shares of common stock issued upon the exercise or conversion of the foregoing securities will result in dilution to our then existing holders of common stock and increase the number of shares eligible for resale in the public market. Sales of a substantial number of such shares in the public market could adversely affect the market price of our common stock.

 

The sale of our common stock by the holders of the May 2023 Notes and May 2023 Warrants, or the perception that stock sales may occur, could cause the price of our common stock to decline.

 

The sale of our common stock in the public market by the holders of our May 2023 Notes and May 2023 Warrants, or the perception that such sales could occur, could harm the prevailing market price of our common stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate (which ability to sell equity securities is also subject to restrictions under the terms of the agreement related to the May 2023 Notes, May 2023 Warrants and Reload Warrants). If and when we do issue shares of common stock to the holders of the May 2023 Notes and May 2023 Warrants upon the conversion or exercise, as applicable, of the May 2023 Notes, May 2023 Warrants, and Reload Warrants, the holders may resell all, some or none of those shares of common stock at any time or from time to time in their discretion. Resales of our common stock may cause the market price of our securities to drop significantly, regardless of the performance of our business.

 

If we fail to satisfy all applicable continued listing requirements of the Nasdaq Capital Market our common stock may be delisted from Nasdaq, which could have an adverse impact on the liquidity and market price of our common stock.

 

Our common stock is currently listed on the Nasdaq Capital Market. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum bid price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with the applicable listing standards.

 

On July 5, 2023, we received a notice from Nasdaq that we were not in compliance with Nasdaq’s Listing Rule 5550(b)(2), which requires that we maintain a market value of listed securities (“MVLS”) of $35 million. MVLS is calculated by multiplying our shares outstanding by the closing price of our common stock. On July 6, 2023, we received a notice from Nasdaq that we were not in compliance with Nasdaq’s Listing Rule 5550(a)(2), (the “Bid Price Rule”) as the minimum bid price of our common stock had been below $1.00 per share for 30 consecutive business days. On October 30, 2023, the Company received a notice from Nasdaq that it has now regained compliance with Rule 5550(a)(2), as the minimum bid price of its common stock was above $1.00 for 10 consecutive business days.

 

We have until January 2, 2024, to regain compliance with the MVLS requirement. To regain compliance with the MVLS requirement, our MVLS must close at $35 million or more for a minimum of ten consecutive business days during this grace period. If we do not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that our shares of common stock will be subject to delisting.

 

In the event that our common stock is delisted from Nasdaq and is not eligible for quotation or listing on another market or exchange, trading of our common stock could be conducted only in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such an event, it could become more difficult to dispose of, or obtain accurate price quotations for, our common stock, and there would likely also be a reduction in our coverage by securities analysts and the news media, which could cause the price of our common stock to decline further. Also, it may be difficult for us to raise additional capital if we are not listed on a major exchange.

 

 

 

 44 

 

 

We completed a reverse stock split on October 13, 2023 in an effort to regain compliance with Nasdaq listing rules and we cannot predict the effect that such reverse stock split will have on the market price for shares of our common stock.

 

Our board of directors approved a one-for-five (1:5) reverse stock split of our common stock, which became effective on October 13, 2023, in order to regain compliance with the Bid Price Rule. We cannot predict the effect that the reverse stock split will have on the market price for shares of our common stock, and the history of similar reverse stock splits for companies in like circumstances has varied. Some investors may have a negative view of a reverse stock split. Even if the reverse stock split has a positive effect on the market price for shares of our common stock, performance of our business and financial results, general economic conditions and the market perception of our business, and other adverse factors which may not be in our control could lead to a decrease in the price of our common stock following the reverse stock split.

 

Furthermore, even if the reverse stock split does result in an increased market price per share of our common stock, the market price per share following the reverse stock split may not increase in proportion to the reduction of the number of shares of our common stock outstanding before the implementation of the reverse stock split. Accordingly, even with an increased market price per share, the total market capitalization of shares of our common stock after a reverse stock split could be lower than the total market capitalization before the reverse stock split. Also, even if there is an initial increase in the market price per share of our common stock after a reverse stock split, the market price may not remain at that level.

 

If the market price of shares of our common stock declines following the reverse stock split, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the reverse stock split due to decreased liquidity in the market for our common stock. Accordingly, the total market capitalization of our common stock following the reverse stock split could be lower than the total market capitalization before the reverse stock split.

 

We primarily sell our vehicles and accessories through a network of third-parties, and there is no assurance that we will be able to successfully build out this network.

 

In November 2021 we began negotiating dealer agreements to sell our vehicles and accessories in the United States to powersport vehicle dealers. As of September 30, 2023, we have 133 active dealers to sell our vehicles and accessories. We hired our first regional sales manager in Canada in June 2022 to begin developing our dealer network for Canadian powersports vehicle dealers. To date we have not signed any Canadian dealers as we have not homologated our products to meet Canadian vehicle regulations. In October 2023, we determined that we will postpone expansion of our dealer network in Canada for the foreseeable future and we have eliminated our Canadian regional sales managers.

 

We are required to comply with manufacture/dealer laws in each state in which we sell our vehicles through dealers. Dealer laws vary by state and although our dealer agreements are intended to comply with these laws, we may be required to amend our agreements if these laws are changed or are challenged by dealers or other OEMs. Our dealer and distribution agreements are generally short-term in nature and the dealer, distributor or we may cancel these agreements under certain circumstances and we may not be able to retain or expand the scope of our dealer and/or distribution network in the future.

 

Many dealers will require us to identify financing sources for dealers to purchase vehicle inventory and to identify financing sources for the dealers’ customers to finance their purchase. Because we are a young company with limited sales history and recurring losses, we have not been able to obtain these inventory financing sources which may result in dealers not wanting to sell our vehicles. We continue to look for alternative financing sources, we may not be successful in obtaining a source that could finance dealer inventory at a scale that will allow us to be profitable. To the extent we do find a financing source, we will incur costs under these financing arrangements to incentivize dealers to buy our vehicles including free dealer financing for certain periods or based on purchase volumes, interest rate buydowns on the dealers’ customer financing to incentivize their customers’ purchase of our vehicles which will reduce our profit margin on our vehicles.

 

We believe our success will be highly dependent on our ability to build out this dealer network in the major markets in which we intend to compete for customers, and to maintain this network in the future. Our business model is dependent not only on our ability to create the foregoing network, but also on the commitment and motivation of these third-parties to promote our brand and products.

 

 

 

 45 

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There were no unregistered sales of the Company’s equity securities during the quarter ended September 30, 2023, that were not previously disclosed in a Current Report on Form 8-K.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

 

ITEM 6. EXHIBITS

 

INDEX TO EXHIBITS

 

Exhibit

Number

  Description
1.1   Underwriting Agreement, dated September 15, 2023, with Aegis Capital Corp. (incorporated by reference to exhibit 1.1 of the Form 8-K filed September 18, 2023)
3.1   Amendment to Amended and Restated Certificate of Incorporation of Volcon, Inc. (incorporated by reference to exhibit 3.1 of the Form 8-K filed October 16, 2023)
4.1   Underwriter Warrant dated September 15, 2023, with Aegis Capital Corp (incorporated by reference to exhibit 4.1 of the Form 8-K filed September 18, 2023)
4.2   Form of New Warrant issued in connection with warrant inducement letter dated September 29, 2023 (incorporated by reference to exhibit 4.1 of the Form 8-K filed October 2, 2023)
4.3   Form of Warrant issued to GLV Ventures (incorporated by reference to exhibit 4.1 of the Form 8-K filed October 16, 2023)
4.4   Form of Exchange Warrants (incorporated by reference to exhibit 4.1 of the Form 8-K filed May 22, 2023)
10.1 +   Amendment No. 2 to the Volcon, Inc. 2021 Stock Plan, as amended and restated (incorporated by reference to exhibit 10.1 of the Form 8-K filed July 14, 2023)
10.2   Waiver and Modification Agreement, dated September 14, 2023 (incorporated by reference to exhibit 10.1 of the Form 8-K filed September 15, 2023)
10.3   Note Amendment, dated September 14, 2023 (incorporated by reference to exhibit 10.2 of the Form 8-K filed September 15, 2023)
10.4   Security Agreement between the Company, the Volcon Subsidiaries and Empery Tax Efficient, LP, in its capacity as collateral agent, dated September 22, 2023. (incorporated by reference to exhibit 10.2 of the Form 8-K filed September 27, 2023)
10.5   Guaranty Agreement between the Volcon Subsidiaries and Empery Tax Efficient, LP, in its capacity as collateral agent, dated September 22, 2023 (incorporated by reference to exhibit 10.3 of the Form 8-K filed September 27, 2023)
10.6   Form of Warrant Inducement Letter dated September 29, 2023 (incorporated by reference to exhibit 10.2 of the Form 8-K filed October 2, 2023)
10.7   Cooperative Research and Development Agreement with the United States Army Engineer Research and Development Center Construction Engineering Research Laboratory dated October 4, 2023 (incorporated by reference to exhibit 10.1 of the Form 8-K filed October 10, 2023)

 

 

 

 46 

 

 

10.8   First Amendment dated October 11, 2023 to the Volcon Stag Supplier Agreement (incorporated by reference to exhibit 10.1 of the Form 8-K filed October 16, 2023)
10.9   Form of Warrant Inducement Letter dated October 13, 2023 (incorporated by reference to exhibit 10.2 of the Form 8-K filed October 16, 2023)
10.10   Form of Warrant Inducement Letter dated October 30, 2023 (incorporated by reference to exhibit 10.1 of the Form 8-K filed October 30, 2023)
1.1   Underwriting Agreement, dated May 22, 2023, with Aegis Capital Corp. (incorporated by reference to exhibit 1.1 of the Form 8-K filed May 25, 2023)
4.1   Form of Convertible Notes issued in May 2023 Offering (incorporated by reference to exhibit 4.1 of the Form 8-K filed May 22, 2023)
4.2   Form of New Warrants (incorporated by reference to exhibit 4.2 of the Form 8-K filed May 22, 2023)
4.3   Form of Exchange Notes (incorporated by reference to exhibit 4.3 of the Form 8-K filed May 22, 2023)
31.1*   Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2*   Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1*(1)   Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*(1)   Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted in inline XBRL, and included in exhibit 101).

______________

* Filed herewith.
+ Indicates management contract or compensatory plan, contract or arrangement.

 

(1) The certifications on Exhibit 32 hereto are deemed not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

 

 

 

 

 

 

 

 

 

 

 

 

 47 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

VOLCON, INC.        
         
SIGNATURE   TITLE   DATE

 

 

       
/s/ Jordan Davis   Chief Executive Officer and Director   November 1, 2023
Jordan Davis   (principal executive officer)    
         
/s/ Greg Endo   Chief Financial Officer  

November 1, 2023

Greg Endo   (principal financial and accounting officer)    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 48 

Exhibit 31.1

 

CERTIFICATION BY CHIEF EXECUTIVE OFFICER

 

I, Jordan Davis, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of Volcon, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

November 1, 2023

 

 

By: /s/ Jordan Davis               

Jordan Davis

Chief Executive Officer

(Principal executive officer)

 

 

Exhibit 31.2

 

CERTIFICATION BY CHIEF FINANCIAL OFFICER

 

I, Greg Endo, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of Volcon, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

November 1, 2023

 

 

By: /s/ Greg Endo                     

Greg Endo

Chief Financial Officer

(Principal financial and accounting officer)

 

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Volcon, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer’s knowledge, that:

 

The quarterly report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

November 1, 2023

 

 

By: /s/ Jordan Davis                  

Jordan Davis

Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Volcon, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer’s knowledge, that:

 

The quarterly report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

November 1, 2023

 

 

By: /s/ Greg Endo                          

Greg Endo

Chief Financial Officer

(Principal financial and accounting officer)

 

 

v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Oct. 30, 2023
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description This amendment (Form 10-Q/A) is being provided for the sole purpose of providing a conformed signature on Exhibit 32.1 inadvertently omitted from our Form 10-Q for the period ended September 30, 2023, as filed on November 1, 2023. No other changes have been made to the Form 10-Q.  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40867  
Entity Registrant Name Volcon, Inc.  
Entity Central Index Key 0001829794  
Entity Tax Identification Number 84-4882689  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 3121 Eagles Nest Street  
Entity Address, Address Line Two Suite 120  
Entity Address, City or Town Round Rock  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78665  
City Area Code (512)  
Local Phone Number 400-4271  
Title of 12(b) Security Common Stock  
Trading Symbol VLCN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,819,278
v3.23.3
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 2,425,820 $ 10,986,592
Restricted cash 551,250 551,250
Accounts receivable, net of allowance for doubtful accounts of $118,689 and $62,451 at September 30, 2023 and December 31, 2022, respectively 206,447 864,957
Inventory 7,051,537 5,645,883
Inventory deposits 406,743 427,662
Prepaid expenses and other current assets 2,807,355 1,850,666
Total current assets 13,449,152 20,327,010
Long term assets:    
Property and equipment, net 1,264,166 601,766
Intangible assets, net 1,453 5,813
Other long-term assets 199,281 285,037
Right-of-use assets - operating leases 1,231,092 1,505,987
TOTAL ASSETS 16,145,144 22,725,613
Current liabilities:    
Accounts payable 3,470,898 1,036,628
Accrued liabilities 1,809,092 2,045,239
Exercised Warrants - Shares to be issued 537,250 0
Accrued Purchase commitments 0 28,600
Current portion of notes payable 14,910 18,670
Convertible notes, net of issuance costs 29,709,960 17,353,748
Right-of-use operating lease liabilities, short-term 423,849 391,117
Customer deposits 201,005 23,471
Total current liabilities 36,166,964 20,897,472
Notes payable, net of current portion 73,099 50,116
Right-of-use operating lease liabilities, long-term 845,117 1,143,011
Total liabilities 37,085,180 22,090,599
COMMITMENTS AND CONTINGENCIES
Stockholders' (deficit) equity:    
Preferred stock: $0.00001 par value, 5,000,000 shares authorized, no shares outstanding 0 0
Common stock: $0.00001 par value, 250,000,000 shares authorized, 6,403,166 shares issued and outstanding at September 30, 2023 and 100,000,000 shares authorized, 4,885,252 shares issued and outstanding as of December 31, 2022 63 48
Additional paid-in capital 96,450,387 76,369,892
Accumulated deficit (117,390,486) (75,734,927)
Total stockholders’ (deficit) equity (20,940,036) 635,013
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 16,145,144 $ 22,725,613
v3.23.3
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 118,689 $ 62,451
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 250,000,000 100,000,000
Common stock, shares issued 6,403,166 4,885,252
Common stock, shares outstanding 6,403,166 4,885,252
v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 487,430 $ 242,710 $ 2,177,188 $ 3,795,065
Cost of goods sold (3,542,468) (2,012,829) (5,107,096) (11,549,871)
Gross margin (3,055,038) (1,770,119) (2,929,908) (7,754,806)
Operating expenses:        
Sales and marketing 1,870,532 1,282,014 6,040,519 3,942,827
Product development 2,983,197 2,177,347 5,936,280 6,775,768
General and administrative expenses 1,544,344 2,085,211 5,003,135 7,409,601
Total operating expenses 6,398,073 5,544,572 16,979,934 18,128,196
Loss from operations (9,453,111) (7,314,691) (19,909,842) (25,883,002)
Other income (expense) (54,702) 33,814 (38,199) 72,800
Loss on extinguishment of Convertible Notes 0 0 (22,296,988) 0
Gain (loss) on change in fair value of financial liabilities (684,994) 0 5,107,794 0
Interest expense (1,135,089) (618,307) (4,518,324) (627,789)
Total other expense (1,874,785) (584,493) (21,745,717) (554,989)
Loss before provision for income taxes (11,327,896) (7,899,184) (41,655,559) (26,437,991)
Provision for income taxes 0 0 0 0
Net loss $ (11,327,896) $ (7,899,184) $ (41,655,559) $ (26,437,991)
Net loss per common share – basic $ (1.84) $ (1.62) $ (7.57) $ (5.64)
Net loss per common share – diluted $ (1.84) $ (1.62) $ (7.57) $ (5.64)
Weighted average common shares outstanding – basic 6,162,589 4,869,044 5,502,512 4,690,805
Weighted average common shares outstanding – diluted 6,162,589 4,869,044 5,502,512 4,690,805
v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 35 $ 47,803,736 $ (41,499,522) $ 6,304,249
Beginning balance, shares at Dec. 31, 2021 3,461,837      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 $ 13 18,089,171 18,089,184
Issuance of common stock for public offerings, net of issuance costs, shares 1,333,334      
Issuance of common stock for cashless exercise of warrants
Issuance of common stock for cashless exercise of warrants, shares 16,711      
Issuance of common stock for exercise of stock options and restricted stock 40,000 40,000
Issuance of common stock for exercise of stock options and restricted stock, shares 48,022      
Stock-based compensation 2,642,139 2,642,139
Stock-based compensation, shares 10,925      
Forfeiture of performance shares
Forfeiture of performance shares, shares (576)      
Issuance of Note Warrants and underwriter warrants, net of issuance costs of $1,003,513 7,177,976   7,177,976
Net loss (26,437,991) (26,437,991)
Ending balance, value at Sep. 30, 2022 $ 48 75,753,022 (67,937,513) 7,815,557
Ending balance, shares at Sep. 30, 2022 4,870,253      
Beginning balance, value at Dec. 31, 2022 $ 48 76,369,892 (75,734,927) 635,013
Beginning balance, shares at Dec. 31, 2022 4,885,252      
Issuance of common stock for exercise of stock options and vesting of restricted stock 25,000 25,000
Issuance of common stock for exercise of stock options and vesting of restricted stock, shares 10,000      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 $ 15 4,570,085 4,570,100
Issuance of common stock for public offerings, net of issuance costs, shares 1,480,000      
Stock-based compensation 2,223,356 2,223,356
Stock-based compensation, shares 27,772      
Reclassification of derivative liabilities to equity 13,262,055 13,262,055
Shares issued for rounding due to reverse stock split
Stock-based compensation, shares 142      
Net loss (41,655,559) (41,655,559)
Ending balance, value at Sep. 30, 2023 $ 63 $ 96,450,387 $ (117,390,486) $ (20,940,036)
Ending balance, shares at Sep. 30, 2023 6,403,166      
v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs $ 629,900 $ 1,910,816
Common Stock [Member]    
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs $ 629,900 1,910,816
Warrants Convertible Note [Member]    
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs   $ 1,003,513
v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flow from operating activities:    
Net loss $ (41,655,559) $ (26,437,991)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on extinguishment of convertible notes 22,296,988 0
Gain on change in fair value of financial liabilities (5,107,794) 0
Stock-based compensation 2,223,356 2,642,139
Loss on write down of inventory and inventory deposits 1,786,365 1,650,838
Loss on lease terminations 85,756 395,138
(Gain) loss on sale/write off of property & equipment (6,423) 250,369
Bad debt expense 66,990 0
Write off of intangible assets 0 6,427
Non-cash interest expense 4,516,041 614,366
Amortization of right-of-use assets 274,895 342,112
Depreciation and amortization 173,803 574,117
Changes in operating assets and liabilities:    
Accounts receivable 591,520 (1,541,983)
Inventory (3,192,019) (1,463,778)
Inventory deposits 20,919 1,061,846
Prepaid assets and other current assets (956,689) 289,387
Other assets 0 (29,120)
Accounts payable 2,434,270 (978,962)
Accrued liabilities (264,747) 293,626
Right-of-use liabilities - operating leases (265,161) (269,836)
Customer deposits 177,534 (2,218,856)
Net cash provided by (used in) operating activities (16,799,955) (24,820,161)
Cash flow from investing activities:    
Purchase of property and equipment (818,399) (620,290)
Proceeds from sale of vehicles 89,000 0
Net cash used by investing activities (729,399) (620,290)
Cash flow from financing activities:    
Repayment of notes payable (76,801) (12,768)
Proceeds from issuance of common stock from public offerings, net if issuance costs of $629,900 4,570,100 0
Proceeds from issuance of convertible notes and warrants, net of issuance costs of $586,968 3,913,033 0
Proceeds from exercise of warrants 537,250  
Proceeds from issuance of common stock from public offering, net of issuance costs of $1,910,816 0 18,089,184
Proceeds from issuance of convertible notes, net of issuance costs of $2,312,895 0 15,122,345
Proceeds from issuance of warrants to convertible note holders, net of issuance costs of $1,003,513 0 7,177,976
Proceeds from exercise of stock options 25,000 40,000
Net cash provided by financing activities 8,968,582 40,416,737
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (8,560,772) 14,976,286
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 11,537,842 5,572,199
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 2,977,070 20,548,485
Supplemental disclosure of cash flow information:    
Cash paid for interest 6,474 4,401
Cash paid for income taxes 0 0
Non-cash transactions    
Recognition of initial right-of-use asset - operating lease 0 1,128,609
Acquisition of property and equipment with note payable $ 96,024 $ 0
v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs $ 629,900 $ 1,910,816
Convertible Notes And Warrants [Member]    
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs $ 586,968  
Convertible Notes [Member]    
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs   2,312,895
Warrants Convertible Note [Member]    
Securities Financing Transaction [Line Items]    
Payment of stock issuance costs   $ 1,003,513
v3.23.3
ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN

NOTE 1 – ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN

 

Organization and Nature of Operations

 

Volcon, Inc. (“Volcon” or the “Company”) was formed on February 21, 2020, as a Delaware corporation, under the name Frog ePowersports, Inc. The Company was renamed Volcon, Inc. on October 1, 2020. Volcon designs and sells all-electric off-road powersport vehicles.

 

On January 5, 2021, the Company created Volcon ePowersports, LLC (“Volcon LLC ''), a Colorado wholly-owned subsidiary of the Company, to sell Volcon vehicles and accessories in the United States. Volcon LLC is no longer used for selling vehicles and accessories.

 

Going Concern

 

The accompanying interim consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has recurring losses and has generated negative cash flows from operations since inception.

 

In August 2022, the Company ceased manufacturing the Grunt motorcycle in Round Rock, Texas and has outsourced all manufacturing of its vehicles to third-parties. Further, the Company has, or plans to, outsource the manufacturing of all its future vehicles to third-parties for the foreseeable future. The Company has also outsourced certain design and prototype services of its vehicles to third-parties. In September 2022, management reduced headcount and employee related costs in its product development and administrative departments to reduce operating costs.

 

Also in August 2022, the Company received net proceeds of approximately $22.3 million for the issuance of convertible notes due February 2024 (“Convertible Notes”) and warrants (see Note 6).

 

The Company received net proceeds of approximately $3.9 million for the issuance of additional convertible notes in May 2023 due February 2024 (“New Notes”) and warrants. On the issuance date of the New Notes, the Company exchanged the Convertible Notes for Series A and Series B notes (collectively the “Exchange Notes). The Exchange Notes require the Company to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the Exchange Notes is $15,000,000 or greater as of December 31, 2023 (the September 30, 2023 requirement under the Convertible Notes was removed). The cash on deposit requirement is reduced dollar for dollar to the extent the outstanding principal (and interest, if any) of the Exchange Notes is less than $15 million on this date. The Company also exchanged the warrants issued with the Convertible Notes for new warrants (the “Exchange Warrants”) (see Note 6 for further discussion).

 

On September 14, 2023, the holders of the New Notes and Exchange Notes (collectively the “May 2023 Notes”) entered into an agreement to modify the terms to extend the due date to January 31, 2025. In addition, the requirement to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the Exchange Notes is $15 million or greater as of December 31, 2023 was amended to reduce the unrestricted and unencumbered cash on deposit to $5 million if the outstanding principal (and interest, if an) of the Exchange Notes is $15 million or greater as of June 30, 2024. The cash on deposit requirement is reduced dollar for dollar to the extent the outstanding principal (and interest, if any) of the Exchange Notes is less than $15 million on this date. In addition, the Company must sell 250 units of its Stag UTV by December 31, 2023. The Company may factor up to $10 million of its accounts receivables provided the factoring lender executed a subordination and intercreditor agreement on terms acceptable to the holders of the May 2023 Notes, which was completed on October 17, 2023. The Company was also required to perfect a security interest in the assets of the Company no later than September 22, 2023, which the Company has completed.

 

In May 2023, the Company received net proceeds of approximately $4.0 million for the issuance of 1,200,000 shares of common stock at $3.75 per share.

 

On September 18, 2023, the Company received net proceeds of approximately $571,400 for the issuance of 280,000 shares of common stock at $2.50 per share.

 

In a series of warrant inducement transactions from September 29, 2023 to October 30, 2023, as more fully discussed below, the Company raised $1,027,495.

 

Management anticipates that our cash on hand as of September 30, 2023 plus, the cash received from the warrant inducements, and cash expected to be generated from operations will not be sufficient to fund planned operations and maintain required cash balances for the Exchange Notes beyond one year from the date of the issuance of the financial statements as of and for the three and nine months ended September 30, 2023. There can be no assurance that additional funding, if needed, would be available to the Company on acceptable terms, or at all. These factors raise substantial doubt regarding our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that may result should the Company be unable to continue as a going concern.

 

Nasdaq Compliance


On July 5, 2023, the Company received a notice from Nasdaq that it was not in compliance with Nasdaq’s Listing Rule 5550(b)(2), which requires that it maintain a market value of listed securities (“MVLS”) of $35 million. MVLS is calculated by multiplying the Company’s shares outstanding by the closing price of its common stock. On July 6, 2023, the Company received a notice from Nasdaq that it was not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of its common stock had been below $1.00 per share for 30 consecutive business days. On October 30, 2023, the Company received a notice from Nasdaq that it has now regained compliance with Rule 5550(a)(2), as the minimum bid price of its common stock was above $1.00 for 10 consecutive business days.

 

The Company has until January 2, 2024, to regain compliance with the MVLS requirement. To regain compliance with the MVLS requirement, the Company’s MVLS must close at $35 million or more for a minimum of ten consecutive business days during this grace period. While the Company may be able to qualify for additional time to attempt to regain compliance, there can be no assurance that it will qualify for additional time to regain compliance, or that it will regain compliance with or without such additional time. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting.

Impact of Russia and Ukraine Conflict


On February 24, 2022, Russia invaded Ukraine. The conflict between Russia and Ukraine could impact the availability of nickel, an element used in the production of lithium ion cells used in batteries that power our vehicles. The shortage of these cells could have an impact on our ability to produce vehicles to meet our customers’ demands. In addition, sanctions against Russia could impact the price of elements, including nickel, that are used in the production of batteries which would result in higher costs to produce our vehicles. These sanctions have also impacted the U.S. and global economies and could result in an economic recession which could cause a broader disruption to the Company’s supply chain and distribution network and customer demand for our products.

 

Impact of the United Auto Workers Union Strike

 

On September 15, 2023, the United Auto Workers Union went on strike. This strike could cause a disruption to the Company’s supply chain, specifically General Motors’ ability to supply batteries and drive train components used in the Stag UTV. Shortages of these components could have an impact on our ability to produce vehicles to meet our customers’ demands.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Interim Unaudited Financial Information

 

The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (“SEC”) on March 7, 2023. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted from this report on Form 10-Q pursuant to the rules and regulations of the SEC.

 

Results for the interim periods in this report are not necessarily indicative of future financial results and have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary to present fairly our interim consolidated financial statements as of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022. These adjustments are of a normal recurring nature and consistent with the adjustments recorded to prepare the annual audited consolidated financial statements as of December 31, 2022.

 

Basis of Presentation

 

As discussed in Note 14, the Company completed a reverse 1 for 5 stock split on October 13, 2023, all share and per share amounts have been adjusted to reflect the impact of this reverse stock split.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts, transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of any contingent assets and liabilities as of the dates of the financial statements and the reported amounts of expenses during the reporting periods.

 

Making estimates requires management to exercise judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ significantly from those estimates.

  

Cash, Cash Equivalents and Restricted Cash

 

Cash and cash equivalents include short-term investments with original maturities of 90 days or less at the date of purchase. The recorded value of our cash and cash equivalents approximates their fair value. There were no cash equivalents as of September 30, 2023 or December 31, 2022. Restricted cash includes cash restricted as collateral for the Company’s corporate credit cards and a letter of credit with the Company’s bank.

 

Revenue Recognition

 

For sales of the Grunt motorcycle directly to consumers, revenue was recognized when the Company transferred control of the product to the consumer and the 14-day acceptance period had expired, or earlier acceptance had been received from the consumer. Sales directly to consumers were completed as of June 1, 2022. Beginning in February 2023 the Company began selling the Brat E-Bike and Volcon Youth motorcycles directly to consumers in addition to dealers, revenue for direct to consumer sales is recognized when transfer of control of the product is made to the consumer.
 

For sales to dealers or distributors revenue is recognized when transfer of control of the product is made as there is no acceptance period or right of return. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring control of vehicles, parts, and accessories. Consideration that is received in advance of the transfer of goods is recorded as customer deposits until delivery has occurred or the customer cancels their order, and the consideration is returned to the customer. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s sales do not presently have a financing component.

 

Sales promotions and incentives. The Company provides for estimated sales promotions and incentives, which are recognized as a component of sales in measuring the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Examples of sales promotion and incentive programs include rebates, distributor fees, dealer co-op advertising and volume incentives. Sales promotions and incentives are estimated based on contractual requirements. The Company records these amounts as a liability in the balance sheet until they are ultimately paid. Adjustments to sales promotions and incentives accruals are made as actual usage becomes known to properly estimate the amounts necessary to generate consumer demand based on market conditions as of the balance sheet date.

 

Shipping and handling charges and costs. The Company records shipping and handling amounts charged to the customer and related shipping costs as a component of cost of goods sold when control has transferred to the customer.

 

Product Warranties

 

The Company provides a one-year warranty on vehicles, and a two-year warranty on the battery pack. The Company accrues warranty reserves at the time revenue is recognized. Warranty reserves include the Company’s best estimate of the projected cost to repair or to replace any items under warranty, based on actual warranty experience as it becomes available and other known factors that may impact the evaluation of historical data. The Company reviews its reserves quarterly to ensure that the accruals are adequate to meet expected future warranty obligations and will adjust estimates as needed. Factors that could have an impact on the warranty reserve include the following: changes in manufacturing quality, shifts in product mix, changes in warranty coverage periods, product recalls and changes in sales volume. Warranty expense is recorded as a component of cost of goods sold in the statement of operations and is recognized as a current liability.

  

Inventory and Inventory Deposits

 

Inventories and prepaid inventory deposits are stated at the lower of cost (first-in, first-out method) or net realizable value.

 

Certain vendors require the Company to pay an upfront deposit before they will manufacture and ship the Company’s parts or accessories. These payments are classified as prepaid inventory deposits on the balance sheet until title and risk of loss transfers to the Company, at which time they are classified as inventory.

 

Raw materials inventory costs include the cost of parts, including duties, tariffs, and shipping. Work-in-process and finished goods include the cost of parts, labor and manufacturing overhead costs associated with the assembly of the vehicle. Finished goods also include accessories for the vehicle and branded merchandise such as hats and shirts.

 

Through August 2022 the Company assembled the Grunt motorcycle in a leased facility. The Company ceased assembly operations at the end of August and outsourced the assembly of the Grunt to a third-party. In May 2023, the Company transferred substantially all of its raw materials and work-in-process inventory for the Grunt to the third-party manufacturer. Title to the inventory transferred to the third-party manufacturer and it will provide the Company with a credit towards future purchases of finished goods once it begins production of the Grunt EVO.
 

Property and Equipment

 

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

   
Category   Estimated
Useful Lives
Machinery, tooling and equipment   3-7 years
Vehicles   5 years
Internal use manufactured vehicles   1 year
Furniture & Fixtures   5 years
Computers   3 years

 

Leasehold improvements are depreciated over the shorter period of their estimated useful life or term of the lease.

 

Intangible Assets


Intangible assets include acquired domain names and software. Domain names are amortized over 15 years and software is amortized over the life of the shorter of the software term or three years.

 

Long-Lived Assets

 

The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the historical carrying cost value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to the carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset.

 

Leases

 

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expenses for these leases on a straight-line basis over the lease term. The Company does not separate non-lease components from the lease components to which they relate, and instead accounts for each separate lease and non-lease component associated with that lease component as a single lease component.

  

ASC 842 defines initial direct costs as only the incremental costs of signing a lease. Initial direct costs related to leasing that are not incremental are expensed as general and administrative expenses in our statements of operations.

 

The Company’s operating lease agreements primarily consist of leased real estate and are included within ROU assets – operating leases and ROU lease liabilities – operating leases on the balance sheets. The Company’s lease agreements may include options to extend the lease, which are not included in minimum lease payments unless they are reasonably certain to be exercised at lease commencement. The Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

 

Research and Development Expenses

 

The Company records research and development expenses in the period in which they are incurred as a component of product development expenses.

 

Income Taxes

 

Deferred taxes are determined utilizing the “asset and liability” method, whereby deferred tax asset and liability account balances are determined based on the differences between financial reporting and the tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, when it's more likely than not that deferred tax assets will not be realized in the foreseeable future. Deferred tax liabilities and assets are classified as current or non-current based on the underlying asset or liability or if not directly related to an asset or liability based on the expected reversal dates of the specific temporary differences.

 

Fair Value of Financial Instruments

 
ASC Topic 820 Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  · Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
  · Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  · Level 3 — Inputs that are unobservable for the asset or liability.

 

The following section describes the valuation methodologies that the Company used to measure different financial instruments at fair value.

 

Debt

 

The fair value of the Company’s debt approximated the carrying value of the Company’s debt as of September 30, 2023 and December 31, 2022. Factors that the Company considered when estimating the fair value of its debt included market conditions, and term of the debt. The level of the debt would be considered as Level 2.

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

The Company accounts for derivative instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC Topic 815”), and all derivative instruments are reflected as either assets or liabilities at fair value on the consolidated balance sheets. The Company uses estimates of fair value to value its derivative instruments. Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between able and willing market participants. In general, the Company’s policy in estimating fair values is to first look at observable market prices for identical assets and liabilities in active markets, where available. When these are not available, other inputs are used to model fair value such as prices of similar instruments, yield curves, volatilities, prepayment speeds, default rates and credit spreads, relying first on observable data from active markets. Depending on the availability of observable inputs and prices, different valuation models could produce materially different fair value estimates. The values presented may not represent future fair values and may not be realizable. The Company categorizes its fair value estimates in accordance with ASC Topic 820, based on the hierarchical framework associated with the three levels or price transparency utilized in measuring financial instruments at fair value as discussed above.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e., at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Initial Measurement

 

The Company records its financial instruments classified as a liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement - Financial instruments classified as liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other expense/income. The Monte Carlo simulation is used to determine the fair value of derivatives for instruments with embedded conversion features and for free standing warrants as discussed further in Note 7.

 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash, accounts receivable, inventory, other assets, and accounts payable and accrued expenses approximate their fair value due to the short-term maturity of those items.

 

Warrant Liabilities and Convertible Liabilities

 

The fair value of the derivative liabilities is classified as Level 3 within the Company’s fair value hierarchy. Please refer to Note 7, Derivative Instruments, for further discussion of the measurement of fair value of the derivatives and their underlying assumptions.

 

Stock-Based Compensation

 

The Company has a stock-based incentive award plan for employees, consultants and directors. The Company measures stock-based compensation at the estimated fair value on the grant date and recognizes the amortization of stock-based compensation expense on a straight-line basis over the requisite service period, or when it is probable criteria will be achieved for performance-based awards. Fair value is determined based on assumptions related to the fair value of the Company common stock, stock volatility and risk-free rate of return. The Company has elected to recognize forfeitures when realized.

 

Concentration Risk

 

The Company outsources certain portions of product design and development for its vehicles to third-parties. In addition, the Company has outsourced the manufacturing of all of its vehicles to third-party manufacturers, including one manufacturer for three of its vehicles and this third-party is also performing product design and development services on these vehicles.

 

One supplier provides the battery and drivetrain components for the Company’s utility terrain vehicle, the Stag. The components are critical to the operation of the Stag.

 

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU 2016-13 effective January 1, 2023. The Company determined that the update applied to trade receivables, but that there was no material impact to the consolidated financial statements from the adoption of ASU 2016-13.

  

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

 

v3.23.3
INVENTORY
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 3 – INVENTORY

 

Inventory consists of the following:

        
  

September 30,

2023

  

December 31,

2022

 
Raw materials  $3,561,150   $3,060,160 
Work-in-process       439,839 
Finished goods   3,490,387    2,145,884 
Total inventory  $7,051,537   $5,645,883 

 

The Company has purchase commitments for future payments due for inventory where initial deposits were paid as of September 30, 2023. The total additional payments due subsequent to September 30, 2023 are $252,548. In June 2023, the Company wrote down all remaining Torrot branded inventory in the amount of $84,000. In September 2023, the Company wrote down the Volcon co-branded Torrot youth motorcycles in the amount of $1,622,262 to reduce their cost to the estimated net realizable value.

 

v3.23.3
LONG – LIVED ASSETS
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
LONG – LIVED ASSETS

NOTE 4 – LONG – LIVED ASSETS

 

Property and Equipment

 

Property and equipment consist of the following:

        
  

September 30,

2023

  

December 31,

2022

 
Machinery, tooling and equipment  $1,011,351   $352,137 
Vehicles   213,528    156,648 
Internal use manufactured vehicles   274,385    274,385 
Fixtures & furniture   90,768    50,768 
Leasehold improvements   44,663    44,663 
Computers   234,898    228,671 
    1,869,593    1,107,272 
Less: Accumulated depreciation   (605,427)   (505,506)
Total property and equipment  $1,264,166   $601,766 

 

Depreciation expense for the three and nine months ended September 30, 2023 was $65,725 and $169,443, respectively. Depreciation expense for the three and nine months ended September 30, 2022 was $265,907 and $569,757, respectively.

 

v3.23.3
NOTES PAYABLE
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 5 – NOTES PAYABLE

 

In December 2020, the Company entered into a financing arrangement for $75,702 with an interest rate of 8.64% for a vehicle. The Company was required to make monthly payments of $1,211 over 72 months. In April 2021, the Company entered into a financing arrangement for $30,942 with an interest rate of 7.64% for a vehicle. The Company was required to make monthly payments of $753 over 48 months. The Company sold both vehicles in the three months ended March 31, 2023 and paid off these notes.

 

In March 2023, the Company entered into two financing arrangements to purchase two vehicles. The total principal of these arrangements is $96,024 with interest rates of 11.44% and 8.63% and monthly payments totaling $1,923 are due through January 2028 and $908 per month until February 2029.

 

The following table provides the maturities of notes payable as of September 30, 2023: 

    
Remainder of 2023  $5,768 
2024   23,073 
2025   23,073 
2026   23,073 
2027   23,073 
2028   12,927 
2029   1,816 
Total future payments   112,803 
Less: Interest   (24,794)
Total notes payable   88,009 
Less current portion   (14,910)
Long-term notes payable  $73,099 

 

v3.23.3
CONVERTIBLE NOTES
9 Months Ended
Sep. 30, 2023
Convertible Notes  
CONVERTIBLE NOTES

NOTE 6 - CONVERTIBLE NOTES

 

On August 24, 2022, the Company issued senior convertible notes with an aggregate principal amount of $27,173,913 due February 24, 2024. The Convertible Notes had an initial conversion price of $11.25 per share of common stock (2,415,459 total shares if fully converted) and were issued with an original issue discount of 8.0% and did not bear interest unless an event of default occurred, upon which interest would have accrued at 10% per annum. The holders of the Convertible Notes could have converted any portion of the principal at any time during the term of the notes. The holders of the Convertible Notes also received fully vested warrants (the “Note Warrants”) to purchase 1,811,595 shares of the Company’s common stock at an initial exercise price of $14.25 per share. The conversion and warrant exercise prices were subject to adjustment if the Company declared a stock dividend, stock split or recapitalization. The Company received net cash proceeds, after issuance costs (excluding the value of the warrants issued to the placement agent as discussed below) of $22,300,321.

 

Company allocated the net proceeds received from the issuance of the Convertible Notes and Note Warrants based on the relative fair values of each resulting in net proceeds of $15,122,345 being allocated to the Convertible Notes recorded as a current liability in the balance sheet and net proceeds of $6,561,247 being allocated to the Note Warrants which was recorded in equity. The Company recorded non-cash interest expense through May 24, 2023 (see below for discussion of issuance of additional convertible notes) to accrete the allocated value of the Convertible Notes using the effective interest method and an interest rate of 39.6%. The Company incurred debt issuance costs of $3,316,409 upon issuance of the Convertible Notes, which includes $616,730 for the fair value of the warrants issued to the placement agent of the Convertible Notes as further described in Note 9. These debt issuance costs were amortized as additional interest expense through May 24, 2023. Total interest expense for the Convertible Notes for the three and nine months ended September 30, 2023 was zero and $2,913,632, respectively, prior to the recognition of the unamortized discount and issuance costs upon issuance of the additional senior convertible notes noted below. Substantially all of the assets of the Company are collateral for the Convertible Notes.

 

On May 24, 2023, the Company issued additional senior convertible notes (“New Notes'') with an aggregate principal amount of $4,934,783 due February 24, 2024 to the same investors of the Convertible Notes. The New Notes had an initial conversion price of $12.70 per share of common stock, which was subject to adjustment to $3.75 upon stockholder approval (1,315,942 total shares if fully converted at $3.75 per share, stockholder approval was received on August 3, 2023). The conversion price is also subject to further adjustment if the Company completes an equity or convertible note offering with a price below $3.75, or completes a stock split, reverse stock split or recapitalization where the lowest day’s volume weighted average price (“VWAP”) of the Company’s stock price is below $3.75 in the five days following the stock split, with a floor price of $0.22 (subject to stockholder approval, which was obtained on August 3, 2023). The conversion price is also subject to further adjustment if the Company completes an equity or convertible note offering with a price below $3.75. The New Notes were issued with an original issue discount of 8.8% and do not bear interest unless an event of default has occurred, upon which interest accrues at 10% per annum.

 

The holders of the New Notes also received fully vested warrants (the “New Warrants”) to purchase 1,086,957 shares of the Company’s common stock at an initial exercise price of $5.45 per share.

 

Concurrent with the issuance of the New Notes, the Company exchanged the Convertible Notes into two new notes, Series A Notes and Series B Notes both due February 24, 2024 (collectively the “Exchange Notes” and collectively with the New Notes the “May 2023 Notes”). The aggregate principal amount of Series A Notes is $3,690,422 and these are convertible into the Company’s common stock at an initial conversion price of $3.75 per share (984,113 total shares if fully converted). The aggregate principal amount of the Series B Notes is $23,483,491 and were initially convertible into the Company’s common stock at an initial conversion price of $5.45 per share (4,308,898 total shares if fully converted) but were subject to adjustment to $3.75 upon stockholder approval (6,262,265 total shares if fully converted at $3.75 per share), which approval was received on August 3, 2023.

 

In September 2023, the holders of the May 2023 Notes agreed to modify the due date of these notes to January 31, 2025. In October 2023, the conversion price of the Notes and exercise price of the Warrants were reduced to $1.369 per share. See discussion of further modifications below.

 

The Company completed a public offering and sold 280,000 shares of common stock at $2.50 per share. The holders of the May 2023 Notes waived their right to reduce the conversion price to the equity issuance price and agreed to reduce the conversion price to $2.75 per share (11,675,892 total shares if fully converted at $2.75 per share).


The May 2023 Notes contain certain conversion limitations, providing that no conversion may be made if, after giving effect to the conversion, the holder, together with any of its affiliates, would own in excess of 9.99% of the Company’s outstanding shares of common stock after giving effect to such conversion. The Company can force conversion of the Series A and Series B Notes at any time if the weighted average price of the Company’s common stock for ten consecutive trading days equals or exceeds $5.85 or $8.45, respectively, subject to the share limitations described above. In addition to default interest of 10% accruing on the May 2023 Notes, the holders may require the Company to redeem a portion or all of the outstanding May 2023 Notes.

 

Events of default for the May 2023 Notes are defined in the note agreements and include the following:

 

  · Failure of the Company to file a registration statement, and have declared effective to register the shares of the Company’s common stock within a specified period (the Company has met this requirement as of September 28, 2023)
  · Suspension of trading, or failure to be listed, of the Company’s common stock on an eligible market, as defined, for a period of two consecutive trading days or an aggregate of ten trading days in a 365 day period
  · Failure to deliver shares of the Company’s common stock within five days following a conversion notification
  · Failure to reserve shares of the Company’s common stock for the conversion of the May 2023 Notes and May 2023 Warrants
  · Any acceleration prior to maturity of any indebtedness of the Company, declaration of bankruptcy, or court ordered bankruptcy
  · Final judgment or judgments for payment aggregating in excess of $250,000 are rendered against the Company not covered by insurance or indemnity and are not discharged or stayed pending appeal within 60 days of judgment
  · Breach of any representation, warranty or covenant by the Company to the transaction documents of the May 2023 Notes and Exchange Warrants
  · Any material damage to, or loss, theft or destruction of a material amount of the property of the Company
  · Failure to remove any restrictive legends on any shares of the Company’s common stock issued to the holders of the May 2023 Notes
  · Electronic transfer of shares of the Company’s common stock is not available

 

As of September 30, 2023, the Company is in compliance with all covenants. The May 2023 Notes originally required the Company to have unrestricted and unencumbered cash on deposit of $10 million if the outstanding principal (and interest, if any) of the May 2023 Notes is $15 million or greater as of December 31, 2023. The cash on deposit requirement is reduced dollar for dollar to the extent that the outstanding principal (and interest, if any) of the May 2023 Notes is less than $15 million on December 31, 2023.

In September 2023, the note holders modified this requirement to change the date from December 31, 2023 to June 30, 2024 and reduced the cash on deposit requirement to $5 million. All other provisions for this cash on deposit requirement remain unchanged. The holders also included a new requirement that the Company sell at least 250 units of its Stag utility terrain vehicle by December 31, 2023 or the Company would be in default on the Notes.

 

The Company also exchanged the 1,811,595 Note Warrants with an exercise price of $14.25 per share issued with the Convertible Notes in August 2022 for 3,411,596 warrants which had an initial exercise price of $5.45 per share (the “Exchange Warrants”), and which exercise price was adjusted to $3.75 per share upon stockholder approval, which approval was received on August 3, 2023. The Exchange Warrants expire August 24, 2027.

 

The conversion prices of the Exchange Notes, and the exercise prices of the New Warrants and Exchange Warrants (collectively the “May 2023 Warrants”) are subject to further adjustment in the event that the Company issues additional common stock, stock options, warrants or convertible notes with prices below $3.75 per share, or completes a stock split, reverse stock split or recapitalization where the lowest day’s VWAP of the Company’s stock price is below $3.75 in the five days following the stock split with a floor of $0.22 per share. As discussed above, in September 2023 the Company completed a public offering of 280,000 shares of its common stock at $2.50 per share. The exercise price of the May 2023 Warrants were reduced to $2.50 per share as a result of the public offering.


Also in September 2023, the Company and the holders of the Exchange Warrants entered into a warrant inducement agreement whereby the Exchange Warrant holders agreed to exercise 307,001 Exchange Warrants at a reduced exercise price of $1.75 per share. The Company issued the holders 307,001 warrants (“Reload Warrants”) with an exercise price of $2.50 per share. The Reload Warrants are immediately exercisable for unregistered shares of the Company’s common stock and have the same terms as the May 2023 Warrants and expire August 24, 2027. The Company recognized equity issuance costs of $216,855 for the issuance of the Reload Warrants.

 

As discussed in Note 14, the Company completed a 1 for 5 reverse stock split on October 13, 2023 and the lowest day’s VWAP in the five days following the reverse split was $1.369 per share and the conversion price of New Notes and Exchange Notes, and the exercise price of the New Warrants and Exchange Warrants were reduced to $1.369 per share effective October 20, 2023.

 

Holders of the May 2023 Notes, the May 2023 Warrants and Reload Warrants (collectively the “Holders”) do not have voting rights to the extent they have not converted their notes or exercised their warrants.  

The May 2023 Warrants and Reload Warrants contain certain conversion limitations, providing that a holder thereof may not exercise such warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such exercise. The May 2023 Warrants and Reload Warrants provide the holders the right to exercise these warrants on a non-cash basis if the Company does not have an effective registration statement for the underlying shares of common stock.


The Company has evaluated the issuance of the New Notes and Exchange Notes and related warrants and has determined that the Convertible Notes were extinguished based on the conclusion that the terms of the New Notes and Exchange Notes are substantially different from the Convertible Notes in accordance with ASC 470, Debt. In addition, the Company has recognized a loss on the extinguishment of the Convertible Notes based on the carrying value of the Convertible Notes at the transaction date, plus gross proceeds received from the issuance of New Notes and New Warrants, less the fair value of the i) New Notes and conversion option, ii) New Warrants, iii) Exchange Notes and conversion options, and iv) Exchange Warrants. The resulting loss on extinguishment was $22,296,988, which includes the unamortized issuance costs of $1,330,296 of the Convertible Notes as of the date of the issuance of the New Notes. The fair value of the May 2023 Notes were estimated based on the future cash flows discounted at an interest rate of 14.9%. The May 2023 Notes were recorded at their initial fair values as follows:

 

        
   Fair Value   Principal Amount 
New Notes  $4,410,058   $4,934,783 
Series A Exchange Notes   3,298,012    3,690,422 
Series B Exchange Notes   20,986,449    23,483,891 
Total May 2023 Notes  $28,694,519   $32,109,096 

 

The Company recognized interest expense of $958,640 and $1,364,993 in the three and nine months ended September 30, 2023 for the accretion of the discount on the May 2023 Notes during the periods.

 

The Company estimated the fair value of the conversion features of the New Notes, Exchange Notes, New Warrants and Exchange Warrants as of May 24, 2023 as discussed in Note 7 below.

 

The Company incurred debt issuance costs of $586,968 upon issuance of the New Notes and New Warrants. The Company will amortize these issuance costs as additional interest expense over the remaining term of the New Notes. The Company recognized interest expense of $172,194 and $237,416 for the amortization of these issuance costs for the three and nine months ended September 30, 2023.

 

As of September 30, 2023, there were no conversions of the May 2023 Notes.

 

v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS

NOTE 7 - DERIVATIVE FINANCIAL INSTRUMENTS

 

As discussed in Note 6, the Company recognized a loss on the extinguishment of the Convertible Notes based on the fair values of the New Notes including the conversion feature, New Warrants, Exchange Notes and conversion feature and Exchange Warrants. The Company determined that there was a derivative liability associated with the conversion features in the New Notes and Exchange Notes due to the variable conversion price subject to stockholder approval in the conversion feature. Therefore, the Company has separated conversion features from the New Notes and Exchange Notes and has recorded them at fair value and will continue to adjust them to fair value until the conversion price is fixed. The Company has also determined that the New Warrants and Exchange Warrants are derivative liabilities due to the potential adjustment in the exercise prices. The Company has accounted for the New Warrants and Exchange Warrants as liabilities at fair value and will continue to adjust them to fair value until the exercise prices are fixed.

 

The fair value of the conversion features and warrant liabilities were calculated using a Monte Carlo simulation and the following assumptions and methodologies:

          
  

 

 

May 24, 2023

  

 

August 3, 2023

 
Conversion Feature Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   86.3%    84.1% 
Conversion price per share  $0.75   $0.75 
Note term (years)   0.76    0.56 
Risk free interest rate   5.1%    5.4% 
Warrant Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   119.2%    115.0% 
Conversion price per share  $0.75   $0.75 
Warrant term (years)   4.25    4.06 
Risk free interest rate   3.8%    4.3% 

 

In addition to the above factors, the Company also used a probability assessment for the initial and June 30, 2023 valuation to evaluate whether stockholder approval would be received to lower the conversion and exercise prices. The Company utilized a 50/50 assessment that stockholders would or would not approve the lower conversion and exercise price. Management notes that at the time of the assessment, the stockholder vote had not yet started therefore there was no data to determine whether one scenario was more likely than another. Since the stockholders approve the lower conversion and exercise price on August 3, 2023, no probability assessment was used.

 

Based on the above factors, the estimated fair value of the Company’s financial derivative liabilities carried at fair value at May 24, 2023 and August 2, 2023 as follows:

 

          
   May 24, 2023   August 3, 2023 
Conversion Feature - New Notes  $663,096   $557,168 
Conversion Feature - Series A Exchange Notes   970,805    416,672 
Conversion Feature - Series B Exchange Notes   4,324,792    2,651,436 
New Warrants   3,123,682    2,445,244 
Exchange Warrants   9,287,474    7,191,535 
Total  $18,369,849   $13,262,055 

 

 

On August 3, 2023, shareholders approved the adjustment of the conversion price of the New Notes and Exchange Notes and the exercise price of the New Warrants and Exchange Warrants. The conversion and exercise prices can adjust to a floor of $0.22 per share based on certain events defined in the agreements related to these instruments. The Company has concluded that as of August 3, 2023, the conversion feature of the May 2023 Notes and the May 2023 Warrants are no longer derivative liabilities. The Company recognized a (loss) gain of $(690,290) and 2,333,417 for the change in the fair values of the conversion features of the May 2023 Notes for the three and nine months ended September 30, 2023, respectively.

 

The Company has calculated the fair value of May 2023 Warrants at August 3, 2023, and recognized a gain of $5,296 and $2,774,377 in the three and nine months ended September 30, 2023. The total gain recognized for the nine months ended September 30, 2023 for the May 2023 Notes conversion features and May 2023 Warrants is $5,107,794.

 

v3.23.3
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 8 – RELATED PARTY TRANSACTIONS

 

During 2022, the Company issued purchase orders and made prepayments for prototype parts of $21,860 to a vendor that Pink Possum, LLC (“Pink Possum”), an entity controlled by Mr. Okonsky, one of the Company’s founders, Chairman of the Board and Chief Technology Officer, holds an equity interest of 25% as of September 30, 2023. This vendor is expected to provide additional prototype and product parts for a prototype of an upgraded version of the Stag expected to be released in the future.

 

In November 2020, the Company entered into an operating lease with an entity controlled by the Company’s two founders for its future headquarters and production facility in Liberty Hill, Texas. The lease had a lease term of 5 years, and monthly payments ranging from approximately $15,000 per month to $17,000 per month over the lease term and gave the Company access to the land for use in testing its vehicles prior to the construction of any facilities. In February 2021, the Company entered into an amendment of the lease related to its future headquarters to expand the leased premises. The Company paid an additional security deposit of $139,230 and additional prepaid rent of $315,588. The total minimum lease payments under the amended lease totaled approximately $3,930,170.

 

In October 2021, the Company began discussions for an additional amendment to the lease, in anticipation of manufacturing the Stag at this location, which would have resulted in the monthly payment increasing to $100,000 for the first year of the lease and increasing annually throughout the term of the lease to $107,000 in the final year. Monthly payments for the initial lease and the amended agreement would have begun at the time a certificate of occupancy was received by the landlord.

 

The Company evaluated the cost of this facility in relation to other lower cost options, including having a third-party manufacturer the Stag, and determined that it would be in the best interest of the Company to terminate this lease. On April 27, 2022, the Company informed the landlord that it would be terminating the lease. On May 27, 2022, the landlord notified the Company that the landlord would refund $85,756 of the prepaid rent and security deposit balance of $601,818 paid by the Company. The unrefunded portion of the prepaid rent and security deposit related to some survey, architecture and construction design costs that were incurred by the landlord prior to the Company terminating the lease. In September and October 2023, the landlord notified the Company that there were additional costs that exceeded the amount of the refund and the landlord released the Company from paying any amounts in excess of the original expected refund. The landlord also released the Company from any remaining obligations under the lease and amendments. The Company has recognized a loss on the termination of this lease of $247,525 in the year ended December 31, 2022 and $85,756 in the three and nine months ended September 2023.

 

Total amortization expense for the right-of-use asset recorded for the initial lease for the nine months ended September 30, 2022 was $61,709. There was no amortization expense recorded in 2023.

In June 2021, the Company entered into an agreement with a company controlled by the Company’s Chairman and co-founder to lease office space for $2,000 per month for a period of one year. In May 2022, the Company informed the landlord that it would terminate this lease, and the landlord confirmed that the lease terminated effective September 1, 2022. Total expense recorded for this lease for the three and nine months ended September 30, 2022 was $4,000 and $16,000, respectively.

 

On August 28, 2020, the Company entered into three-year consulting agreements with Pink Possum, and Highbridge Consultants, LLC (“Highbridge”), an entity controlled by Mr. Adrian James, a co-founder of the Company, pursuant to which Messrs. Okonsky and James provide the Company with services. In consideration for entering into the consulting agreements, the Company issued the two entities ten-year warrants to purchase the Company’s common stock at an exercise price of $0.004 per share. The number of shares of common stock issuable pursuant to the warrants was based on the number of shares of the Company’s common stock outstanding at the time of exercise and provided that Pink Possum and Highbridge would receive 18.75% and 25%, respectively, of the Company’s shares of common stock outstanding at the time of exercise on a fully diluted basis. On March 26, 2021 and March 25, 2021, respectively, Pink Possum and Highbridge entered into amendments to the consulting agreements agreeing to exchange the original warrants for new ten-year warrants to purchase 950,000 and 1,250,000 shares, respectively, of common stock at an exercise price of $4.90. During the year ended December 31, 2021, the Company recognized compensation expenses of $5.6 million and $7.4 million for the warrants issued to Pink Possum and Highbridge, respectively. On December 20, 2021, Highbridge exercised all of its warrants on a cashless basis and the Company issued 1,101,515 shares of common stock to Highbridge.

 

In addition, pursuant to the consulting agreements, upon the occurrence of a Fundamental Transaction (as defined below) for an aggregate gross sales price of $100.0 million or more, each entity will receive a cash payment equal to 1% of such gross sales price. For the purposes of the consulting agreements, “Fundamental Transaction” means any of the following: (i) a consolidation or merger involving the Company if the holders of the voting securities of the Company that are outstanding immediately prior to the consummation of such consolidation or merger do not, immediately after the consummation of such consolidation or merger, hold voting securities that collectively possess at least a majority of the voting power of all the outstanding securities of the surviving entity of such consolidation or merger or such surviving entity’s parent entity; (ii) a transfer or issuance (in a single transaction or series of related transactions) by one or more of the Company and its stockholders to one person or to any group of persons acting in concert, of shares of the Company’s capital stock then collectively possessing 50% or more of the voting power of all then outstanding shares of the Company’s capital stock (computed on an as-converted to common stock basis); or (iii) any sale, license, lease, assignment or other disposition of all or substantially all of the assets of the Company. Furthermore, commencing upon the completion of the Company’s initial public offering of the shares of our common stock, if the Company’s market capitalization exceeds $300.0 million for a period of 21 consecutive trading days, each of the entities will receive an additional cash payment equal to $15.0 million; provided that the Company will have the right, in its sole discretion, to make the foregoing $15.0 million payment by the issuance of shares of the Company’s common stock. The foregoing amounts will be payable to the entities if the above milestones occur any time prior to the ten-year anniversary of the original consulting agreements, or August 28, 2030.

 

In December 2022, the Company entered into an employment agreement with Mr. Okonsky whereby Mr. Okonsky became an employee on January 2, 2023 and the consulting agreement with Pink Possum was terminated. However, the warrants to Pink Possum, and the provisions for a Fundamental Transaction and the market capitalization thresholds and related payments owed to Pink Possum if these were to occur remain in effect subsequent to the employment agreement.

 

v3.23.3
STOCKHOLDERS’ EQUITY
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

 
NOTE 9 – STOCKHOLDERS’ EQUITY

 

On June 14, 2023, the Company’s stockholders approved an increase in the Company’s authorized shares of common stock from 100,000,000 to 250,000,000. The Company’s common stock has a par value of $0.00001. In addition, the Company is authorized to issue 5,000,000 shares of preferred stock with a par value of $0.00001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

 

Common Stock

 

On February 1, 2022, the Company sold 1,333,334 shares of its common stock in a public offering at $15.00 per share. The Company received net proceeds of $18,089,184 after underwriter commissions and expenses of $1,910,816. The underwriter was also issued a warrant to purchase 66,667 shares of the Company’s common stock at an exercise price of $18.75 per share that expires 5.5 years from the date of issuance.

 

On May 24, 2023, the Company sold 1,200,000 shares of its common stock in a public offering at $3.75 per share. The Company received net proceeds of $3,998,700 after underwriter commissions and expenses of $501,300.

 

On September 18, 2023, the Company sold 280,000 shares of its common stock in a public offering at $2.50 per share. The Company received net proceeds of $571,400 after underwriter commissions and expenses of $128,600. The underwriter was also issued a warrant to purchase 56,000 shares of the Company’s common stock at an exercise price of $3.13 per share that expires 5.5 years from the date of issuance. The underwriter agreement provided the underwriter with a right of first refusal for any additional securities offerings within twelve months of this offering.

 

As discussed in Note 6 above, on May 24, 2023, the Company issued the May 2023 Notes and May 2023 Warrants, along with the warrants to the placement agent in August 2022 with the issuance of the Convertible Notes. The Company received consent from the underwriter to issue such securities. In addition, the Company was required to reserve 21,623,189 shares of common stock for future issuance of shares for the conversion of the May 2023 Notes and exercise of the May 2023 Warrants and 120,773 shares for the exercise of the placement agent warrants.  

 

Warrants

  

As discussed in Note 6, the Company issued the Note Warrants, which were fully vested, to purchase 1,811,595 shares of the Company’s common stock at an initial exercise price of $14.25. The Note Warrants expire August 24, 2027. Also, the Company issued to the placement agent of the Convertible Notes, fully vested warrants to purchase 120,773 shares of the Company’s common stock at an exercise price of $17.8125. The warrants were not exercisable until February 24, 2023 and expire on February 24, 2028. The Company valued all of these warrants using the closing price of the Company’s common stock on August 24, 2022 of $12.20, volatility of 79.81% based on peer companies, risk free interest rate of 3.03%, no dividends and an estimated life of 2.5 years.

 

In May 2023, all of the Note Warrants to purchase 1,811,595 shares of the Company’s common stock were exchanged for Exchange Warrants to purchase 3,411,595 shares of the Company’s common stock with an initial exercise price of $5.45 per share (which was adjusted to $3.75 per share upon stockholder approval). The Exchange Warrants expire August 24, 2027. Also in May 2023, in connection with the issuance of the New Notes, the Company also issued New Warrants to purchase 1,086,957 shares of common stock at an initial exercise price of $5.45 (which was adjusted to $3.75 per share upon stockholder approval which was received on August 3, 2023). As discussed in Note 14, as of October 20, 2023, the exercise price of the Exchange Warrants and New Warrants were adjusted to $1.369 per share.

 

As noted above, 307,001 of the Exchange Warrants were exercised at a price of $1.75 per share and 307,001 Reload Warrants were issued with an exercise price of $2.50 per share. The Reload warrants expire August 24, 2027.

 

During the three and nine months ended September 30, 2023, the Company recognized no expense from warrants and during the three and nine months ended September 30, 2022, the Company recognized expense of $0 and $7,302, respectively, related to common stock warrants as all warrants are fully vested as of September 30, 2023. As noted in Note 7 above, the Company has determined that the Exchange Warrants and New Warrants are derivative liabilities and is recording them at fair value with changes being recorded in earnings through August 3, 2023, the date of stockholder approval to fix the exercise price of these warrants.

 

The following is the activity related to common stock warrants during the nine months ended September 30, 2023:

                 
    Common Stock Warrants 
    Shares    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value 
                     
Outstanding at January 1, 2023   3,017,126   $11.67           
Granted   4,861,555   $2.35           
Canceled      $           
Exchanged   (1,811,595)  $14.25           
Expired      $           
Exercised   (307,001)  $1.75           
Outstanding at September 30, 2023   5,760,085   $3.61    4.52   $146,442 
Exercisable at September 30, 2023   5,760,085   $3.61    4.52   $146,442 

 

v3.23.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCK-BASED COMPENSATION

NOTE 10 – STOCK-BASED COMPENSATION

 

In January 2021, the Company’s board of directors adopted the Volcon, Inc. 2021 Stock Plan, (the “2021 Plan”). The 2021 Plan is a stock-based compensation plan that provides for discretionary grants of stock options, stock awards, and restricted stock unit awards to employees, members of the board of directors and consultants (including restricted stock units issued prior to the adoption of the plan as further discussed below). The Company initially reserved a total of 600,000 shares of the Company’s common stock for issuance under the 2021 Plan. On July 26, 2022, the Company’s stockholders approved an increase of 800,000 shares of the Company’s common stock for issuance under the 2021 plan, which may be adjusted for changes in capitalization and certain corporate transactions. To the extent that an award, if forfeitable, expires, terminates or lapses, or an award is otherwise settled in cash without the delivery of shares of common stock to the participant, then any unpaid shares subject to the award will be available for future grant or issuance under the 2021 Plan. Shares available for issuance under the 2021 Plan as of September 30, 2023, were 251,351 shares. Awards vest according to each agreement and as long as the employee remains employed with the Company or the consultant continues to provide services in accordance with the terms of the agreement.

  

Restricted Stock Units

 

The following is the restricted stock unit activity for the nine months ended September 30, 2023

    
Outstanding January 1, 2023   15,000 
Granted    
Vested (1)   (5,000)
Canceled   (5,000)
Outstanding September 30, 2023   5,000 

 

  (1) 5,000 RSUs were subject to cancellation due to termination of employment. However, the Company entered into a modification to allow the employee to fully vest in these RSUs as part of a severance agreement. The Company recorded additional expense of $31,487 during the three months ended March 31, 2023 related to this modification.

 

In January 2022, the Company modified the vesting terms of 20,000 RSUs that had vested as of December 31, 2021 to extend the vesting through May 15, 2022. The Company granted an additional 5,000 RSUs to the holders of these RSUs that vesting was extended and these additional RSUs vested as of May 15, 2022. The Company recorded an additional expense of $1,267,250 during 2022 related to these modifications.

 

For the three and nine months ended September 30, 2023, the Company recognized expense for RSUs of $(15,700) and $61,623, respectively. For the three and nine months ended September 30, 2022, the Company recognized expense for RSUs of $35,325 and $1,232,135, respectively. The Company expects to recognize additional compensation expenses of $3,925 related to RSUs assuming all awards outstanding at September 30, 2023 will vest.

  

Performance Shares

 

On March 1, 2022, the Compensation Committee of the board of directors approved a grant of 8,925 shares for the achievement of some of the Company’s 2021 performance milestones, and the Company recognized share-based compensation expenses of $82,050 related to the grant of these shares in the quarter ended March 31, 2022. Certain individuals whose employment terminated subsequent to December 31, 2021 forfeited their share grants totaling 576 shares and such shares are available for future issuance under the 2021 Plan.

 

In 2022 the compensation committee approved reserving 50,000 shares from the 2021 Plan to issue based on achievement of the Company’s 2022 performance milestones to employees who are employed in 2022 and are active employees on the date of approval in 2023 by the compensation committee. On February 6, 2023 the compensation committee of the board of directors approved a grant of 30,997 shares (27,772 were issued due a forfeiture of 132 shares and 3,093 shares withheld for payment of employee withholding taxes) for the achievement of some of the Company’s 2022 performance milestones. The Company recognized share-based compensation expenses of $257,717 related to the grant of these shares in the quarter ended March 31, 2023. The compensation committee also approved reserving the remaining 19,003 not issued for 2022 performance milestones for issuance to active employees on the date the first Stag is shipped to a customer.

 

In addition, the compensation committee also approved reserving 50,000 shares from the 2021 Plan to issue to employees based on achievement of the Company’s 2023 performance milestones to employees who are employed in 2023 and are active employees on the date of approval in 2024 by the compensation committee.

 

Stock Options

 

The following summarizes activity relating to common stock options to employees and consultants for services during the nine months ended September 30, 2023:

                
   Common Stock Options 
   Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Life in years
   Intrinsic Value 
Outstanding at January 1, 2023   657,782   $15.41           
Granted   497,103   $3.81           
Forfeited   (149.885)  $13.02           
Exercised   (5,000)  $5.00           
Outstanding at September 30, 2023   1,000,016   $10.06    8.98   $ 
Exercisable at September 30, 2023   399,024   $12.93    8.37   $ 

 

The Company valued the options using the closing stock price of the Company’s common stock on the date of grant, an estimated volatility between 78.7% - 81.5% based on peer companies, risk free interest rate between 3.54% - 3.95%, no dividends and an estimated life of 6 years. During the three and nine months ended September 30, 2023, the Company recognized share-based compensation expenses of $556,228, and $1,904,016, respectively, related to common stock options. During the three and nine months ended September 30, 2022 the Company recognized share-based compensation expenses of $389,745, and $1,385,402, respectively, related to common stock options. The Company expects to recognize additional compensation expense of $2,136,860 related to these common stock options assuming all awards will vest.

 

Total stock-based compensation recorded for the three and nine months ended September 30, 2023 and 2022 for all stock based compensation awards, including warrants, has been recorded as follows:

                     
   

Three Months
Ended

September 30,

2023

 

Three Months
Ended

September 30,

2022

 

Nine Months
Ended

September 30,

2023

 

Nine Months
Ended

September 30,

2022

 
Cost of Goods Sold   $ 131,525   $ 113,794   $ 487,605   $ 391,674  
Sales and Marketing     134,073     106,478     678,945     568,333  
Product Development     80,759     82,560     389,729     661,754  
General and Administrative     194,171     122,238     667,077     1,003,088  
Total   $ 540,528   $ 425,070   $ 2,223,356   $ 2,624,849  

 

v3.23.3
LOSS PER COMMON SHARE
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
LOSS PER COMMON SHARE

NOTE 11 – LOSS PER COMMON SHARE

 

The basic net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the weighted average number of common shares during the year. The diluted net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the diluted weighted average number of common shares outstanding during the year. The diluted weighted average number of common shares outstanding is the basic weighted number of common shares adjusted for any potentially dilutive debt or equity. Diluted net loss per common share is equal to basic net loss per share due to the Company’s net loss and any potentially issuable shares are anti-dilutive.

                
  

Three months

Ended

  

Three months

Ended

  

Nine months

Ended

  

Nine months

Ended

 
  

September 30,

2023

  

September 30,

2022

  

September 30,

2023

  

September 30,

2022

 
                 
Numerator:                    
                     
Net loss  $(11,327,896)  $(7,899,184)  $(41,655,559)  $(26,437,991)
                     
Denominator:                    
                     
Denominator for basic and diluted net loss per common share - weighted average of common shares   6,162,589    4,869,044    5,502,512    4,690,805 
                     
Basic and diluted net loss per common share  $(1.84)  $(1.62)  $(7.57)  $(5.64)

 

Common shares consisting of shares potentially dilutive as of September 30, 2023 and 2022 are as follows:

        
   September 30, 2023   September 30, 2022 
Convertible Notes   11,675,892    2,415,459 
Warrants   5,760,085    3,017,124 
Stock options   1,000,016    681,567 
Restricted stock units   5,000    30,000 
Total   18,440,993    6,144,150 

 

v3.23.3
INCOME TAXES
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 12 – INCOME TAXES

 

Deferred taxes are determined by applying the provisions of enacted tax laws and rates for the jurisdictions in which the Company operates to the estimated future tax effects of the differences between the tax basis of assets and liabilities and their reported amounts in the Company's financial statements. A valuation allowance is established to reduce deferred tax assets if it is more likely than not that the related tax benefits will not be realized.

 

Due to losses since inception and for all periods presented, no income tax benefit or expense has been recognized as a full valuation allowance has been established for any tax benefit that would have been recognized for the loss in any period presented.

 

Significant components of the Company's deferred tax assets and liabilities at September 30, 2023 and December 31, 2022 are as follows:

        
  

September 30,

2023

  

December 31,

2022

 
Deferred tax assets          
Net operating losses  $12,016,943   $9,106,430 
Depreciation and intangible assets   1,770,632    1,502,868 
Debt basis difference   5,029,077     
Research & development credit   1,457,768    1,308,956 
Lease liability   266,483    322,167 
Inventory   1,249,375    1,290,968 
Stock-based compensation   3,259,583    3,103,037 
Accrued expenses   154,650    233,284 
Capital loss carryover   276,522    261,922 
Other   222,062    177,074 
Total   25,703,095    17,306,705 
Valuation allowance   (25,244,039)   (16,661,612)
Net deferred tax asset   459,056    645,093 
Deferred tax liabilities          
Prepaid expenses   (200,526)   (328,836)
Right-of-use assets   (258,530)   (316,257)
Total net deferred taxes deferred tax liabilities  $   $ 

  

Management currently believes that since the Company has a history of losses it is more likely than not that the deferred tax regarding the loss carry forwards and other temporary differences will not be realized in the foreseeable future. The Company believes that carryforward limitations will be applied to the historical net operating losses due to the change of control that occurred upon the completion of the Company’s initial public offering. The Company's cumulative net operating loss carry forward of approximately $57.2 million as of September 30, 2023, may be limited in future years depending on future taxable income in any given fiscal year. The net operating losses can be carried forward indefinitely.

 

The Company has recorded no liability for income taxes associated with unrecognized tax benefits at the date of adoption and has not recorded any liability associated with unrecognized tax benefits. Accordingly, the Company has not recorded any interest or penalty in regard to any unrecognized benefit.

 

v3.23.3
LEASES
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
LEASES

NOTE 13 – LEASES

 

The components of lease cost for operating leases for the three and nine months ended September 30, 2023 and 2022 is as follows:

                
  

Three Months

Ended

September 30,

2023

  

Three Months

Ended

September 30,

2022

  

Nine Months

Ended

September 30,

2023

  

Nine Months

Ended

September 30,

2022

 
Lease Cost                    
Operating lease cost  $117,249   $107,534   $351,748   $406,786 
Short-term lease cost   30,751    75,015    120,271    208,009 
Variable lease cost                
Sublease income                
Total lease cost  $148,000   $182,549   $472,019   $614,795 

 

Supplemental cash flow information related to leases for the nine months ended September 30, 2023 and 2022, is as follows:

        
   2023   2022 
Other Lease Information          
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flows from operating leases  $265,161   $269,836 
Amortization of right-of-use assets  $274,895   $342,112 

 

The following table summarizes the lease-related assets and liabilities recorded on the balance sheet at September 30, 2023 and December 31, 2022:

        
  

September 30,

2023

  

December 31,

2022

 
Lease Position          
Operating Leases:          
Operating lease right-of-use assets  $1,231,092   $1,505,987 
Right-of-use liabilities operating leases short-term   423,849    391,117 
Right-of-use liabilities operating leases long-term   845,117    1,143,011 
Total operating lease liabilities  $1,268,966   $1,534,128 

 

The Company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.

    
Lease Term and Discount Rate  September 30, 2023 
Weighted-average remaining lease term (years):     
Operating leases   2.9 
Weighted-average discount rate:     
Operating leases   6.05% 

 

The following table provides the maturities of lease liabilities at September 30, 2023:

    
   Operating 
   Leases 
Remainder of 2023  $116,557 
2024   471,638 
2025   485,702 
2026   340,591 
Total future undiscounted lease payments   1,414,488 
Less: Interest   (145,522)
Present value of lease liabilities  $1,268,966 

 

v3.23.3
SUBSEQUENT EVENT
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENT

NOTE 14 - SUBSEQUENT EVENT

 

Elimination of Chief Operating Officer Position

 

On October 10, 2023, the Company eliminated the position of Chief Operating Officer, and terminated Stephanie Davis, the Company’s Chief Operating Officer, from that position. The responsibilities of the Chief Operating Officer will be assumed by other members of management.

 

Warrants Granted to GLV Ventures

 

On October 11, 2023, the Company entered into an amendment (the “Amendment”) to its Stag development and Stag supplier agreements with GLV Ventures (“GLV”). Pursuant to the Amendment, GLV agreed to provide the Company with extended payment terms and provide the Company with credit against new vehicles for the value of certain parts purchased by the Company. In consideration for entering into the Amendment No. 1, the Company agreed to issue GLV (or its designee) five-year warrants to purchase 400,000 shares of Company common stock with an exercise price of $2.10 per share, which was equal to the closing price of the Company's common stock on the date of the Amendment No. 1, 200,000 shares were fully vested upon issuance and the remaining warrants will vest 45 days from the issuance date.


Reverse Stock Split

 

On October 13, 2023, the Company completed a reverse 1 for 5 stock split effective at 4:01pm U.S. Eastern Standard Time. Any fractional shares as a result of the reverse stock split were rounded up to one full share of common stock. As discussed in Note 6, the conversion price of New Notes and Exchange Notes and exercise price of the New Warrants and Exchange Warrants were subject to adjustment to the lowest day’s VWAP in the five days following the reverse split, which was $1.369 per share. Total shares issuable for the New Notes and Exchange Notes based on this adjusted price would be 23,454,124.

 

Warrant Inducement

 

On October 13, 2023, the Company entered into an inducement offer letter agreement (the “Inducement Letter”) with the three holders (each, a “Holder”) of the May 2023 Warrants. The Company reduced the exercise price of up to 973,000 to the lesser of (i) $1.75 (after giving effect to the 1:5 reverse stock split that went into effect on October 13, 2023) and (ii) the exercise price in effect at the time of exercise of the Existing Warrants if further adjusted in accordance with the terms of the May 2023 Warrants ($1.369 per share after adjustment for the lowest day’s VWAP for the five days following the reverse stock split). The reduction of the exercise price of such Existing Warrants will remain in effect until October 27, 2023 (the “Inducement Period”). Any Warrants not exercised prior to the end of the Inducement Period be $1.369 (after given effect to the 1:5 reverse stock split and lowest day’s VWAP for the five days following the reverse stock split) as adjusted pursuant to other events that would result in a change in the exercise price under the original terms of the Existing Warrants.

 

In addition, pursuant to the Inducement Letter, the Holders who exercise such Existing Warrants for cash on or prior to October 27, 2023 would receive a new warrant (“Reload Warrant”) to purchase a number of shares of common stock equal to the number of shares of common stock exercised under the Existing Warrants. The exercise price of the Reload Warrants was determined based on the terms of the Existing Warrants, which was $1.369 per share.

 

On October 20, 2023, the Holders exercised 105,000 warrants at $1.369 per share.

 

On October 29, 2023, in an effort to raise cash, the Company entered into an inducement offer letter agreement (the “Inducement Reprice Letter”) with the Holders of the Company’s May 2023 Warrants. Pursuant to the Inducement Reprice Letter, in exchange for an aggregate cash payment of $346,500, the Company reduced the exercise price with respect to May 2023 Warrants exercisable into an aggregate of 350,000 shares of common stock from $1.369 per share to $0.01 per share.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Interim Unaudited Financial Information

Interim Unaudited Financial Information

 

The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (“SEC”) on March 7, 2023. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted from this report on Form 10-Q pursuant to the rules and regulations of the SEC.

 

Results for the interim periods in this report are not necessarily indicative of future financial results and have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary to present fairly our interim consolidated financial statements as of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022. These adjustments are of a normal recurring nature and consistent with the adjustments recorded to prepare the annual audited consolidated financial statements as of December 31, 2022.

 

Basis of Presentation

Basis of Presentation

 

As discussed in Note 14, the Company completed a reverse 1 for 5 stock split on October 13, 2023, all share and per share amounts have been adjusted to reflect the impact of this reverse stock split.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts, transactions and balances have been eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of any contingent assets and liabilities as of the dates of the financial statements and the reported amounts of expenses during the reporting periods.

 

Making estimates requires management to exercise judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ significantly from those estimates.

  

Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

 

Cash and cash equivalents include short-term investments with original maturities of 90 days or less at the date of purchase. The recorded value of our cash and cash equivalents approximates their fair value. There were no cash equivalents as of September 30, 2023 or December 31, 2022. Restricted cash includes cash restricted as collateral for the Company’s corporate credit cards and a letter of credit with the Company’s bank.

 

Revenue Recognition

Revenue Recognition

 

For sales of the Grunt motorcycle directly to consumers, revenue was recognized when the Company transferred control of the product to the consumer and the 14-day acceptance period had expired, or earlier acceptance had been received from the consumer. Sales directly to consumers were completed as of June 1, 2022. Beginning in February 2023 the Company began selling the Brat E-Bike and Volcon Youth motorcycles directly to consumers in addition to dealers, revenue for direct to consumer sales is recognized when transfer of control of the product is made to the consumer.
 

For sales to dealers or distributors revenue is recognized when transfer of control of the product is made as there is no acceptance period or right of return. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring control of vehicles, parts, and accessories. Consideration that is received in advance of the transfer of goods is recorded as customer deposits until delivery has occurred or the customer cancels their order, and the consideration is returned to the customer. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s sales do not presently have a financing component.

 

Sales promotions and incentives. The Company provides for estimated sales promotions and incentives, which are recognized as a component of sales in measuring the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Examples of sales promotion and incentive programs include rebates, distributor fees, dealer co-op advertising and volume incentives. Sales promotions and incentives are estimated based on contractual requirements. The Company records these amounts as a liability in the balance sheet until they are ultimately paid. Adjustments to sales promotions and incentives accruals are made as actual usage becomes known to properly estimate the amounts necessary to generate consumer demand based on market conditions as of the balance sheet date.

 

Shipping and handling charges and costs. The Company records shipping and handling amounts charged to the customer and related shipping costs as a component of cost of goods sold when control has transferred to the customer.

 

Product Warranties

Product Warranties

 

The Company provides a one-year warranty on vehicles, and a two-year warranty on the battery pack. The Company accrues warranty reserves at the time revenue is recognized. Warranty reserves include the Company’s best estimate of the projected cost to repair or to replace any items under warranty, based on actual warranty experience as it becomes available and other known factors that may impact the evaluation of historical data. The Company reviews its reserves quarterly to ensure that the accruals are adequate to meet expected future warranty obligations and will adjust estimates as needed. Factors that could have an impact on the warranty reserve include the following: changes in manufacturing quality, shifts in product mix, changes in warranty coverage periods, product recalls and changes in sales volume. Warranty expense is recorded as a component of cost of goods sold in the statement of operations and is recognized as a current liability.

  

Inventory and Inventory Deposits

Inventory and Inventory Deposits

 

Inventories and prepaid inventory deposits are stated at the lower of cost (first-in, first-out method) or net realizable value.

 

Certain vendors require the Company to pay an upfront deposit before they will manufacture and ship the Company’s parts or accessories. These payments are classified as prepaid inventory deposits on the balance sheet until title and risk of loss transfers to the Company, at which time they are classified as inventory.

 

Raw materials inventory costs include the cost of parts, including duties, tariffs, and shipping. Work-in-process and finished goods include the cost of parts, labor and manufacturing overhead costs associated with the assembly of the vehicle. Finished goods also include accessories for the vehicle and branded merchandise such as hats and shirts.

 

Through August 2022 the Company assembled the Grunt motorcycle in a leased facility. The Company ceased assembly operations at the end of August and outsourced the assembly of the Grunt to a third-party. In May 2023, the Company transferred substantially all of its raw materials and work-in-process inventory for the Grunt to the third-party manufacturer. Title to the inventory transferred to the third-party manufacturer and it will provide the Company with a credit towards future purchases of finished goods once it begins production of the Grunt EVO.
 

Property and Equipment

Property and Equipment

 

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

   
Category   Estimated
Useful Lives
Machinery, tooling and equipment   3-7 years
Vehicles   5 years
Internal use manufactured vehicles   1 year
Furniture & Fixtures   5 years
Computers   3 years

 

Leasehold improvements are depreciated over the shorter period of their estimated useful life or term of the lease.

 

Intangible Assets

Intangible Assets


Intangible assets include acquired domain names and software. Domain names are amortized over 15 years and software is amortized over the life of the shorter of the software term or three years.

 

Long-Lived Assets

Long-Lived Assets

 

The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the historical carrying cost value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to the carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset.

 

Leases

Leases

 

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expenses for these leases on a straight-line basis over the lease term. The Company does not separate non-lease components from the lease components to which they relate, and instead accounts for each separate lease and non-lease component associated with that lease component as a single lease component.

  

ASC 842 defines initial direct costs as only the incremental costs of signing a lease. Initial direct costs related to leasing that are not incremental are expensed as general and administrative expenses in our statements of operations.

 

The Company’s operating lease agreements primarily consist of leased real estate and are included within ROU assets – operating leases and ROU lease liabilities – operating leases on the balance sheets. The Company’s lease agreements may include options to extend the lease, which are not included in minimum lease payments unless they are reasonably certain to be exercised at lease commencement. The Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

 

Research and Development Expenses

Research and Development Expenses

 

The Company records research and development expenses in the period in which they are incurred as a component of product development expenses.

 

Income Taxes

Income Taxes

 

Deferred taxes are determined utilizing the “asset and liability” method, whereby deferred tax asset and liability account balances are determined based on the differences between financial reporting and the tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, when it's more likely than not that deferred tax assets will not be realized in the foreseeable future. Deferred tax liabilities and assets are classified as current or non-current based on the underlying asset or liability or if not directly related to an asset or liability based on the expected reversal dates of the specific temporary differences.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 
ASC Topic 820 Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  · Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
  · Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  · Level 3 — Inputs that are unobservable for the asset or liability.

 

The following section describes the valuation methodologies that the Company used to measure different financial instruments at fair value.

 

Debt

 

The fair value of the Company’s debt approximated the carrying value of the Company’s debt as of September 30, 2023 and December 31, 2022. Factors that the Company considered when estimating the fair value of its debt included market conditions, and term of the debt. The level of the debt would be considered as Level 2.

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

The Company accounts for derivative instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC Topic 815”), and all derivative instruments are reflected as either assets or liabilities at fair value on the consolidated balance sheets. The Company uses estimates of fair value to value its derivative instruments. Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between able and willing market participants. In general, the Company’s policy in estimating fair values is to first look at observable market prices for identical assets and liabilities in active markets, where available. When these are not available, other inputs are used to model fair value such as prices of similar instruments, yield curves, volatilities, prepayment speeds, default rates and credit spreads, relying first on observable data from active markets. Depending on the availability of observable inputs and prices, different valuation models could produce materially different fair value estimates. The values presented may not represent future fair values and may not be realizable. The Company categorizes its fair value estimates in accordance with ASC Topic 820, based on the hierarchical framework associated with the three levels or price transparency utilized in measuring financial instruments at fair value as discussed above.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e., at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Initial Measurement

 

The Company records its financial instruments classified as a liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement - Financial instruments classified as liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other expense/income. The Monte Carlo simulation is used to determine the fair value of derivatives for instruments with embedded conversion features and for free standing warrants as discussed further in Note 7.

 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash, accounts receivable, inventory, other assets, and accounts payable and accrued expenses approximate their fair value due to the short-term maturity of those items.

 

Warrant Liabilities and Convertible Liabilities

 

The fair value of the derivative liabilities is classified as Level 3 within the Company’s fair value hierarchy. Please refer to Note 7, Derivative Instruments, for further discussion of the measurement of fair value of the derivatives and their underlying assumptions.

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company has a stock-based incentive award plan for employees, consultants and directors. The Company measures stock-based compensation at the estimated fair value on the grant date and recognizes the amortization of stock-based compensation expense on a straight-line basis over the requisite service period, or when it is probable criteria will be achieved for performance-based awards. Fair value is determined based on assumptions related to the fair value of the Company common stock, stock volatility and risk-free rate of return. The Company has elected to recognize forfeitures when realized.

 

Concentration Risk

Concentration Risk

 

The Company outsources certain portions of product design and development for its vehicles to third-parties. In addition, the Company has outsourced the manufacturing of all of its vehicles to third-party manufacturers, including one manufacturer for three of its vehicles and this third-party is also performing product design and development services on these vehicles.

 

One supplier provides the battery and drivetrain components for the Company’s utility terrain vehicle, the Stag. The components are critical to the operation of the Stag.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU 2016-13 effective January 1, 2023. The Company determined that the update applied to trade receivables, but that there was no material impact to the consolidated financial statements from the adoption of ASU 2016-13.

  

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

 

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of estimated useful lives for property, plant and equipment
   
Category   Estimated
Useful Lives
Machinery, tooling and equipment   3-7 years
Vehicles   5 years
Internal use manufactured vehicles   1 year
Furniture & Fixtures   5 years
Computers   3 years
v3.23.3
INVENTORY (Tables)
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of inventory
        
  

September 30,

2023

  

December 31,

2022

 
Raw materials  $3,561,150   $3,060,160 
Work-in-process       439,839 
Finished goods   3,490,387    2,145,884 
Total inventory  $7,051,537   $5,645,883 
v3.23.3
LONG – LIVED ASSETS (Tables)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
        
  

September 30,

2023

  

December 31,

2022

 
Machinery, tooling and equipment  $1,011,351   $352,137 
Vehicles   213,528    156,648 
Internal use manufactured vehicles   274,385    274,385 
Fixtures & furniture   90,768    50,768 
Leasehold improvements   44,663    44,663 
Computers   234,898    228,671 
    1,869,593    1,107,272 
Less: Accumulated depreciation   (605,427)   (505,506)
Total property and equipment  $1,264,166   $601,766 
v3.23.3
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of maturities for notes payable
    
Remainder of 2023  $5,768 
2024   23,073 
2025   23,073 
2026   23,073 
2027   23,073 
2028   12,927 
2029   1,816 
Total future payments   112,803 
Less: Interest   (24,794)
Total notes payable   88,009 
Less current portion   (14,910)
Long-term notes payable  $73,099 
v3.23.3
CONVERTIBLE NOTES (Tables)
9 Months Ended
Sep. 30, 2023
Convertible Notes  
Schedule of summary of convertible notes
        
   Fair Value   Principal Amount 
New Notes  $4,410,058   $4,934,783 
Series A Exchange Notes   3,298,012    3,690,422 
Series B Exchange Notes   20,986,449    23,483,891 
Total May 2023 Notes  $28,694,519   $32,109,096 
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of assumptions
          
  

 

 

May 24, 2023

  

 

August 3, 2023

 
Conversion Feature Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   86.3%    84.1% 
Conversion price per share  $0.75   $0.75 
Note term (years)   0.76    0.56 
Risk free interest rate   5.1%    5.4% 
Warrant Liabilities          
Company stock price on valuation date  $0.70   $0.551 
Volatility (closing prices of guideline comparable public companies)   119.2%    115.0% 
Conversion price per share  $0.75   $0.75 
Warrant term (years)   4.25    4.06 
Risk free interest rate   3.8%    4.3% 
Schedule of fair value of derivative liabilities
          
   May 24, 2023   August 3, 2023 
Conversion Feature - New Notes  $663,096   $557,168 
Conversion Feature - Series A Exchange Notes   970,805    416,672 
Conversion Feature - Series B Exchange Notes   4,324,792    2,651,436 
New Warrants   3,123,682    2,445,244 
Exchange Warrants   9,287,474    7,191,535 
Total  $18,369,849   $13,262,055 

 

v3.23.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of warrant activity
                 
    Common Stock Warrants 
    Shares    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value 
                     
Outstanding at January 1, 2023   3,017,126   $11.67           
Granted   4,861,555   $2.35           
Canceled      $           
Exchanged   (1,811,595)  $14.25           
Expired      $           
Exercised   (307,001)  $1.75           
Outstanding at September 30, 2023   5,760,085   $3.61    4.52   $146,442 
Exercisable at September 30, 2023   5,760,085   $3.61    4.52   $146,442 
v3.23.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of restricted stock unit activity
    
Outstanding January 1, 2023   15,000 
Granted    
Vested (1)   (5,000)
Canceled   (5,000)
Outstanding September 30, 2023   5,000 

 

  (1) 5,000 RSUs were subject to cancellation due to termination of employment. However, the Company entered into a modification to allow the employee to fully vest in these RSUs as part of a severance agreement. The Company recorded additional expense of $31,487 during the three months ended March 31, 2023 related to this modification.
Schedule of stock option activity
                
   Common Stock Options 
   Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Life in years
   Intrinsic Value 
Outstanding at January 1, 2023   657,782   $15.41           
Granted   497,103   $3.81           
Forfeited   (149.885)  $13.02           
Exercised   (5,000)  $5.00           
Outstanding at September 30, 2023   1,000,016   $10.06    8.98   $ 
Exercisable at September 30, 2023   399,024   $12.93    8.37   $ 
Schedule of stock-based compensation expense
                     
   

Three Months
Ended

September 30,

2023

 

Three Months
Ended

September 30,

2022

 

Nine Months
Ended

September 30,

2023

 

Nine Months
Ended

September 30,

2022

 
Cost of Goods Sold   $ 131,525   $ 113,794   $ 487,605   $ 391,674  
Sales and Marketing     134,073     106,478     678,945     568,333  
Product Development     80,759     82,560     389,729     661,754  
General and Administrative     194,171     122,238     667,077     1,003,088  
Total   $ 540,528   $ 425,070   $ 2,223,356   $ 2,624,849  
v3.23.3
LOSS PER COMMON SHARE (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of earnings per share
                
  

Three months

Ended

  

Three months

Ended

  

Nine months

Ended

  

Nine months

Ended

 
  

September 30,

2023

  

September 30,

2022

  

September 30,

2023

  

September 30,

2022

 
                 
Numerator:                    
                     
Net loss  $(11,327,896)  $(7,899,184)  $(41,655,559)  $(26,437,991)
                     
Denominator:                    
                     
Denominator for basic and diluted net loss per common share - weighted average of common shares   6,162,589    4,869,044    5,502,512    4,690,805 
                     
Basic and diluted net loss per common share  $(1.84)  $(1.62)  $(7.57)  $(5.64)
Schedule of anti-dilutive shares
        
   September 30, 2023   September 30, 2022 
Convertible Notes   11,675,892    2,415,459 
Warrants   5,760,085    3,017,124 
Stock options   1,000,016    681,567 
Restricted stock units   5,000    30,000 
Total   18,440,993    6,144,150 
v3.23.3
INCOME TAXES (Tables)
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities
        
  

September 30,

2023

  

December 31,

2022

 
Deferred tax assets          
Net operating losses  $12,016,943   $9,106,430 
Depreciation and intangible assets   1,770,632    1,502,868 
Debt basis difference   5,029,077     
Research & development credit   1,457,768    1,308,956 
Lease liability   266,483    322,167 
Inventory   1,249,375    1,290,968 
Stock-based compensation   3,259,583    3,103,037 
Accrued expenses   154,650    233,284 
Capital loss carryover   276,522    261,922 
Other   222,062    177,074 
Total   25,703,095    17,306,705 
Valuation allowance   (25,244,039)   (16,661,612)
Net deferred tax asset   459,056    645,093 
Deferred tax liabilities          
Prepaid expenses   (200,526)   (328,836)
Right-of-use assets   (258,530)   (316,257)
Total net deferred taxes deferred tax liabilities  $   $ 
v3.23.3
LEASES (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of lease cost for operating leases
                
  

Three Months

Ended

September 30,

2023

  

Three Months

Ended

September 30,

2022

  

Nine Months

Ended

September 30,

2023

  

Nine Months

Ended

September 30,

2022

 
Lease Cost                    
Operating lease cost  $117,249   $107,534   $351,748   $406,786 
Short-term lease cost   30,751    75,015    120,271    208,009 
Variable lease cost                
Sublease income                
Total lease cost  $148,000   $182,549   $472,019   $614,795 
Schedule of supplemental cash flow information related to leases
        
   2023   2022 
Other Lease Information          
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flows from operating leases  $265,161   $269,836 
Amortization of right-of-use assets  $274,895   $342,112 
Schedule of lease- related assets and liabilities
        
  

September 30,

2023

  

December 31,

2022

 
Lease Position          
Operating Leases:          
Operating lease right-of-use assets  $1,231,092   $1,505,987 
Right-of-use liabilities operating leases short-term   423,849    391,117 
Right-of-use liabilities operating leases long-term   845,117    1,143,011 
Total operating lease liabilities  $1,268,966   $1,534,128 
Schedule of lease payments
    
Lease Term and Discount Rate  September 30, 2023 
Weighted-average remaining lease term (years):     
Operating leases   2.9 
Weighted-average discount rate:     
Operating leases   6.05% 
Schedule of maturities of lease liabilities
    
   Operating 
   Leases 
Remainder of 2023  $116,557 
2024   471,638 
2025   485,702 
2026   340,591 
Total future undiscounted lease payments   1,414,488 
Less: Interest   (145,522)
Present value of lease liabilities  $1,268,966 
v3.23.3
ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Sep. 18, 2023
Oct. 30, 2023
May 31, 2023
Aug. 31, 2022
Sep. 30, 2023
Debt Instrument [Line Items]          
Net proceeds from issuance of stock $ 571,400   $ 4,000,000    
Number of shares issued 280,000   1,200,000    
Stock price per share $ 2.50   $ 3.75    
Proceeds from warrant inducement transactions   $ 1,027,495      
Convertible Notes And Warrants [Member]          
Debt Instrument [Line Items]          
Proceeds from issuance of convertible notes       $ 22,300,000  
Additional Convertible Notes [Member]          
Debt Instrument [Line Items]          
Proceeds from issuance of convertible notes         $ 3,900,000
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
9 Months Ended
Sep. 30, 2023
Machinery and Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 3-7 years
Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 5 years
Internal Use Manufactured Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 1 year
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 5 years
Computer Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful life 3 years
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
9 Months Ended
Oct. 13, 2023
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]      
Reverse stock split reverse 1 for 5 stock split 1 for 5 reverse stock split  
Cash equivalents   $ 0 $ 0
v3.23.3
INVENTORY (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 3,561,150 $ 3,060,160
Work-in-process 0 439,839
Finished goods 3,490,387 2,145,884
Total inventory $ 7,051,537 $ 5,645,883
v3.23.3
INVENTORY (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Jun. 30, 2023
Sep. 30, 2023
Inventory Disclosure [Abstract]    
Contractual obligation   $ 252,548
Inventory wrote down $ 84,000 $ 1,622,262
v3.23.3
LONG - LIVED ASSETS (Details - Property and Equipment) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross $ 1,869,593 $ 1,107,272
Less: Accumulated depreciation (605,427) (505,506)
Total property and equipment 1,264,166 601,766
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross 1,011,351 352,137
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross 213,528 156,648
Internal Use Manufactured Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross 274,385 274,385
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross 90,768 50,768
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross 44,663 44,663
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment gross $ 234,898 $ 228,671
v3.23.3
LONG – LIVED ASSETS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 65,725 $ 265,907 $ 169,443 $ 569,757
v3.23.3
NOTES PAYABLE (Details - Debt maturities)
Sep. 30, 2023
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2023 $ 5,768
2024 23,073
2025 23,073
2026 23,073
2027 23,073
2028 12,927
2029 1,816
Total future payments 112,803
Less: Interest (24,794)
Total notes payable 88,009
Less current portion (14,910)
Long-term notes payable $ 73,099
v3.23.3
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended
Mar. 31, 2023
Apr. 30, 2021
Dec. 31, 2020
Financing Arrangement [Member] | Vehicles [Member]      
Debt Instrument [Line Items]      
Monthly payments $ 1,923    
Principal amount $ 96,024    
Financing Arrangement [Member] | Vehicles [Member] | Maximum [Member]      
Debt Instrument [Line Items]      
Interest rate 11.44%    
Financing Arrangement [Member] | Vehicles [Member] | Minimum [Member]      
Debt Instrument [Line Items]      
Interest rate 8.63%    
Vehicle Financing [Member]      
Debt Instrument [Line Items]      
Financing arrangement     $ 75,702
Interest rate     8.64%
Monthly payments     $ 1,211
Debt payment term     72 months
Vehicle Financing 1 [Member]      
Debt Instrument [Line Items]      
Financing arrangement   $ 30,942  
Interest rate   7.64%  
Monthly payments   $ 753  
Debt payment term   48 months  
v3.23.3
CONVERTIBLE NOTES (Details)
Sep. 30, 2023
USD ($)
New Notes [Member]  
Debt Instrument [Line Items]  
Fair value $ 4,410,058
Principal amount 4,934,783
Series A Exchange Notes [Member]  
Debt Instrument [Line Items]  
Fair value 3,298,012
Principal amount 3,690,422
Series B Exchange Notes [Member]  
Debt Instrument [Line Items]  
Fair value 20,986,449
Principal amount 23,483,891
Total May 2023 Notes [Member]  
Debt Instrument [Line Items]  
Fair value 28,694,519
Principal amount $ 32,109,096
v3.23.3
CONVERTIBLE NOTES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Oct. 13, 2023
May 24, 2023
Aug. 31, 2022
Aug. 24, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Oct. 31, 2023
Sep. 18, 2023
May 31, 2023
Debt Instrument [Line Items]                      
Interest rate       10.00% 14.90%   14.90%        
Exercise price     $ 5.45   $ 14.25   $ 14.25        
Net proceeds from convertible notes             $ 0 $ 15,122,345      
Cash on deposit         $ 5,000,000   $ 5,000,000        
Number of warrants exchanged         1,811,595   1,811,595        
Number of warrants issued     3,411,596                
Exercise price adjusted     $ 3.75                
Warrants expire date     Aug. 24, 2027                
Share price                   $ 2.50 $ 3.75
Equity issuance costs             $ 629,900 1,910,816      
Reverse stock split reverse 1 for 5 stock split           1 for 5 reverse stock split        
Loss on extinguishment         $ 0 $ 0 $ 22,296,988 $ 0      
Unamortized issuance costs         $ 1,330,296   $ 1,330,296        
Warrant Inducement Agreement [Member]                      
Debt Instrument [Line Items]                      
Exercise price         $ 1.75   $ 1.75        
Number of warrants exchanged         307,001   307,001        
IPO [Member]                      
Debt Instrument [Line Items]                      
Exercise price         $ 2.50   $ 2.50        
Sale of stock, shares   280,000         280,000        
Sale of stock, price per share   $ 2.50     2.50   $ 2.50        
Subsequent Event [Member]                      
Debt Instrument [Line Items]                      
Exercise price                 $ 1.369    
Note Warrants [Member]                      
Debt Instrument [Line Items]                      
Warrants issued shares       1,811,595              
Exercise price       $ 14.25              
Debt issuance costs             $ 22,300,321        
New Warrants [Member]                      
Debt Instrument [Line Items]                      
Warrants issued shares   1,086,957                  
Exercise price   $ 5.45                  
New Warrants And Exchange Warrants [Member]                      
Debt Instrument [Line Items]                      
Exercise price         1.369   $ 1.369        
Stock price   3.75                  
Floor price         0.22   0.22        
Share price   $ 3.75                  
Reload Warrants [Member]                      
Debt Instrument [Line Items]                      
Exercise price         $ 2.50   $ 2.50        
Number of warrants issued         307,001   307,001        
Warrants expire date             Aug. 24, 2027        
Equity issuance costs             $ 216,855        
Senior Convertible Notes [Member]                      
Debt Instrument [Line Items]                      
Aggregate principal amount       $ 27,173,913              
Conversion price       $ 11.25              
Number of shares issued if converted       2,415,459              
Interest rate       8.00%              
Convertible Notes [Member]                      
Debt Instrument [Line Items]                      
Interest rate       39.60%              
Net proceeds from convertible notes       $ 15,122,345              
Debt issuance costs       3,316,409              
Interest expense         $ 0   2,913,632        
Convertible Notes [Member] | Note Warrants [Member]                      
Debt Instrument [Line Items]                      
Net proceeds from convertible notes       6,561,247              
Debt issuance costs       $ 616,730              
Senior Convertible New Notes [Member]                      
Debt Instrument [Line Items]                      
Aggregate principal amount   $ 4,934,783                  
Conversion price   $ 12.70                  
Number of shares issued if converted   1,315,942                  
Interest rate   10.00%                  
Stock price   $ 3.75                  
Fully converted price per share   3.75                  
Conversion price   3.75                  
Floor price   $ 0.22                  
Original issue discount   8.80%                  
Series A Notes [Member]                      
Debt Instrument [Line Items]                      
Aggregate principal amount   $ 3,690,422                  
Conversion price   $ 3.75                  
Number of shares issued if converted   984,113                  
Series B Notes [Member]                      
Debt Instrument [Line Items]                      
Aggregate principal amount   $ 23,483,491                  
Conversion price   $ 3.75                  
Number of shares issued if converted   4,308,898                  
Stock price   $ 5.45                  
Number of shares issued if converted   6,262,265                  
May 2023 Notes [Member]                      
Debt Instrument [Line Items]                      
Conversion price   $ 2.75                  
Interest expense         $ 958,640   $ 1,364,993        
Number of shares issued if converted   11,675,892                  
New Notes And Exchange Notes [Member]                      
Debt Instrument [Line Items]                      
Conversion price         $ 1.369   $ 1.369        
New Notes And New Warrants [Member]                      
Debt Instrument [Line Items]                      
Debt issuance costs         $ 586,968   $ 586,968        
New Notes [Member]                      
Debt Instrument [Line Items]                      
Aggregate principal amount         4,934,783   4,934,783        
Interest expense         $ 172,194   $ 237,416        
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS (Details - Assumptions)
Aug. 03, 2023
May 24, 2023
Conversion Feature Liabilities [Member] | Measurement Input, Share Price [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 0.551 0.70
Conversion Feature Liabilities [Member] | Measurement Input, Price Volatility [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 84.1% 86.3%
Conversion Feature Liabilities [Member] | Measurement Input, Conversion Price [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 0.75 0.75
Conversion Feature Liabilities [Member] | Measurement Input, Expected Term [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 0.56 0.76
Conversion Feature Liabilities [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 5.4% 5.1%
Warrant Liabilities [Member] | Measurement Input, Share Price [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 0.551 0.70
Warrant Liabilities [Member] | Measurement Input, Price Volatility [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 115.0% 119.2%
Warrant Liabilities [Member] | Measurement Input, Conversion Price [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 0.75 0.75
Warrant Liabilities [Member] | Measurement Input, Expected Term [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 4.06 4.25
Warrant Liabilities [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Debt Conversion [Line Items]    
Fair value measurement input 4.3% 3.8%
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS (Details - Fair value of derivatives) - USD ($)
Aug. 03, 2023
May 24, 2023
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities $ 13,262,055 $ 18,369,849
Conversion Feature New Notes [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities 557,168 663,096
Conversion Feature Series A Exchange Notes [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities 416,672 970,805
Conversion Feature Series B Exchange Notes [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities 2,651,436 4,324,792
New Warrants [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities 2,445,244 3,123,682
Exchange Warrants [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Financial derivative liabilities $ 7,191,535 $ 9,287,474
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 03, 2023
Sep. 30, 2023
Sep. 30, 2023
May 2023 Notes [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized Gain (Loss) on Derivatives $ 690,290    
Unrealized Gain (Loss) on Derivatives (690,290)    
May 2023 Warrants [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Unrealized Gain (Loss) on Derivatives (2,333,417)    
Unrealized Gain (Loss) on Derivatives $ 2,333,417    
Derivative, Gain on Derivative   $ 5,296 $ 2,774,377
May 2023 Notes And May 2023 Warrants [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative, Gain on Derivative     $ 5,107,794
v3.23.3
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2021
Mar. 26, 2021
Mar. 25, 2021
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]              
Loss on termination of lease       $ 85,756 $ 85,756   $ 247,525
Amortization expense         0 $ 61,709  
Pink Possum [Member]              
Related Party Transaction [Line Items]              
Purchase orders and prepayments         $ 21,860    
Warrants issued, shares   950,000          
Exercise price   $ 4.90          
Highbridge [Member]              
Related Party Transaction [Line Items]              
Warrants issued, shares     1,250,000        
Exercise price     $ 4.90        
Number of shares issued 1,101,515            
v3.23.3
STOCKHOLDERS' EQUITY (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted average exercise price, Outstanding ending balance $ 14.25
Common Stock Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Shares, Outstanding beginning balance | shares 3,017,126
Weighted average exercise price, Outstanding beginning balance $ 11.67
Shares, Granted | shares 4,861,555
Weighted average exercise price, Granted $ 2.35
Shares, Canceled | shares 0
Weighted average exercise price, Canceled $ 0
Shares, Exchanged | shares (1,811,595)
Weighted average exercise price, Exchanged $ 14.25
Shares, Expired | shares 0
Weighted average exercise price, Expired $ 0
Shares, Exercised | shares (307,001)
Weighted average exercise price, Exercised $ 1.75
Shares, Outstanding ending balance | shares 5,760,085
Weighted average exercise price, Outstanding ending balance $ 3.61
Weighted average remaining life in years, Outstanding 4 years 6 months 7 days
Intrinsic value, Outstanding | $ $ 146,442
Shares, Exercisable | shares 5,760,085
Weighted average exercise price, Exercisable $ 3.61
Weighted average remaining life in years, Exercisable 4 years 6 months 7 days
Intrinsic value, Exercisable | $ $ 146,442
v3.23.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 18, 2023
May 24, 2023
Aug. 31, 2022
Feb. 01, 2022
May 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 14, 2023
Dec. 31, 2022
Aug. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized           250,000,000   250,000,000     100,000,000  
Common stock, par value           $ 0.00001   $ 0.00001     $ 0.00001  
Preferred stock, shares authorized           5,000,000   5,000,000     5,000,000  
Preferred stock, par value           $ 0.00001   $ 0.00001     $ 0.00001  
Proceeds from issuance of common stock $ 571,400       $ 4,000,000              
Exercise price     $ 5.45     $ 14.25   $ 14.25        
Number of shares reserved for future issuance           21,623,189   21,623,189        
Number of warrants issued     3,411,596                  
Warrants expire date     Aug. 24, 2027                  
Other expense               $ 2,223,356 $ 2,642,139      
Note Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price                       $ 14.25
Warrants issued shares                       1,811,595
Note Warrants [Member] | Placement Agent [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price                       $ 17.8125
Warrants issued shares                       120,773
Warrants and Rights Outstanding, Maturity Date                       Feb. 24, 2028
Common Stock Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price           $ 3.61   $ 3.61     $ 11.67  
Exchange of warrants exercised               307,001        
Warrants exercise price               $ 1.75        
Other expense           $ 0 $ 0 $ 0 $ 7,302      
Reload Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price           $ 2.50   $ 2.50        
Number of warrants issued           307,001   307,001        
Warrants expire date               Aug. 24, 2027        
Reserved For Conversion Of Notes And Exercise Of Warrants [Member] | May 2023 Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares reserved for future issuance           120,773   120,773        
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized                   250,000,000    
Common stock, par value                   $ 0.00001    
Number of shares sold, shares 280,000 1,200,000   1,333,334                
Share price $ 2.50 $ 3.75   $ 15.00                
Proceeds from issuance of common stock $ 571,400 $ 3,998,700   $ 18,089,184                
Commissions and expenses $ 128,600 $ 501,300   $ 1,910,816                
Warrant to purchase 56,000     66,667                
Exercise price $ 3.13     $ 18.75                
Expiration date 5 years 6 months     5 years 6 months                
Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Preferred stock, shares authorized                   5,000,000    
Preferred stock, par value                   $ 0.00001    
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Purchase of warrants         1,811,595              
Exchange warrants purchase         3,411,595              
Exercise price increase         $ 5.45              
Exercise price decrease         $ 3.75              
Warrants issued shares         1,086,957              
v3.23.3
STOCK-BASED COMPENSATION (Details - Restricted stock unit activity) - Restricted Stock Units (RSUs) [Member] - shares
9 Months Ended
May 15, 2022
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Outstanding, Beginning balance   15,000
Granted 5,000 0
Vested [1]   (5,000)
Cancelled   (5,000)
Outstanding, Ending balance   5,000
[1] 5,000 RSUs were subject to cancellation due to termination of employment. However, the Company entered into a modification to allow the employee to fully vest in these RSUs as part of a severance agreement. The Company recorded additional expense of $31,487 during the three months ended March 31, 2023 related to this modification.
v3.23.3
STOCK-BASED COMPENSATION (Details - Stock option activity) - Equity Option [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Offsetting Assets [Line Items]  
Common stock options shares, Outstanding beginning balance | shares 657,782
Common stock options weighted avarage exerice price, Outstanding beginning balance | $ / shares $ 15.41
Common stock options shares, Granted | shares 497,103
Common stock options weighted avarage exerice price, Granted | $ / shares $ 3.81
Common stock options shares, Forfeited | shares (149.885)
Common stock options weighted avarage exerice price, Forfeited | $ / shares $ 13.02
Common stock options shares, Exercised | shares (5,000)
Common stock options weighted avarage exerice price, Exercised | $ / shares $ 5.00
Common stock options shares, Outstanding ending balance | shares 1,000,016
Common stock options weighted avarage exerice price, Outstanding ending balance | $ / shares $ 10.06
Common stock options weighted average remaining life in years, Outstanding 8 years 11 months 23 days
Common stock options intrinsic value, Outstanding ending balance | $ $ 0
Common stock options shares, Exercisable | shares 399,024
Common stock options weighted avarage exerice price, Exercisable | $ / shares $ 12.93
Common stock options weighted average remaining life in years, Exercisable 8 years 4 months 13 days
Common stock options intrinsic value, Exercisable | $ $ 0
v3.23.3
STOCK-BASED COMPENSATION (Details - Stock based compensation) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stock-based compensation $ 540,528 $ 425,070 $ 2,223,356 $ 2,624,849
Cost Of Goods Sold [Member]        
Stock-based compensation 131,525 113,794 487,605 391,674
Sales And Marketing [Member]        
Stock-based compensation 134,073 106,478 678,945 568,333
Product Development [Member]        
Stock-based compensation 80,759 82,560 389,729 661,754
General And Administrative [Member]        
Stock-based compensation $ 194,171 $ 122,238 $ 667,077 $ 1,003,088
v3.23.3
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 06, 2023
May 15, 2022
Mar. 01, 2022
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jul. 26, 2022
Dec. 31, 2021
Jan. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Common stock shares reserved       21,623,189     21,623,189          
Stock based compensation             $ 2,223,356 $ 2,642,139        
Estimated life             6 years          
Equity Option [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Stock based compensation       $ 556,228   $ 389,745 $ 1,904,016 1,385,402        
Future compensation expense       2,136,860     $ 2,136,860          
Restricted Stock Units (RSUs) [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares approved for grants   5,000         0          
Stock based compensation       (15,700)   $ 35,325 $ 61,623 $ 1,232,135        
Future compensation expense       $ 3,925     $ 3,925          
Performance Based Shares [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares approved for grants     8,925                  
Stock based compensation     $ 82,050                  
Volcon 2021 Plan [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Common stock shares reserved                   800,000   600,000
Number of shares granted       251,351     251,351          
Volcon 2021 Plan [Member] | Performance Milestones For 2022 [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares approved for grants 30,997                      
Stock based compensation         $ 257,717              
Shares reserved for compensation                 50,000      
Number of shares issued 27,772                      
Number of shares forfeited 132                      
Shares withheld for employee withholding taxes 3,093                      
Volcon 2021 Plan [Member] | Performance Milestones For 2023 [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Shares reserved for compensation       50,000     50,000          
Volcon 2021 Plan [Member] | Performance Based Shares [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares granted                     576  
v3.23.3
LOSS PER COMMON SHARE (Details - Earnings Per Share) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:        
Net loss $ (11,327,896) $ (7,899,184) $ (41,655,559) $ (26,437,991)
Denominator:        
Denominator for basic net loss per common share - weighted average of common shares 6,162,589 4,869,044 5,502,512 4,690,805
Denominator for diluted net loss per common share - weighted average of common shares 6,162,589 4,869,044 5,502,512 4,690,805
Basic net loss per common share $ (1.84) $ (1.62) $ (7.57) $ (5.64)
Diluted net loss per common share $ (1.84) $ (1.62) $ (7.57) $ (5.64)
v3.23.3
LOSS PER COMMON SHARE (Details - Antidilutive shares) - shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 18,440,993 6,144,150
Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 11,675,892 2,415,459
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 5,760,085 3,017,124
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 1,000,016 681,567
Restricted Stock Units (RSUs) [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 5,000 30,000
v3.23.3
INCOME TAXES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Deferred tax assets    
Net operating losses $ 12,016,943 $ 9,106,430
Depreciation and intangible assets 1,770,632 1,502,868
Debt basis difference 5,029,077 0
Research & development credit 1,457,768 1,308,956
Lease liability 266,483 322,167
Inventory 1,249,375 1,290,968
Stock-based compensation 3,259,583 3,103,037
Accrued expenses 154,650 233,284
Capital loss carryover 276,522 261,922
Other 222,062 177,074
Total 25,703,095 17,306,705
Valuation allowance (25,244,039) (16,661,612)
Net deferred tax asset 459,056 645,093
Deferred tax liabilities    
Prepaid expenses (200,526) (328,836)
Right-of-use assets (258,530) (316,257)
Total net deferred taxes deferred tax liabilities $ 0 $ 0
v3.23.3
INCOME TAXES (Details Narrative)
$ in Millions
Sep. 30, 2023
USD ($)
Income Tax Disclosure [Abstract]  
Cumulative net operating loss carry forward $ 57.2
v3.23.3
LEASES (Details - Lease cost) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Lease Cost        
Operating lease cost $ 117,249 $ 107,534 $ 351,748 $ 406,786
Short-term lease cost 30,751 75,015 120,271 208,009
Variable lease cost 0 0 0 0
Sublease income 0 0 0 0
Total lease cost $ 148,000 $ 182,549 $ 472,019 $ 614,795
v3.23.3
LEASES (Details - Supplemental cash flow information related to leases) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases $ 265,161 $ 269,836
Amortization of right-of-use assets $ 274,895 $ 342,112
v3.23.3
LEASES (Details - Lease-related assets and liabilities) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Operating Leases:    
Operating lease right-of-use assets $ 1,231,092 $ 1,505,987
Right-of-use liabilities operating leases short-term 423,849 391,117
Right-of-use liabilities operating leases long-term 845,117 1,143,011
Total operating lease liabilities $ 1,268,966 $ 1,534,128
v3.23.3
LEASES (Details - Other information)
Sep. 30, 2023
Leases [Abstract]  
Weighted-average remaining lease term operating leases 2 years 10 months 24 days
Weighted-average discount rate operating leases 6.05%
v3.23.3
LEASES (Details - Maturities of lease liabilities)
Sep. 30, 2023
USD ($)
Leases [Abstract]  
Remainder of 2023 $ 116,557
2024 471,638
2025 485,702
2026 340,591
Total future undiscounted lease payments 1,414,488
Less: Interest (145,522)
Present value of lease liabilities $ 1,268,966

Volcon (NASDAQ:VLCN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Volcon Charts.
Volcon (NASDAQ:VLCN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Volcon Charts.